NodeType: Pathway | PathwayName: Regulation of innate immune responses to cytosolic DNA | PathwayId: R-HSA-3134975
NodeType: Pathway | PathwayName: Regulation of insulin secretion | PathwayId: R-HSA-422356
NodeType: Pathway | PathwayName: Regulation of lipid metabolism by PPARalpha | PathwayId: R-HSA-400206
NodeType: Pathway | PathwayName: Regulation of localization of FOXO transcription factors | PathwayId: R-HSA-9614399
NodeType: Pathway | PathwayName: Regulation of mRNA stability by proteins that bind AU-rich elements | PathwayId: R-HSA-450531
NodeType: Pathway | PathwayName: Regulation of mitotic cell cycle | PathwayId: R-HSA-453276
NodeType: Pathway | PathwayName: Regulation of necroptotic cell death | PathwayId: R-HSA-5675482
NodeType: Pathway | PathwayName: Regulation of ornithine decarboxylase (ODC) | PathwayId: R-HSA-350562
NodeType: Pathway | PathwayName: Regulation of pyruvate dehydrogenase (PDH) complex | PathwayId: R-HSA-204174
NodeType: Pathway | PathwayName: Regulation of pyruvate metabolism | PathwayId: R-HSA-9861718
NodeType: Pathway | PathwayName: Regulation of signaling by CBL | PathwayId: R-HSA-912631
NodeType: Pathway | PathwayName: Regulation of signaling by NODAL | PathwayId: R-HSA-1433617
NodeType: Pathway | PathwayName: Regulation of the apoptosome activity | PathwayId: R-HSA-9627069
NodeType: Pathway | PathwayName: Regulation of thyroid hormone activity | PathwayId: R-HSA-350864
NodeType: Pathway | PathwayName: Relaxin receptors | PathwayId: R-HSA-444821
NodeType: Pathway | PathwayName: Release | PathwayId: R-HSA-168298
NodeType: Pathway | PathwayName: Release of Hh-Np from the secreting cell | PathwayId: R-HSA-5362798
NodeType: Pathway | PathwayName: Release of apoptotic factors from the mitochondria | PathwayId: R-HSA-111457
NodeType: Pathway | PathwayName: Removal of aminoterminal propeptides from gamma-carboxylated proteins | PathwayId: R-HSA-159782
NodeType: Pathway | PathwayName: Removal of the Flap Intermediate | PathwayId: R-HSA-69166
NodeType: Pathway | PathwayName: Removal of the Flap Intermediate from the C-strand | PathwayId: R-HSA-174437
NodeType: Pathway | PathwayName: Replacement of protamines by nucleosomes in the male pronucleus | PathwayId: R-HSA-9821993
NodeType: Pathway | PathwayName: Replication of the SARS-CoV-1 genome | PathwayId: R-HSA-9682706
NodeType: Pathway | PathwayName: Replication of the SARS-CoV-2 genome | PathwayId: R-HSA-9694686
NodeType: Pathway | PathwayName: Repression of WNT target genes | PathwayId: R-HSA-4641265
NodeType: Pathway | PathwayName: Reproduction | PathwayId: R-HSA-1474165
NodeType: Pathway | PathwayName: Resistance of ERBB2 KD mutants to AEE788 | PathwayId: R-HSA-9665250
NodeType: Pathway | PathwayName: Resistance of ERBB2 KD mutants to afatinib | PathwayId: R-HSA-9665249
NodeType: Pathway | PathwayName: Resistance of ERBB2 KD mutants to lapatinib | PathwayId: R-HSA-9665251
NodeType: Pathway | PathwayName: Resistance of ERBB2 KD mutants to neratinib | PathwayId: R-HSA-9665246
NodeType: Pathway | PathwayName: Resistance of ERBB2 KD mutants to osimertinib | PathwayId: R-HSA-9665247
NodeType: Pathway | PathwayName: Resistance of ERBB2 KD mutants to sapitinib | PathwayId: R-HSA-9665244
NodeType: Pathway | PathwayName: Resistance of ERBB2 KD mutants to tesevatinib | PathwayId: R-HSA-9665245
NodeType: Pathway | PathwayName: Resistance of ERBB2 KD mutants to trastuzumab | PathwayId: R-HSA-9665233
NodeType: Pathway | PathwayName: Resolution of AP sites via the multiple-nucleotide patch replacement pathway | PathwayId: R-HSA-110373
NodeType: Pathway | PathwayName: Resolution of AP sites via the single-nucleotide replacement pathway | PathwayId: R-HSA-110381
NodeType: Pathway | PathwayName: Resolution of Abasic Sites (AP sites) | PathwayId: R-HSA-73933
NodeType: Pathway | PathwayName: Resolution of D-Loop Structures | PathwayId: R-HSA-5693537
NodeType: Pathway | PathwayName: Resolution of D-loop Structures through Holliday Junction Intermediates | PathwayId: R-HSA-5693568
NodeType: Pathway | PathwayName: Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | PathwayId: R-HSA-5693554
NodeType: Pathway | PathwayName: Resolution of Sister Chromatid Cohesion | PathwayId: R-HSA-2500257
NodeType: Pathway | PathwayName: Respiratory Syncytial Virus Infection Pathway | PathwayId: R-HSA-9820952
NodeType: Pathway | PathwayName: Respiratory electron transport | PathwayId: R-HSA-611105
NodeType: Pathway | PathwayName: Respiratory syncytial virus (RSV) attachment and entry | PathwayId: R-HSA-9820960
NodeType: Pathway | PathwayName: Respiratory syncytial virus (RSV) genome replication, transcription and translation | PathwayId: R-HSA-9820965
NodeType: Pathway | PathwayName: Respiratory syncytial virus genome replication | PathwayId: R-HSA-9834752
NodeType: Pathway | PathwayName: Respiratory syncytial virus genome transcription | PathwayId: R-HSA-9828642
NodeType: Pathway | PathwayName: Response of EIF2AK1 (HRI) to heme deficiency | PathwayId: R-HSA-9648895
NodeType: Pathway | PathwayName: Response of EIF2AK4 (GCN2) to amino acid deficiency | PathwayId: R-HSA-9633012
NodeType: Pathway | PathwayName: Response of Mtb to phagocytosis | PathwayId: R-HSA-9637690
NodeType: Pathway | PathwayName: Response to elevated platelet cytosolic Ca2+ | PathwayId: R-HSA-76005
NodeType: Pathway | PathwayName: Response to metal ions | PathwayId: R-HSA-5660526
NodeType: Pathway | PathwayName: Retinoid cycle disease events | PathwayId: R-HSA-2453864
NodeType: Pathway | PathwayName: Retinoid metabolism and transport | PathwayId: R-HSA-975634
NodeType: Pathway | PathwayName: Retinoid metabolism disease events | PathwayId: R-HSA-6809583
NodeType: Pathway | PathwayName: Retrograde neurotrophin signalling | PathwayId: R-HSA-177504
NodeType: Pathway | PathwayName: Retrograde transport at the Trans-Golgi-Network | PathwayId: R-HSA-6811440
NodeType: Pathway | PathwayName: Reuptake of GABA | PathwayId: R-HSA-888593
NodeType: Pathway | PathwayName: Rev-mediated nuclear export of HIV RNA | PathwayId: R-HSA-165054
NodeType: Pathway | PathwayName: Reversal of alkylation damage by DNA dioxygenases | PathwayId: R-HSA-73943
NodeType: Pathway | PathwayName: Reverse Transcription of HIV RNA | PathwayId: R-HSA-162589
NodeType: Pathway | PathwayName: Reversible DNA damage induced by alkylating chemotherapeutic drugs | PathwayId: R-HSA-9729902
NodeType: Pathway | PathwayName: Reversible hydration of carbon dioxide | PathwayId: R-HSA-1475029
NodeType: Pathway | PathwayName: Rhesus blood group biosynthesis | PathwayId: R-HSA-9037628
NodeType: Pathway | PathwayName: Rhesus glycoproteins mediate ammonium transport. | PathwayId: R-HSA-444411
NodeType: Pathway | PathwayName: Ribavirin ADME | PathwayId: R-HSA-9755088
NodeType: Pathway | PathwayName: Ribosomal scanning and start codon recognition | PathwayId: R-HSA-72702
NodeType: Pathway | PathwayName: Role of ABL in ROBO-SLIT signaling | PathwayId: R-HSA-428890
NodeType: Pathway | PathwayName: Role of LAT2/NTAL/LAB on calcium mobilization | PathwayId: R-HSA-2730905
NodeType: Pathway | PathwayName: Role of phospholipids in phagocytosis | PathwayId: R-HSA-2029485
NodeType: Pathway | PathwayName: Role of second messengers in netrin-1 signaling | PathwayId: R-HSA-418890
NodeType: Pathway | PathwayName: S Phase | PathwayId: R-HSA-69242
NodeType: Pathway | PathwayName: SARS-CoV Infections | PathwayId: R-HSA-9679506
NodeType: Pathway | PathwayName: SARS-CoV-1 Genome Replication and Transcription | PathwayId: R-HSA-9679514
NodeType: Pathway | PathwayName: SARS-CoV-1 Infection | PathwayId: R-HSA-9678108
NodeType: Pathway | PathwayName: SARS-CoV-1 activates/modulates innate immune responses | PathwayId: R-HSA-9692916
NodeType: Pathway | PathwayName: SARS-CoV-1 modulates host translation machinery | PathwayId: R-HSA-9735869
NodeType: Pathway | PathwayName: SARS-CoV-1 targets PDZ proteins in cell-cell junction | PathwayId: R-HSA-9692912
NodeType: Pathway | PathwayName: SARS-CoV-1 targets host intracellular signalling and regulatory pathways | PathwayId: R-HSA-9735871
NodeType: Pathway | PathwayName: SARS-CoV-1-host interactions | PathwayId: R-HSA-9692914
NodeType: Pathway | PathwayName: SARS-CoV-1-mediated effects on programmed cell death | PathwayId: R-HSA-9692913
NodeType: Pathway | PathwayName: SARS-CoV-2 Genome Replication and Transcription | PathwayId: R-HSA-9694682
NodeType: Pathway | PathwayName: SARS-CoV-2 Infection | PathwayId: R-HSA-9694516
NodeType: Pathway | PathwayName: SARS-CoV-2 activates/modulates innate and adaptive immune responses | PathwayId: R-HSA-9705671
NodeType: Pathway | PathwayName: SARS-CoV-2 modulates autophagy | PathwayId: R-HSA-9754560
NodeType: Pathway | PathwayName: SARS-CoV-2 modulates host translation machinery | PathwayId: R-HSA-9754678
NodeType: Pathway | PathwayName: SARS-CoV-2 targets PDZ proteins in cell-cell junction | PathwayId: R-HSA-9705677
NodeType: Pathway | PathwayName: SARS-CoV-2 targets host intracellular signalling and regulatory pathways | PathwayId: R-HSA-9755779
NodeType: Pathway | PathwayName: SARS-CoV-2-host interactions | PathwayId: R-HSA-9705683
NodeType: Pathway | PathwayName: SCF(Skp2)-mediated degradation of p27/p21 | PathwayId: R-HSA-187577
NodeType: Pathway | PathwayName: SCF-beta-TrCP mediated degradation of Emi1 | PathwayId: R-HSA-174113
NodeType: Pathway | PathwayName: SDK interactions | PathwayId: R-HSA-373756
NodeType: Pathway | PathwayName: SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | PathwayId: R-HSA-399955
NodeType: Pathway | PathwayName: SHC-mediated cascade:FGFR1 | PathwayId: R-HSA-5654688
NodeType: Pathway | PathwayName: SHC-mediated cascade:FGFR2 | PathwayId: R-HSA-5654699
NodeType: Pathway | PathwayName: SHC-mediated cascade:FGFR3 | PathwayId: R-HSA-5654704
NodeType: Pathway | PathwayName: SHC-mediated cascade:FGFR4 | PathwayId: R-HSA-5654719
NodeType: Pathway | PathwayName: SHC-related events triggered by IGF1R | PathwayId: R-HSA-2428933
NodeType: Pathway | PathwayName: SHC1 events in EGFR signaling | PathwayId: R-HSA-180336
NodeType: Pathway | PathwayName: SHC1 events in ERBB2 signaling | PathwayId: R-HSA-1250196
NodeType: Pathway | PathwayName: SHC1 events in ERBB4 signaling | PathwayId: R-HSA-1250347
NodeType: Pathway | PathwayName: SHOC2 M1731 mutant abolishes MRAS complex function | PathwayId: R-HSA-9726840
NodeType: Pathway | PathwayName: SIRT1 negatively regulates rRNA expression | PathwayId: R-HSA-427359
NodeType: Pathway | PathwayName: SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | PathwayId: R-HSA-77588
NodeType: Pathway | PathwayName: SLBP independent Processing of Histone Pre-mRNAs | PathwayId: R-HSA-111367
NodeType: Pathway | PathwayName: SLC transporter disorders | PathwayId: R-HSA-5619102
NodeType: Pathway | PathwayName: SLC-mediated transmembrane transport | PathwayId: R-HSA-425407
NodeType: Pathway | PathwayName: SLC15A4:TASL-dependent IRF5 activation | PathwayId: R-HSA-9860276
NodeType: Pathway | PathwayName: SLIT2:ROBO1 increases RHOA activity | PathwayId: R-HSA-8985586
NodeType: Pathway | PathwayName: SMAC (DIABLO) binds to IAPs | PathwayId: R-HSA-111463
NodeType: Pathway | PathwayName: SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | PathwayId: R-HSA-111464
NodeType: Pathway | PathwayName: SMAC, XIAP-regulated apoptotic response | PathwayId: R-HSA-111469
NodeType: Pathway | PathwayName: SMAD2/3 MH2 Domain Mutants in Cancer | PathwayId: R-HSA-3315487
NodeType: Pathway | PathwayName: SMAD2/3 Phosphorylation Motif Mutants in Cancer | PathwayId: R-HSA-3304356
NodeType: Pathway | PathwayName: SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | PathwayId: R-HSA-2173796
NodeType: Pathway | PathwayName: SMAD4 MH2 Domain Mutants in Cancer | PathwayId: R-HSA-3311021
NodeType: Pathway | PathwayName: SOS-mediated signalling | PathwayId: R-HSA-112412
NodeType: Pathway | PathwayName: SRP-dependent cotranslational protein targeting to membrane | PathwayId: R-HSA-1799339
NodeType: Pathway | PathwayName: STAT3 nuclear events downstream of ALK signaling | PathwayId: R-HSA-9701898
NodeType: Pathway | PathwayName: STAT5 Activation | PathwayId: R-HSA-9645135
NodeType: Pathway | PathwayName: STAT5 activation downstream of FLT3 ITD mutants | PathwayId: R-HSA-9702518
NodeType: Pathway | PathwayName: STAT6-mediated induction of chemokines | PathwayId: R-HSA-3249367
NodeType: Pathway | PathwayName: STING mediated induction of host immune responses | PathwayId: R-HSA-1834941
NodeType: Pathway | PathwayName: SUMO E3 ligases SUMOylate target proteins | PathwayId: R-HSA-3108232
NodeType: Pathway | PathwayName: SUMO is conjugated to E1 (UBA2:SAE1) | PathwayId: R-HSA-3065676
NodeType: Pathway | PathwayName: SUMO is proteolytically processed | PathwayId: R-HSA-3065679
NodeType: Pathway | PathwayName: SUMO is transferred from E1 to E2 (UBE2I, UBC9) | PathwayId: R-HSA-3065678
NodeType: Pathway | PathwayName: SUMOylation | PathwayId: R-HSA-2990846
NodeType: Pathway | PathwayName: SUMOylation of DNA damage response and repair proteins | PathwayId: R-HSA-3108214
NodeType: Pathway | PathwayName: SUMOylation of DNA methylation proteins | PathwayId: R-HSA-4655427
NodeType: Pathway | PathwayName: SUMOylation of DNA replication proteins | PathwayId: R-HSA-4615885
NodeType: Pathway | PathwayName: SUMOylation of RNA binding proteins | PathwayId: R-HSA-4570464
NodeType: Pathway | PathwayName: SUMOylation of SUMOylation proteins | PathwayId: R-HSA-4085377
NodeType: Pathway | PathwayName: SUMOylation of chromatin organization proteins | PathwayId: R-HSA-4551638
NodeType: Pathway | PathwayName: SUMOylation of immune response proteins | PathwayId: R-HSA-4755510
NodeType: Pathway | PathwayName: SUMOylation of intracellular receptors | PathwayId: R-HSA-4090294
NodeType: Pathway | PathwayName: SUMOylation of nuclear envelope proteins | PathwayId: R-HSA-9793242
NodeType: Pathway | PathwayName: SUMOylation of transcription cofactors | PathwayId: R-HSA-3899300
NodeType: Pathway | PathwayName: SUMOylation of transcription factors | PathwayId: R-HSA-3232118
NodeType: Pathway | PathwayName: SUMOylation of ubiquitinylation proteins | PathwayId: R-HSA-3232142
NodeType: Pathway | PathwayName: Scavenging by Class A Receptors | PathwayId: R-HSA-3000480
NodeType: Pathway | PathwayName: Scavenging by Class B Receptors | PathwayId: R-HSA-3000471
NodeType: Pathway | PathwayName: Scavenging by Class F Receptors | PathwayId: R-HSA-3000484
NodeType: Pathway | PathwayName: Scavenging by Class H Receptors | PathwayId: R-HSA-3000497
NodeType: Pathway | PathwayName: Scavenging of heme from plasma | PathwayId: R-HSA-2168880
NodeType: Pathway | PathwayName: Sealing of the nuclear envelope (NE) by ESCRT-III | PathwayId: R-HSA-9668328
NodeType: Pathway | PathwayName: Selective autophagy | PathwayId: R-HSA-9663891
NodeType: Pathway | PathwayName: Selenoamino acid metabolism | PathwayId: R-HSA-2408522
NodeType: Pathway | PathwayName: Selenocysteine synthesis | PathwayId: R-HSA-2408557
NodeType: Pathway | PathwayName: Sema3A PAK dependent Axon repulsion | PathwayId: R-HSA-399954
NodeType: Pathway | PathwayName: Sema4D in semaphorin signaling | PathwayId: R-HSA-400685
NodeType: Pathway | PathwayName: Sema4D induced cell migration and growth-cone collapse | PathwayId: R-HSA-416572
NodeType: Pathway | PathwayName: Sema4D mediated inhibition of cell attachment and migration | PathwayId: R-HSA-416550
NodeType: Pathway | PathwayName: Semaphorin interactions | PathwayId: R-HSA-373755
NodeType: Pathway | PathwayName: Senescence-Associated Secretory Phenotype (SASP) | PathwayId: R-HSA-2559582
NodeType: Pathway | PathwayName: Sensing of DNA Double Strand Breaks | PathwayId: R-HSA-5693548
NodeType: Pathway | PathwayName: Sensory Perception | PathwayId: R-HSA-9709957
NodeType: Pathway | PathwayName: Sensory perception of salty taste | PathwayId: R-HSA-9730628
NodeType: Pathway | PathwayName: Sensory perception of sour taste | PathwayId: R-HSA-9729555
NodeType: Pathway | PathwayName: Sensory perception of sweet, bitter, and umami (glutamate) taste | PathwayId: R-HSA-9717207
NodeType: Pathway | PathwayName: Sensory perception of taste | PathwayId: R-HSA-9717189
NodeType: Pathway | PathwayName: Sensory processing of sound | PathwayId: R-HSA-9659379
NodeType: Pathway | PathwayName: Sensory processing of sound by inner hair cells of the cochlea | PathwayId: R-HSA-9662360
NodeType: Pathway | PathwayName: Sensory processing of sound by outer hair cells of the cochlea | PathwayId: R-HSA-9662361
NodeType: Pathway | PathwayName: Separation of Sister Chromatids | PathwayId: R-HSA-2467813
NodeType: Pathway | PathwayName: Serine biosynthesis | PathwayId: R-HSA-977347
NodeType: Pathway | PathwayName: Serotonin Neurotransmitter Release Cycle | PathwayId: R-HSA-181429
NodeType: Pathway | PathwayName: Serotonin and melatonin biosynthesis | PathwayId: R-HSA-209931
NodeType: Pathway | PathwayName: Serotonin clearance from the synaptic cleft | PathwayId: R-HSA-380615
NodeType: Pathway | PathwayName: Serotonin receptors | PathwayId: R-HSA-390666
NodeType: Pathway | PathwayName: Severe congenital neutropenia type 4 (G6PC3) | PathwayId: R-HSA-3282872
NodeType: Pathway | PathwayName: Sialic acid metabolism | PathwayId: R-HSA-4085001
NodeType: Pathway | PathwayName: Signal Transduction | PathwayId: R-HSA-162582
NodeType: Pathway | PathwayName: Signal amplification | PathwayId: R-HSA-392518
NodeType: Pathway | PathwayName: Signal attenuation | PathwayId: R-HSA-74749
NodeType: Pathway | PathwayName: Signal regulatory protein family interactions | PathwayId: R-HSA-391160
NodeType: Pathway | PathwayName: Signal transduction by L1 | PathwayId: R-HSA-445144
NodeType: Pathway | PathwayName: Signaling by ALK | PathwayId: R-HSA-201556
NodeType: Pathway | PathwayName: Signaling by ALK fusions and activated point mutants | PathwayId: R-HSA-9725370
NodeType: Pathway | PathwayName: Signaling by ALK in cancer | PathwayId: R-HSA-9700206
NodeType: Pathway | PathwayName: Signaling by AMER1 mutants | PathwayId: R-HSA-4839748
NodeType: Pathway | PathwayName: Signaling by APC mutants | PathwayId: R-HSA-4839744
NodeType: Pathway | PathwayName: Signaling by AXIN mutants | PathwayId: R-HSA-4839735
NodeType: Pathway | PathwayName: Signaling by Activin | PathwayId: R-HSA-1502540
NodeType: Pathway | PathwayName: Signaling by BMP | PathwayId: R-HSA-201451
NodeType: Pathway | PathwayName: Signaling by BRAF and RAF1 fusions | PathwayId: R-HSA-6802952
NodeType: Pathway | PathwayName: Signaling by CSF1 (M-CSF) in myeloid cells | PathwayId: R-HSA-9680350
NodeType: Pathway | PathwayName: Signaling by CSF3 (G-CSF) | PathwayId: R-HSA-9674555
NodeType: Pathway | PathwayName: Signaling by CTNNB1 phospho-site mutants | PathwayId: R-HSA-4839743
NodeType: Pathway | PathwayName: Signaling by EGFR | PathwayId: R-HSA-177929
NodeType: Pathway | PathwayName: Signaling by EGFR in Cancer | PathwayId: R-HSA-1643713
NodeType: Pathway | PathwayName: Signaling by EGFRvIII in Cancer | PathwayId: R-HSA-5637812
NodeType: Pathway | PathwayName: Signaling by ERBB2 | PathwayId: R-HSA-1227986
NodeType: Pathway | PathwayName: Signaling by ERBB2 ECD mutants | PathwayId: R-HSA-9665348
NodeType: Pathway | PathwayName: Signaling by ERBB2 KD Mutants | PathwayId: R-HSA-9664565
NodeType: Pathway | PathwayName: Signaling by ERBB2 TMD/JMD mutants | PathwayId: R-HSA-9665686
NodeType: Pathway | PathwayName: Signaling by ERBB2 in Cancer | PathwayId: R-HSA-1227990
NodeType: Pathway | PathwayName: Signaling by ERBB4 | PathwayId: R-HSA-1236394
NodeType: Pathway | PathwayName: Signaling by Erythropoietin | PathwayId: R-HSA-9006335
NodeType: Pathway | PathwayName: Signaling by FGFR | PathwayId: R-HSA-190236
NodeType: Pathway | PathwayName: Signaling by FGFR in disease | PathwayId: R-HSA-1226099
NodeType: Pathway | PathwayName: Signaling by FGFR1 | PathwayId: R-HSA-5654736
NodeType: Pathway | PathwayName: Signaling by FGFR1 amplification mutants | PathwayId: R-HSA-1839120
NodeType: Pathway | PathwayName: Signaling by FGFR1 in disease | PathwayId: R-HSA-5655302
NodeType: Pathway | PathwayName: Signaling by FGFR2 | PathwayId: R-HSA-5654738
NodeType: Pathway | PathwayName: Signaling by FGFR2 IIIa TM | PathwayId: R-HSA-8851708
NodeType: Pathway | PathwayName: Signaling by FGFR2 amplification mutants | PathwayId: R-HSA-2023837
NodeType: Pathway | PathwayName: Signaling by FGFR2 fusions | PathwayId: R-HSA-8853333
NodeType: Pathway | PathwayName: Signaling by FGFR2 in disease | PathwayId: R-HSA-5655253
NodeType: Pathway | PathwayName: Signaling by FGFR3 | PathwayId: R-HSA-5654741
NodeType: Pathway | PathwayName: Signaling by FGFR3 fusions in cancer | PathwayId: R-HSA-8853334
NodeType: Pathway | PathwayName: Signaling by FGFR3 in disease | PathwayId: R-HSA-5655332
NodeType: Pathway | PathwayName: Signaling by FGFR4 | PathwayId: R-HSA-5654743
NodeType: Pathway | PathwayName: Signaling by FGFR4 in disease | PathwayId: R-HSA-5655291
NodeType: Pathway | PathwayName: Signaling by FLT3 ITD and TKD mutants | PathwayId: R-HSA-9703648
NodeType: Pathway | PathwayName: Signaling by FLT3 fusion proteins | PathwayId: R-HSA-9703465
NodeType: Pathway | PathwayName: Signaling by GPCR | PathwayId: R-HSA-372790
NodeType: Pathway | PathwayName: Signaling by GSK3beta mutants | PathwayId: R-HSA-5339716
NodeType: Pathway | PathwayName: Signaling by Hedgehog | PathwayId: R-HSA-5358351
NodeType: Pathway | PathwayName: Signaling by Hippo | PathwayId: R-HSA-2028269
NodeType: Pathway | PathwayName: Signaling by Insulin receptor | PathwayId: R-HSA-74752
NodeType: Pathway | PathwayName: Signaling by Interleukins | PathwayId: R-HSA-449147
NodeType: Pathway | PathwayName: Signaling by KIT in disease | PathwayId: R-HSA-9669938
NodeType: Pathway | PathwayName: Signaling by LRP5 mutants | PathwayId: R-HSA-5339717
NodeType: Pathway | PathwayName: Signaling by LTK | PathwayId: R-HSA-9842663
NodeType: Pathway | PathwayName: Signaling by LTK in cancer | PathwayId: R-HSA-9842640
NodeType: Pathway | PathwayName: Signaling by Leptin | PathwayId: R-HSA-2586552
NodeType: Pathway | PathwayName: Signaling by Ligand-Responsive EGFR Variants in Cancer | PathwayId: R-HSA-5637815
NodeType: Pathway | PathwayName: Signaling by MAP2K mutants | PathwayId: R-HSA-9652169
NodeType: Pathway | PathwayName: Signaling by MAPK mutants | PathwayId: R-HSA-9652817
NodeType: Pathway | PathwayName: Signaling by MET | PathwayId: R-HSA-6806834
NodeType: Pathway | PathwayName: Signaling by MRAS-complex mutants | PathwayId: R-HSA-9660537
NodeType: Pathway | PathwayName: Signaling by MST1 | PathwayId: R-HSA-8852405
NodeType: Pathway | PathwayName: Signaling by NODAL | PathwayId: R-HSA-1181150
NodeType: Pathway | PathwayName: Signaling by NOTCH | PathwayId: R-HSA-157118
NodeType: Pathway | PathwayName: Signaling by NOTCH1 | PathwayId: R-HSA-1980143
NodeType: Pathway | PathwayName: Signaling by NOTCH1 HD Domain Mutants in Cancer | PathwayId: R-HSA-2691230
NodeType: Pathway | PathwayName: Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | PathwayId: R-HSA-2894858
NodeType: Pathway | PathwayName: Signaling by NOTCH1 PEST Domain Mutants in Cancer | PathwayId: R-HSA-2644602
NodeType: Pathway | PathwayName: Signaling by NOTCH1 in Cancer | PathwayId: R-HSA-2644603
NodeType: Pathway | PathwayName: Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | PathwayId: R-HSA-2660825
NodeType: Pathway | PathwayName: Signaling by NOTCH2 | PathwayId: R-HSA-1980145
NodeType: Pathway | PathwayName: Signaling by NOTCH3 | PathwayId: R-HSA-9012852
NodeType: Pathway | PathwayName: Signaling by NOTCH4 | PathwayId: R-HSA-9013694
NodeType: Pathway | PathwayName: Signaling by NTRK1 (TRKA) | PathwayId: R-HSA-187037
NodeType: Pathway | PathwayName: Signaling by NTRK2 (TRKB) | PathwayId: R-HSA-9006115
NodeType: Pathway | PathwayName: Signaling by NTRK3 (TRKC) | PathwayId: R-HSA-9034015
NodeType: Pathway | PathwayName: Signaling by NTRKs | PathwayId: R-HSA-166520
NodeType: Pathway | PathwayName: Signaling by Non-Receptor Tyrosine Kinases | PathwayId: R-HSA-9006927
NodeType: Pathway | PathwayName: Signaling by Nuclear Receptors | PathwayId: R-HSA-9006931
NodeType: Pathway | PathwayName: Signaling by Overexpressed Wild-Type EGFR in Cancer | PathwayId: R-HSA-5638302
NodeType: Pathway | PathwayName: Signaling by PDGF | PathwayId: R-HSA-186797
NodeType: Pathway | PathwayName: Signaling by PDGFR in disease | PathwayId: R-HSA-9671555
NodeType: Pathway | PathwayName: Signaling by PDGFRA extracellular domain mutants | PathwayId: R-HSA-9673770
NodeType: Pathway | PathwayName: Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | PathwayId: R-HSA-9673767
NodeType: Pathway | PathwayName: Signaling by PTK6 | PathwayId: R-HSA-8848021
NodeType: Pathway | PathwayName: Signaling by RAF1 mutants | PathwayId: R-HSA-9656223
NodeType: Pathway | PathwayName: Signaling by RAS GAP mutants | PathwayId: R-HSA-9753510
NodeType: Pathway | PathwayName: Signaling by RAS GTPase mutants | PathwayId: R-HSA-9753512
NodeType: Pathway | PathwayName: Signaling by RAS mutants | PathwayId: R-HSA-6802949
NodeType: Pathway | PathwayName: Signaling by RNF43 mutants | PathwayId: R-HSA-5340588
NodeType: Pathway | PathwayName: Signaling by ROBO receptors | PathwayId: R-HSA-376176
NodeType: Pathway | PathwayName: Signaling by Receptor Tyrosine Kinases | PathwayId: R-HSA-9006934
NodeType: Pathway | PathwayName: Signaling by Retinoic Acid | PathwayId: R-HSA-5362517
NodeType: Pathway | PathwayName: Signaling by Rho GTPases | PathwayId: R-HSA-194315
NodeType: Pathway | PathwayName: Signaling by Rho GTPases, Miro GTPases and RHOBTB3 | PathwayId: R-HSA-9716542
NodeType: Pathway | PathwayName: Signaling by SCF-KIT | PathwayId: R-HSA-1433557
NodeType: Pathway | PathwayName: Signaling by TCF7L2 mutants | PathwayId: R-HSA-5339700
NodeType: Pathway | PathwayName: Signaling by TGF-beta Receptor Complex | PathwayId: R-HSA-170834
NodeType: Pathway | PathwayName: Signaling by TGF-beta Receptor Complex in Cancer | PathwayId: R-HSA-3304351
NodeType: Pathway | PathwayName: Signaling by TGFB family members | PathwayId: R-HSA-9006936
NodeType: Pathway | PathwayName: Signaling by TGFBR3 | PathwayId: R-HSA-9839373
NodeType: Pathway | PathwayName: Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | PathwayId: R-HSA-2404192
NodeType: Pathway | PathwayName: Signaling by VEGF | PathwayId: R-HSA-194138
NodeType: Pathway | PathwayName: Signaling by WNT | PathwayId: R-HSA-195721
NodeType: Pathway | PathwayName: Signaling by WNT in cancer | PathwayId: R-HSA-4791275
NodeType: Pathway | PathwayName: Signaling by activated point mutants of FGFR1 | PathwayId: R-HSA-1839122
NodeType: Pathway | PathwayName: Signaling by activated point mutants of FGFR3 | PathwayId: R-HSA-1839130
NodeType: Pathway | PathwayName: Signaling by cytosolic FGFR1 fusion mutants | PathwayId: R-HSA-1839117
NodeType: Pathway | PathwayName: Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | PathwayId: R-HSA-9673766
NodeType: Pathway | PathwayName: Signaling by extracellular domain mutants of KIT | PathwayId: R-HSA-9680187
NodeType: Pathway | PathwayName: Signaling by high-kinase activity BRAF mutants | PathwayId: R-HSA-6802948
NodeType: Pathway | PathwayName: Signaling by juxtamembrane domain KIT mutants | PathwayId: R-HSA-9669935
NodeType: Pathway | PathwayName: Signaling by kinase domain mutants of KIT | PathwayId: R-HSA-9669933
NodeType: Pathway | PathwayName: Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | PathwayId: R-HSA-9673768
NodeType: Pathway | PathwayName: Signaling by moderate kinase activity BRAF mutants | PathwayId: R-HSA-6802946
NodeType: Pathway | PathwayName: Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | PathwayId: R-HSA-9670439
NodeType: Pathway | PathwayName: Signaling by plasma membrane FGFR1 fusions | PathwayId: R-HSA-8853336
NodeType: Pathway | PathwayName: Signaling by the B Cell Receptor (BCR) | PathwayId: R-HSA-983705
NodeType: Pathway | PathwayName: Signaling downstream of RAS mutants | PathwayId: R-HSA-9649948
NodeType: Pathway | PathwayName: Signalling to ERK5 | PathwayId: R-HSA-198765
NodeType: Pathway | PathwayName: Signalling to ERKs | PathwayId: R-HSA-187687
NodeType: Pathway | PathwayName: Signalling to RAS | PathwayId: R-HSA-167044
NodeType: Pathway | PathwayName: Signalling to STAT3 | PathwayId: R-HSA-198745
NodeType: Pathway | PathwayName: Signalling to p38 via RIT and RIN | PathwayId: R-HSA-187706
NodeType: Pathway | PathwayName: Small interfering RNA (siRNA) biogenesis | PathwayId: R-HSA-426486
NodeType: Pathway | PathwayName: Smooth Muscle Contraction | PathwayId: R-HSA-445355
NodeType: Pathway | PathwayName: Sodium-coupled phosphate cotransporters | PathwayId: R-HSA-427652
NodeType: Pathway | PathwayName: Sodium-coupled sulphate, di- and tri-carboxylate transporters | PathwayId: R-HSA-433137
NodeType: Pathway | PathwayName: Sodium/Calcium exchangers | PathwayId: R-HSA-425561
NodeType: Pathway | PathwayName: Sodium/Proton exchangers | PathwayId: R-HSA-425986
NodeType: Pathway | PathwayName: Somitogenesis | PathwayId: R-HSA-9824272
NodeType: Pathway | PathwayName: Sorafenib-resistant KIT mutants | PathwayId: R-HSA-9669936
NodeType: Pathway | PathwayName: Sorafenib-resistant PDGFR mutants | PathwayId: R-HSA-9674404
NodeType: Pathway | PathwayName: Specification of primordial germ cells | PathwayId: R-HSA-9827857
NodeType: Pathway | PathwayName: Specification of the neural plate border | PathwayId: R-HSA-9834899
NodeType: Pathway | PathwayName: Sperm Motility And Taxes | PathwayId: R-HSA-1300642
NodeType: Pathway | PathwayName: Sphingolipid catabolism | PathwayId: R-HSA-9845614
NodeType: Pathway | PathwayName: Sphingolipid de novo biosynthesis | PathwayId: R-HSA-1660661
NodeType: Pathway | PathwayName: Sphingolipid metabolism | PathwayId: R-HSA-428157
NodeType: Pathway | PathwayName: Spry regulation of FGF signaling | PathwayId: R-HSA-1295596
NodeType: Pathway | PathwayName: Stabilization of p53 | PathwayId: R-HSA-69541
NodeType: Pathway | PathwayName: Sterols are 12-hydroxylated by CYP8B1 | PathwayId: R-HSA-211994
NodeType: Pathway | PathwayName: Stimulation of the cell death response by PAK-2p34 | PathwayId: R-HSA-211736
NodeType: Pathway | PathwayName: Stimuli-sensing channels | PathwayId: R-HSA-2672351
NodeType: Pathway | PathwayName: Striated Muscle Contraction | PathwayId: R-HSA-390522
NodeType: Pathway | PathwayName: Sulfide oxidation to sulfate | PathwayId: R-HSA-1614517
NodeType: Pathway | PathwayName: Sulfur amino acid metabolism | PathwayId: R-HSA-1614635
NodeType: Pathway | PathwayName: Sunitinib-resistant KIT mutants | PathwayId: R-HSA-9669934
NodeType: Pathway | PathwayName: Sunitinib-resistant PDGFR mutants | PathwayId: R-HSA-9674401
NodeType: Pathway | PathwayName: Suppression of apoptosis | PathwayId: R-HSA-9635465
NodeType: Pathway | PathwayName: Suppression of autophagy | PathwayId: R-HSA-9636569
NodeType: Pathway | PathwayName: Suppression of phagosomal maturation | PathwayId: R-HSA-9637687
NodeType: Pathway | PathwayName: Surfactant metabolism | PathwayId: R-HSA-5683826
NodeType: Pathway | PathwayName: Switching of origins to a post-replicative state | PathwayId: R-HSA-69052
NodeType: Pathway | PathwayName: Synaptic adhesion-like molecules | PathwayId: R-HSA-8849932
NodeType: Pathway | PathwayName: Syndecan interactions | PathwayId: R-HSA-3000170
NodeType: Pathway | PathwayName: Synthesis And Processing Of GAG, GAGPOL Polyproteins | PathwayId: R-HSA-174495
NodeType: Pathway | PathwayName: Synthesis and processing of ENV and VPU | PathwayId: R-HSA-171286
NodeType: Pathway | PathwayName: Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE) | PathwayId: R-HSA-2142816
NodeType: Pathway | PathwayName: Synthesis of 12-eicosatetraenoic acid derivatives | PathwayId: R-HSA-2142712
NodeType: Pathway | PathwayName: Synthesis of 15-eicosatetraenoic acid derivatives | PathwayId: R-HSA-2142770
NodeType: Pathway | PathwayName: Synthesis of 5-eicosatetraenoic acids | PathwayId: R-HSA-2142688
NodeType: Pathway | PathwayName: Synthesis of BMP | PathwayId: R-HSA-1483171
NodeType: Pathway | PathwayName: Synthesis of CL | PathwayId: R-HSA-1483076
NodeType: Pathway | PathwayName: Synthesis of DNA | PathwayId: R-HSA-69239
NodeType: Pathway | PathwayName: Synthesis of Dolichyl-phosphate | PathwayId: R-HSA-446199
NodeType: Pathway | PathwayName: Synthesis of GDP-mannose | PathwayId: R-HSA-446205
NodeType: Pathway | PathwayName: Synthesis of Hepoxilins (HX) and Trioxilins (TrX) | PathwayId: R-HSA-2142696
NodeType: Pathway | PathwayName: Synthesis of IP2, IP, and Ins in the cytosol | PathwayId: R-HSA-1855183
NodeType: Pathway | PathwayName: Synthesis of IP3 and IP4 in the cytosol | PathwayId: R-HSA-1855204
NodeType: Pathway | PathwayName: Synthesis of IPs in the ER lumen | PathwayId: R-HSA-1855231
NodeType: Pathway | PathwayName: Synthesis of IPs in the nucleus | PathwayId: R-HSA-1855191
NodeType: Pathway | PathwayName: Synthesis of Ketone Bodies | PathwayId: R-HSA-77111
NodeType: Pathway | PathwayName: Synthesis of Leukotrienes (LT) and Eoxins (EX) | PathwayId: R-HSA-2142691
NodeType: Pathway | PathwayName: Synthesis of Lipoxins (LX) | PathwayId: R-HSA-2142700
NodeType: Pathway | PathwayName: Synthesis of PA | PathwayId: R-HSA-1483166
NodeType: Pathway | PathwayName: Synthesis of PC | PathwayId: R-HSA-1483191
NodeType: Pathway | PathwayName: Synthesis of PE | PathwayId: R-HSA-1483213
NodeType: Pathway | PathwayName: Synthesis of PG | PathwayId: R-HSA-1483148
NodeType: Pathway | PathwayName: Synthesis of PI | PathwayId: R-HSA-1483226
NodeType: Pathway | PathwayName: Synthesis of PIPs at the ER membrane | PathwayId: R-HSA-1483248
NodeType: Pathway | PathwayName: Synthesis of PIPs at the Golgi membrane | PathwayId: R-HSA-1660514
NodeType: Pathway | PathwayName: Synthesis of PIPs at the early endosome membrane | PathwayId: R-HSA-1660516
NodeType: Pathway | PathwayName: Synthesis of PIPs at the late endosome membrane | PathwayId: R-HSA-1660517
NodeType: Pathway | PathwayName: Synthesis of PIPs at the plasma membrane | PathwayId: R-HSA-1660499
NodeType: Pathway | PathwayName: Synthesis of PIPs in the nucleus | PathwayId: R-HSA-8847453
NodeType: Pathway | PathwayName: Synthesis of PS | PathwayId: R-HSA-1483101
NodeType: Pathway | PathwayName: Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | PathwayId: R-HSA-2162123
NodeType: Pathway | PathwayName: Synthesis of UDP-N-acetyl-glucosamine | PathwayId: R-HSA-446210
NodeType: Pathway | PathwayName: Synthesis of active ubiquitin: roles of E1 and E2 enzymes | PathwayId: R-HSA-8866652
NodeType: Pathway | PathwayName: Synthesis of bile acids and bile salts | PathwayId: R-HSA-192105
NodeType: Pathway | PathwayName: Synthesis of bile acids and bile salts via 24-hydroxycholesterol | PathwayId: R-HSA-193775
NodeType: Pathway | PathwayName: Synthesis of bile acids and bile salts via 27-hydroxycholesterol | PathwayId: R-HSA-193807
NodeType: Pathway | PathwayName: Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | PathwayId: R-HSA-193368
NodeType: Pathway | PathwayName: Synthesis of diphthamide-EEF2 | PathwayId: R-HSA-5358493
NodeType: Pathway | PathwayName: Synthesis of dolichyl-phosphate mannose | PathwayId: R-HSA-162699
NodeType: Pathway | PathwayName: Synthesis of dolichyl-phosphate-glucose | PathwayId: R-HSA-480985
NodeType: Pathway | PathwayName: Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET) | PathwayId: R-HSA-2142670
NodeType: Pathway | PathwayName: Synthesis of glycosylphosphatidylinositol (GPI) | PathwayId: R-HSA-162710
NodeType: Pathway | PathwayName: Synthesis of pyrophosphates in the cytosol | PathwayId: R-HSA-1855167
NodeType: Pathway | PathwayName: Synthesis of substrates in N-glycan biosythesis | PathwayId: R-HSA-446219
NodeType: Pathway | PathwayName: Synthesis of very long-chain fatty acyl-CoAs | PathwayId: R-HSA-75876
NodeType: Pathway | PathwayName: Synthesis of wybutosine at G37 of tRNA(Phe) | PathwayId: R-HSA-6782861
NodeType: Pathway | PathwayName: Synthesis, secretion, and deacylation of Ghrelin | PathwayId: R-HSA-422085
NodeType: Pathway | PathwayName: Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | PathwayId: R-HSA-381771
NodeType: Pathway | PathwayName: Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | PathwayId: R-HSA-400511
NodeType: Pathway | PathwayName: TAK1-dependent IKK and NF-kappa-B activation | PathwayId: R-HSA-445989
NodeType: Pathway | PathwayName: TALDO1 deficiency: failed conversion of  Fru(6)P, E4P to SH7P, GA3P | PathwayId: R-HSA-6791462
NodeType: Pathway | PathwayName: TALDO1 deficiency: failed conversion of SH7P, GA3P to Fru(6)P, E4P | PathwayId: R-HSA-6791055
NodeType: Pathway | PathwayName: TBC/RABGAPs | PathwayId: R-HSA-8854214
NodeType: Pathway | PathwayName: TCF dependent signaling in response to WNT | PathwayId: R-HSA-201681
NodeType: Pathway | PathwayName: TCR signaling | PathwayId: R-HSA-202403
NodeType: Pathway | PathwayName: TET1,2,3 and TDG demethylate DNA | PathwayId: R-HSA-5221030
NodeType: Pathway | PathwayName: TFAP2 (AP-2) family regulates transcription of cell cycle factors | PathwayId: R-HSA-8866911
NodeType: Pathway | PathwayName: TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | PathwayId: R-HSA-8866910
NodeType: Pathway | PathwayName: TFAP2 (AP-2) family regulates transcription of other transcription factors | PathwayId: R-HSA-8866906
NodeType: Pathway | PathwayName: TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | PathwayId: R-HSA-8869496
NodeType: Pathway | PathwayName: TGF-beta receptor signaling activates SMADs | PathwayId: R-HSA-2173789
NodeType: Pathway | PathwayName: TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | PathwayId: R-HSA-2173791
NodeType: Pathway | PathwayName: TGFBR1 KD Mutants in Cancer | PathwayId: R-HSA-3656532
NodeType: Pathway | PathwayName: TGFBR1 LBD Mutants in Cancer | PathwayId: R-HSA-3656535
NodeType: Pathway | PathwayName: TGFBR2 Kinase Domain Mutants in Cancer | PathwayId: R-HSA-3645790
NodeType: Pathway | PathwayName: TGFBR2 MSI Frameshift Mutants in Cancer | PathwayId: R-HSA-3642279
NodeType: Pathway | PathwayName: TGFBR3 PTM regulation | PathwayId: R-HSA-9839383
NodeType: Pathway | PathwayName: TGFBR3 expression | PathwayId: R-HSA-9839394
NodeType: Pathway | PathwayName: TGFBR3 regulates FGF2 signaling | PathwayId: R-HSA-9839397
NodeType: Pathway | PathwayName: TGFBR3 regulates TGF-beta signaling | PathwayId: R-HSA-9839389
NodeType: Pathway | PathwayName: TGFBR3 regulates activin signaling | PathwayId: R-HSA-9839406
NodeType: Pathway | PathwayName: TICAM1 deficiency - HSE | PathwayId: R-HSA-5602566
NodeType: Pathway | PathwayName: TICAM1, RIP1-mediated IKK complex recruitment | PathwayId: R-HSA-168927
NodeType: Pathway | PathwayName: TICAM1,TRAF6-dependent induction of TAK1 complex | PathwayId: R-HSA-9014325
NodeType: Pathway | PathwayName: TICAM1-dependent activation of IRF3/IRF7 | PathwayId: R-HSA-9013973
NodeType: Pathway | PathwayName: TLR3 deficiency - HSE | PathwayId: R-HSA-5602410
NodeType: Pathway | PathwayName: TLR3-mediated TICAM1-dependent programmed cell death | PathwayId: R-HSA-9013957
NodeType: Pathway | PathwayName: TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | PathwayId: R-HSA-5676594
NodeType: Pathway | PathwayName: TNF signaling | PathwayId: R-HSA-75893
NodeType: Pathway | PathwayName: TNFR1-induced NF-kappa-B signaling pathway | PathwayId: R-HSA-5357956
NodeType: Pathway | PathwayName: TNFR1-induced proapoptotic signaling | PathwayId: R-HSA-5357786
NodeType: Pathway | PathwayName: TNFR1-mediated ceramide production | PathwayId: R-HSA-5626978
NodeType: Pathway | PathwayName: TNFR2 non-canonical NF-kB pathway | PathwayId: R-HSA-5668541
NodeType: Pathway | PathwayName: TNFs bind their physiological receptors | PathwayId: R-HSA-5669034
NodeType: Pathway | PathwayName: TP53 Regulates Metabolic Genes | PathwayId: R-HSA-5628897
NodeType: Pathway | PathwayName: TP53 Regulates Transcription of Caspase Activators and Caspases | PathwayId: R-HSA-6803207
NodeType: Pathway | PathwayName: TP53 Regulates Transcription of Cell Cycle Genes | PathwayId: R-HSA-6791312
NodeType: Pathway | PathwayName: TP53 Regulates Transcription of Cell Death Genes | PathwayId: R-HSA-5633008
NodeType: Pathway | PathwayName: TP53 Regulates Transcription of DNA Repair Genes | PathwayId: R-HSA-6796648
NodeType: Pathway | PathwayName: TP53 Regulates Transcription of Death Receptors and Ligands | PathwayId: R-HSA-6803211
NodeType: Pathway | PathwayName: TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | PathwayId: R-HSA-6803204
NodeType: Pathway | PathwayName: TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | PathwayId: R-HSA-6804116
NodeType: Pathway | PathwayName: TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | PathwayId: R-HSA-6804114
NodeType: Pathway | PathwayName: TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | PathwayId: R-HSA-6804115
NodeType: Pathway | PathwayName: TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | PathwayId: R-HSA-6803205
NodeType: Pathway | PathwayName: TRAF3 deficiency - HSE | PathwayId: R-HSA-5602571
NodeType: Pathway | PathwayName: TRAF3-dependent IRF activation pathway | PathwayId: R-HSA-918233
NodeType: Pathway | PathwayName: TRAF6 mediated IRF7 activation | PathwayId: R-HSA-933541
NodeType: Pathway | PathwayName: TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | PathwayId: R-HSA-975110
NodeType: Pathway | PathwayName: TRAF6 mediated NF-kB activation | PathwayId: R-HSA-933542
NodeType: Pathway | PathwayName: TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | PathwayId: R-HSA-975138
NodeType: Pathway | PathwayName: TRAF6-mediated induction of TAK1 complex within TLR4 complex | PathwayId: R-HSA-937072
NodeType: Pathway | PathwayName: TRAIL  signaling | PathwayId: R-HSA-75158
NodeType: Pathway | PathwayName: TRIF (TICAM1)-mediated TLR4 signaling | PathwayId: R-HSA-937061
NodeType: Pathway | PathwayName: TRIF-mediated programmed cell death | PathwayId: R-HSA-2562578
NodeType: Pathway | PathwayName: TRKA activation by NGF | PathwayId: R-HSA-187042
NodeType: Pathway | PathwayName: TRP channels | PathwayId: R-HSA-3295583
NodeType: Pathway | PathwayName: TWIK related potassium channel (TREK) | PathwayId: R-HSA-1299503
NodeType: Pathway | PathwayName: TWIK-related alkaline pH activated K+ channel (TALK) | PathwayId: R-HSA-1299361
NodeType: Pathway | PathwayName: TWIK-related spinal cord K+ channel (TRESK) | PathwayId: R-HSA-1299344
NodeType: Pathway | PathwayName: TWIK-releated acid-sensitive K+ channel (TASK) | PathwayId: R-HSA-1299316
NodeType: Pathway | PathwayName: TYSND1 cleaves peroxisomal proteins | PathwayId: R-HSA-9033500
NodeType: Pathway | PathwayName: Tachykinin receptors bind tachykinins | PathwayId: R-HSA-380095
NodeType: Pathway | PathwayName: Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK) | PathwayId: R-HSA-1299308
NodeType: Pathway | PathwayName: Tandem pore domain halothane-inhibited K+ channel (THIK) | PathwayId: R-HSA-1299287
NodeType: Pathway | PathwayName: Tandem pore domain potassium channels | PathwayId: R-HSA-1296346
NodeType: Pathway | PathwayName: Tat-mediated HIV elongation arrest and recovery | PathwayId: R-HSA-167243
NodeType: Pathway | PathwayName: Tat-mediated elongation of the HIV-1 transcript | PathwayId: R-HSA-167246
NodeType: Pathway | PathwayName: Telomere C-strand (Lagging Strand) Synthesis | PathwayId: R-HSA-174417
NodeType: Pathway | PathwayName: Telomere C-strand synthesis initiation | PathwayId: R-HSA-174430
NodeType: Pathway | PathwayName: Telomere Extension By Telomerase | PathwayId: R-HSA-171319
NodeType: Pathway | PathwayName: Telomere Maintenance | PathwayId: R-HSA-157579
NodeType: Pathway | PathwayName: Terminal pathway of complement | PathwayId: R-HSA-166665
NodeType: Pathway | PathwayName: Termination of O-glycan biosynthesis | PathwayId: R-HSA-977068
NodeType: Pathway | PathwayName: Termination of translesion DNA synthesis | PathwayId: R-HSA-5656169
NodeType: Pathway | PathwayName: Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | PathwayId: R-HSA-1474151
NodeType: Pathway | PathwayName: The AIM2 inflammasome | PathwayId: R-HSA-844615
NodeType: Pathway | PathwayName: The IPAF inflammasome | PathwayId: R-HSA-844623
NodeType: Pathway | PathwayName: The NLRP1 inflammasome | PathwayId: R-HSA-844455
NodeType: Pathway | PathwayName: The NLRP3 inflammasome | PathwayId: R-HSA-844456
NodeType: Pathway | PathwayName: The activation of arylsulfatases | PathwayId: R-HSA-1663150
NodeType: Pathway | PathwayName: The canonical retinoid cycle in rods (twilight vision) | PathwayId: R-HSA-2453902
NodeType: Pathway | PathwayName: The fatty acid cycling model | PathwayId: R-HSA-167826
NodeType: Pathway | PathwayName: The phototransduction cascade | PathwayId: R-HSA-2514856
NodeType: Pathway | PathwayName: The retinoid cycle in cones (daylight vision) | PathwayId: R-HSA-2187335
NodeType: Pathway | PathwayName: The role of GTSE1 in G2/M progression after G2 checkpoint | PathwayId: R-HSA-8852276
NodeType: Pathway | PathwayName: The role of Nef in HIV-1 replication and disease pathogenesis | PathwayId: R-HSA-164952
NodeType: Pathway | PathwayName: Threonine catabolism | PathwayId: R-HSA-8849175
NodeType: Pathway | PathwayName: Thrombin signalling through proteinase activated receptors (PARs) | PathwayId: R-HSA-456926
NodeType: Pathway | PathwayName: Thromboxane signalling through TP receptor | PathwayId: R-HSA-428930
NodeType: Pathway | PathwayName: Thyroxine biosynthesis | PathwayId: R-HSA-209968
NodeType: Pathway | PathwayName: Tie2 Signaling | PathwayId: R-HSA-210993
NodeType: Pathway | PathwayName: Tight junction interactions | PathwayId: R-HSA-420029
NodeType: Pathway | PathwayName: Tolerance by Mtb to nitric oxide produced by macrophages | PathwayId: R-HSA-1222538
NodeType: Pathway | PathwayName: GRB7 events in ERBB2 signaling | PathwayId: R-HSA-1306955
NodeType: Pathway | PathwayName: GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | PathwayId: R-HSA-9762114
NodeType: Pathway | PathwayName: GTP hydrolysis and joining of the 60S ribosomal subunit | PathwayId: R-HSA-72706
NodeType: Pathway | PathwayName: Gain-of-function MRAS complexes activate RAF signaling | PathwayId: R-HSA-9726842
NodeType: Pathway | PathwayName: Galactose catabolism | PathwayId: R-HSA-70370
NodeType: Pathway | PathwayName: Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | PathwayId: R-HSA-163841
NodeType: Pathway | PathwayName: Gamma-carboxylation of protein precursors | PathwayId: R-HSA-159740
NodeType: Pathway | PathwayName: Gamma-carboxylation, transport, and amino-terminal cleavage of proteins | PathwayId: R-HSA-159854
NodeType: Pathway | PathwayName: Gap junction assembly | PathwayId: R-HSA-190861
NodeType: Pathway | PathwayName: Gap junction degradation | PathwayId: R-HSA-190873
NodeType: Pathway | PathwayName: Gap junction trafficking | PathwayId: R-HSA-190828
NodeType: Pathway | PathwayName: Gap junction trafficking and regulation | PathwayId: R-HSA-157858
NodeType: Pathway | PathwayName: Gap-filling DNA repair synthesis and ligation in GG-NER | PathwayId: R-HSA-5696397
NodeType: Pathway | PathwayName: Gap-filling DNA repair synthesis and ligation in TC-NER | PathwayId: R-HSA-6782210
NodeType: Pathway | PathwayName: Gastrin-CREB signalling pathway via PKC and MAPK | PathwayId: R-HSA-881907
NodeType: Pathway | PathwayName: Gastrulation | PathwayId: R-HSA-9758941
NodeType: Pathway | PathwayName: Gene Silencing by RNA | PathwayId: R-HSA-211000
NodeType: Pathway | PathwayName: Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | PathwayId: R-HSA-8950505
NodeType: Pathway | PathwayName: Gene expression (Transcription) | PathwayId: R-HSA-74160
NodeType: Pathway | PathwayName: Generation of second messenger molecules | PathwayId: R-HSA-202433
NodeType: Pathway | PathwayName: Generic Transcription Pathway | PathwayId: R-HSA-212436
NodeType: Pathway | PathwayName: Germ layer formation at gastrulation | PathwayId: R-HSA-9754189
NodeType: Pathway | PathwayName: Global Genome Nucleotide Excision Repair (GG-NER) | PathwayId: R-HSA-5696399
NodeType: Pathway | PathwayName: Glucagon signaling in metabolic regulation | PathwayId: R-HSA-163359
NodeType: Pathway | PathwayName: Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | PathwayId: R-HSA-381676
NodeType: Pathway | PathwayName: Glucagon-type ligand receptors | PathwayId: R-HSA-420092
NodeType: Pathway | PathwayName: Glucocorticoid biosynthesis | PathwayId: R-HSA-194002
NodeType: Pathway | PathwayName: Gluconeogenesis | PathwayId: R-HSA-70263
NodeType: Pathway | PathwayName: Glucose metabolism | PathwayId: R-HSA-70326
NodeType: Pathway | PathwayName: Glucuronidation | PathwayId: R-HSA-156588
NodeType: Pathway | PathwayName: Glutamate Neurotransmitter Release Cycle | PathwayId: R-HSA-210500
NodeType: Pathway | PathwayName: Glutamate and glutamine metabolism | PathwayId: R-HSA-8964539
NodeType: Pathway | PathwayName: Glutamate binding, activation of AMPA receptors and synaptic plasticity | PathwayId: R-HSA-399721
NodeType: Pathway | PathwayName: Glutathione conjugation | PathwayId: R-HSA-156590
NodeType: Pathway | PathwayName: Glutathione synthesis and recycling | PathwayId: R-HSA-174403
NodeType: Pathway | PathwayName: Glycerophospholipid biosynthesis | PathwayId: R-HSA-1483206
NodeType: Pathway | PathwayName: Glycerophospholipid catabolism | PathwayId: R-HSA-6814848
NodeType: Pathway | PathwayName: Glycine degradation | PathwayId: R-HSA-6783984
NodeType: Pathway | PathwayName: Glycogen breakdown (glycogenolysis) | PathwayId: R-HSA-70221
NodeType: Pathway | PathwayName: Glycogen metabolism | PathwayId: R-HSA-8982491
NodeType: Pathway | PathwayName: Glycogen storage disease type 0 (liver GYS2) | PathwayId: R-HSA-3858516
NodeType: Pathway | PathwayName: Glycogen storage disease type 0 (muscle GYS1) | PathwayId: R-HSA-3828062
NodeType: Pathway | PathwayName: Glycogen storage disease type II (GAA) | PathwayId: R-HSA-5357609
NodeType: Pathway | PathwayName: Glycogen storage disease type IV (GBE1) | PathwayId: R-HSA-3878781
NodeType: Pathway | PathwayName: Glycogen storage disease type Ia (G6PC) | PathwayId: R-HSA-3274531
NodeType: Pathway | PathwayName: Glycogen storage disease type Ib (SLC37A4) | PathwayId: R-HSA-3229133
NodeType: Pathway | PathwayName: Glycogen storage disease type XV (GYG1) | PathwayId: R-HSA-3814836
NodeType: Pathway | PathwayName: Glycogen storage diseases | PathwayId: R-HSA-3229121
NodeType: Pathway | PathwayName: Glycogen synthesis | PathwayId: R-HSA-3322077
NodeType: Pathway | PathwayName: Glycolysis | PathwayId: R-HSA-70171
NodeType: Pathway | PathwayName: Glycoprotein hormones | PathwayId: R-HSA-209822
NodeType: Pathway | PathwayName: Glycosaminoglycan metabolism | PathwayId: R-HSA-1630316
NodeType: Pathway | PathwayName: Glycosphingolipid biosynthesis | PathwayId: R-HSA-9840309
NodeType: Pathway | PathwayName: Glycosphingolipid catabolism | PathwayId: R-HSA-9840310
NodeType: Pathway | PathwayName: Glycosphingolipid metabolism | PathwayId: R-HSA-1660662
NodeType: Pathway | PathwayName: Glycosphingolipid transport | PathwayId: R-HSA-9845576
NodeType: Pathway | PathwayName: Glyoxylate metabolism and glycine degradation | PathwayId: R-HSA-389661
NodeType: Pathway | PathwayName: Golgi Associated Vesicle Biogenesis | PathwayId: R-HSA-432722
NodeType: Pathway | PathwayName: Golgi Cisternae Pericentriolar Stack Reorganization | PathwayId: R-HSA-162658
NodeType: Pathway | PathwayName: Golgi-to-ER retrograde transport | PathwayId: R-HSA-8856688
NodeType: Pathway | PathwayName: Growth hormone receptor signaling | PathwayId: R-HSA-982772
NodeType: Pathway | PathwayName: HATs acetylate histones | PathwayId: R-HSA-3214847
NodeType: Pathway | PathwayName: HCMV Early Events | PathwayId: R-HSA-9609690
NodeType: Pathway | PathwayName: HCMV Infection | PathwayId: R-HSA-9609646
NodeType: Pathway | PathwayName: HCMV Late Events | PathwayId: R-HSA-9610379
NodeType: Pathway | PathwayName: HCN channels | PathwayId: R-HSA-1296061
NodeType: Pathway | PathwayName: HDACs deacetylate histones | PathwayId: R-HSA-3214815
NodeType: Pathway | PathwayName: HDL assembly | PathwayId: R-HSA-8963896
NodeType: Pathway | PathwayName: HDL clearance | PathwayId: R-HSA-8964011
NodeType: Pathway | PathwayName: HDL remodeling | PathwayId: R-HSA-8964058
NodeType: Pathway | PathwayName: HDMs demethylate histones | PathwayId: R-HSA-3214842
NodeType: Pathway | PathwayName: HDR through Homologous Recombination (HRR) | PathwayId: R-HSA-5685942
NodeType: Pathway | PathwayName: HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | PathwayId: R-HSA-5693567
NodeType: Pathway | PathwayName: HDR through MMEJ (alt-NHEJ) | PathwayId: R-HSA-5685939
NodeType: Pathway | PathwayName: HDR through Single Strand Annealing (SSA) | PathwayId: R-HSA-5685938
NodeType: Pathway | PathwayName: HHAT G278V doesn't palmitoylate Hh-Np | PathwayId: R-HSA-5658034
NodeType: Pathway | PathwayName: HIV Infection | PathwayId: R-HSA-162906
NodeType: Pathway | PathwayName: HIV Life Cycle | PathwayId: R-HSA-162587
NodeType: Pathway | PathwayName: HIV Transcription Elongation | PathwayId: R-HSA-167169
NodeType: Pathway | PathwayName: HIV Transcription Initiation | PathwayId: R-HSA-167161
NodeType: Pathway | PathwayName: HIV elongation arrest and recovery | PathwayId: R-HSA-167287
NodeType: Pathway | PathwayName: HS-GAG biosynthesis | PathwayId: R-HSA-2022928
NodeType: Pathway | PathwayName: HS-GAG degradation | PathwayId: R-HSA-2024096
NodeType: Pathway | PathwayName: HSF1 activation | PathwayId: R-HSA-3371511
NodeType: Pathway | PathwayName: HSF1-dependent transactivation | PathwayId: R-HSA-3371571
NodeType: Pathway | PathwayName: HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | PathwayId: R-HSA-3371497
NodeType: Pathway | PathwayName: Hedgehog 'off' state | PathwayId: R-HSA-5610787
NodeType: Pathway | PathwayName: Hedgehog 'on' state | PathwayId: R-HSA-5632684
NodeType: Pathway | PathwayName: Hedgehog ligand biogenesis | PathwayId: R-HSA-5358346
NodeType: Pathway | PathwayName: Heme biosynthesis | PathwayId: R-HSA-189451
NodeType: Pathway | PathwayName: Heme degradation | PathwayId: R-HSA-189483
NodeType: Pathway | PathwayName: Heme signaling | PathwayId: R-HSA-9707616
NodeType: Pathway | PathwayName: Hemostasis | PathwayId: R-HSA-109582
NodeType: Pathway | PathwayName: Heparan sulfate/heparin (HS-GAG) metabolism | PathwayId: R-HSA-1638091
NodeType: Pathway | PathwayName: Hereditary fructose intolerance | PathwayId: R-HSA-5657560
NodeType: Pathway | PathwayName: Hh mutants abrogate ligand secretion | PathwayId: R-HSA-5387390
NodeType: Pathway | PathwayName: Hh mutants are degraded by ERAD | PathwayId: R-HSA-5362768
NodeType: Pathway | PathwayName: Highly calcium permeable nicotinic acetylcholine receptors | PathwayId: R-HSA-629597
NodeType: Pathway | PathwayName: Highly calcium permeable postsynaptic nicotinic acetylcholine receptors | PathwayId: R-HSA-629594
NodeType: Pathway | PathwayName: Highly sodium permeable postsynaptic acetylcholine nicotinic receptors | PathwayId: R-HSA-629587
NodeType: Pathway | PathwayName: Histamine receptors | PathwayId: R-HSA-390650
NodeType: Pathway | PathwayName: Histidine catabolism | PathwayId: R-HSA-70921
NodeType: Pathway | PathwayName: Homologous DNA Pairing and Strand Exchange | PathwayId: R-HSA-5693579
NodeType: Pathway | PathwayName: Homology Directed Repair | PathwayId: R-HSA-5693538
NodeType: Pathway | PathwayName: Hormone ligand-binding receptors | PathwayId: R-HSA-375281
NodeType: Pathway | PathwayName: Host Interactions of HIV factors | PathwayId: R-HSA-162909
NodeType: Pathway | PathwayName: HuR (ELAVL1) binds and stabilizes mRNA | PathwayId: R-HSA-450520
NodeType: Pathway | PathwayName: Hyaluronan biosynthesis and export | PathwayId: R-HSA-2142850
NodeType: Pathway | PathwayName: Hyaluronan metabolism | PathwayId: R-HSA-2142845
NodeType: Pathway | PathwayName: Hyaluronan uptake and degradation | PathwayId: R-HSA-2160916
NodeType: Pathway | PathwayName: Hydrolysis of LPC | PathwayId: R-HSA-1483115
NodeType: Pathway | PathwayName: Hydrolysis of LPE | PathwayId: R-HSA-1483152
NodeType: Pathway | PathwayName: Hydroxycarboxylic acid-binding receptors | PathwayId: R-HSA-3296197
NodeType: Pathway | PathwayName: Hypusine synthesis from eIF5A-lysine | PathwayId: R-HSA-204626
NodeType: Pathway | PathwayName: IFNG signaling activates MAPKs | PathwayId: R-HSA-9732724
NodeType: Pathway | PathwayName: IGF1R signaling cascade | PathwayId: R-HSA-2428924
NodeType: Pathway | PathwayName: IKBKB deficiency causes SCID | PathwayId: R-HSA-5602636
NodeType: Pathway | PathwayName: IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) | PathwayId: R-HSA-5603027
NodeType: Pathway | PathwayName: IKK complex recruitment mediated by RIP1 | PathwayId: R-HSA-937041
NodeType: Pathway | PathwayName: IL-6-type cytokine receptor ligand interactions | PathwayId: R-HSA-6788467
NodeType: Pathway | PathwayName: IP3 and IP4 transport between cytosol and nucleus | PathwayId: R-HSA-1855196
NodeType: Pathway | PathwayName: IP6 and IP7 transport between cytosol and nucleus | PathwayId: R-HSA-1855229
NodeType: Pathway | PathwayName: IPs transport between ER lumen and cytosol | PathwayId: R-HSA-1855215
NodeType: Pathway | PathwayName: IPs transport between ER lumen and nucleus | PathwayId: R-HSA-1855156
NodeType: Pathway | PathwayName: IPs transport between cytosol and ER lumen | PathwayId: R-HSA-1855184
NodeType: Pathway | PathwayName: IPs transport between nucleus and ER lumen | PathwayId: R-HSA-1855192
NodeType: Pathway | PathwayName: IPs transport between nucleus and cytosol | PathwayId: R-HSA-1855170
NodeType: Pathway | PathwayName: IRAK1 recruits IKK complex | PathwayId: R-HSA-937039
NodeType: Pathway | PathwayName: IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | PathwayId: R-HSA-975144
NodeType: Pathway | PathwayName: IRAK2 mediated activation of TAK1 complex | PathwayId: R-HSA-937042
NodeType: Pathway | PathwayName: IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | PathwayId: R-HSA-975163
NodeType: Pathway | PathwayName: IRAK4 deficiency (TLR2/4) | PathwayId: R-HSA-5603041
NodeType: Pathway | PathwayName: IRAK4 deficiency (TLR5) | PathwayId: R-HSA-5603037
NodeType: Pathway | PathwayName: IRE1alpha activates chaperones | PathwayId: R-HSA-381070
NodeType: Pathway | PathwayName: IRF3 mediated activation of type 1 IFN | PathwayId: R-HSA-1606341
NodeType: Pathway | PathwayName: IRF3-mediated induction of type I IFN | PathwayId: R-HSA-3270619
NodeType: Pathway | PathwayName: IRS activation | PathwayId: R-HSA-74713
NodeType: Pathway | PathwayName: IRS-mediated signalling | PathwayId: R-HSA-112399
NodeType: Pathway | PathwayName: IRS-related events triggered by IGF1R | PathwayId: R-HSA-2428928
NodeType: Pathway | PathwayName: ISG15 antiviral mechanism | PathwayId: R-HSA-1169408
NodeType: Pathway | PathwayName: IkBA variant leads to EDA-ID | PathwayId: R-HSA-5603029
NodeType: Pathway | PathwayName: Imatinib-resistant KIT mutants | PathwayId: R-HSA-9669917
NodeType: Pathway | PathwayName: Imatinib-resistant PDGFR mutants | PathwayId: R-HSA-9674396
NodeType: Pathway | PathwayName: Immune System | PathwayId: R-HSA-168256
NodeType: Pathway | PathwayName: Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | PathwayId: R-HSA-198933
NodeType: Pathway | PathwayName: Impaired BRCA2 binding to PALB2 | PathwayId: R-HSA-9709603
NodeType: Pathway | PathwayName: Impaired BRCA2 binding to RAD51 | PathwayId: R-HSA-9709570
NodeType: Pathway | PathwayName: Impaired BRCA2 binding to SEM1 (DSS1) | PathwayId: R-HSA-9763198
NodeType: Pathway | PathwayName: Impaired BRCA2 translocation to the nucleus | PathwayId: R-HSA-9709275
NodeType: Pathway | PathwayName: Inactivation of APC/C via direct inhibition of the APC/C complex | PathwayId: R-HSA-141430
NodeType: Pathway | PathwayName: Inactivation of CDC42 and RAC1 | PathwayId: R-HSA-428543
NodeType: Pathway | PathwayName: Inactivation of CSF3 (G-CSF) signaling | PathwayId: R-HSA-9705462
NodeType: Pathway | PathwayName: Inactivation, recovery and regulation of the phototransduction cascade | PathwayId: R-HSA-2514859
NodeType: Pathway | PathwayName: Incretin synthesis, secretion, and inactivation | PathwayId: R-HSA-400508
NodeType: Pathway | PathwayName: Induction of Cell-Cell Fusion | PathwayId: R-HSA-9733458
NodeType: Pathway | PathwayName: Infection with Mycobacterium tuberculosis | PathwayId: R-HSA-9635486
NodeType: Pathway | PathwayName: Infectious disease | PathwayId: R-HSA-5663205
NodeType: Pathway | PathwayName: Inflammasomes | PathwayId: R-HSA-622312
NodeType: Pathway | PathwayName: Influenza Infection | PathwayId: R-HSA-168255
NodeType: Pathway | PathwayName: Influenza Viral RNA Transcription and Replication | PathwayId: R-HSA-168273
NodeType: Pathway | PathwayName: Influenza Virus Induced Apoptosis | PathwayId: R-HSA-168277
NodeType: Pathway | PathwayName: Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits | PathwayId: R-HSA-997272
NodeType: Pathway | PathwayName: Inhibition of DNA recombination at telomere | PathwayId: R-HSA-9670095
NodeType: Pathway | PathwayName: Inhibition of Host mRNA Processing and RNA Silencing | PathwayId: R-HSA-168315
NodeType: Pathway | PathwayName: Inhibition of IFN-beta | PathwayId: R-HSA-168888
NodeType: Pathway | PathwayName: Inhibition of Interferon Synthesis | PathwayId: R-HSA-168305
NodeType: Pathway | PathwayName: Inhibition of PKR | PathwayId: R-HSA-169131
NodeType: Pathway | PathwayName: Inhibition of Signaling by Overexpressed EGFR | PathwayId: R-HSA-5638303
NodeType: Pathway | PathwayName: Inhibition of TSC complex formation by PKB | PathwayId: R-HSA-165181
NodeType: Pathway | PathwayName: Inhibition of membrane repair | PathwayId: R-HSA-9635644
NodeType: Pathway | PathwayName: Inhibition of nitric oxide production | PathwayId: R-HSA-9636249
NodeType: Pathway | PathwayName: Inhibition of replication initiation of damaged DNA by RB1/E2F1 | PathwayId: R-HSA-113501
NodeType: Pathway | PathwayName: Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | PathwayId: R-HSA-141405
NodeType: Pathway | PathwayName: Initial triggering of complement | PathwayId: R-HSA-166663
NodeType: Pathway | PathwayName: Initiation of Nuclear Envelope (NE) Reformation | PathwayId: R-HSA-2995383
NodeType: Pathway | PathwayName: InlA-mediated entry of Listeria monocytogenes into host cells | PathwayId: R-HSA-8876493
NodeType: Pathway | PathwayName: InlB-mediated entry of Listeria monocytogenes into host cell | PathwayId: R-HSA-8875360
NodeType: Pathway | PathwayName: Innate Immune System | PathwayId: R-HSA-168249
NodeType: Pathway | PathwayName: Inositol phosphate metabolism | PathwayId: R-HSA-1483249
NodeType: Pathway | PathwayName: Inositol transporters | PathwayId: R-HSA-429593
NodeType: Pathway | PathwayName: Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | PathwayId: R-HSA-9609523
NodeType: Pathway | PathwayName: Insulin effects increased synthesis of Xylulose-5-Phosphate | PathwayId: R-HSA-163754
NodeType: Pathway | PathwayName: Insulin processing | PathwayId: R-HSA-264876
NodeType: Pathway | PathwayName: Insulin receptor recycling | PathwayId: R-HSA-77387
NodeType: Pathway | PathwayName: Insulin receptor signalling cascade | PathwayId: R-HSA-74751
NodeType: Pathway | PathwayName: Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | PathwayId: R-HSA-428359
NodeType: Pathway | PathwayName: Integration of energy metabolism | PathwayId: R-HSA-163685
NodeType: Pathway | PathwayName: Integration of provirus | PathwayId: R-HSA-162592
NodeType: Pathway | PathwayName: Integration of viral DNA into host genomic DNA | PathwayId: R-HSA-175567
NodeType: Pathway | PathwayName: Integrin cell surface interactions | PathwayId: R-HSA-216083
NodeType: Pathway | PathwayName: Integrin signaling | PathwayId: R-HSA-354192
NodeType: Pathway | PathwayName: Interaction With Cumulus Cells And The Zona Pellucida | PathwayId: R-HSA-2534343
NodeType: Pathway | PathwayName: Interaction between L1 and Ankyrins | PathwayId: R-HSA-445095
NodeType: Pathway | PathwayName: Interaction between PHLDA1 and AURKA | PathwayId: R-HSA-8854521
NodeType: Pathway | PathwayName: Interactions of Rev with host cellular proteins | PathwayId: R-HSA-177243
NodeType: Pathway | PathwayName: Interactions of Tat with host cellular proteins | PathwayId: R-HSA-176034
NodeType: Pathway | PathwayName: Interactions of Vpr with host cellular proteins | PathwayId: R-HSA-176033
NodeType: Pathway | PathwayName: Interconversion of 2-oxoglutarate and 2-hydroxyglutarate | PathwayId: R-HSA-880009
NodeType: Pathway | PathwayName: Interconversion of nucleotide di- and triphosphates | PathwayId: R-HSA-499943
NodeType: Pathway | PathwayName: Interconversion of polyamines | PathwayId: R-HSA-351200
NodeType: Pathway | PathwayName: Interferon Signaling | PathwayId: R-HSA-913531
NodeType: Pathway | PathwayName: Interferon alpha/beta signaling | PathwayId: R-HSA-909733
NodeType: Pathway | PathwayName: Interferon gamma signaling | PathwayId: R-HSA-877300
NodeType: Pathway | PathwayName: Interleukin receptor SHC signaling | PathwayId: R-HSA-912526
NodeType: Pathway | PathwayName: Interleukin-1 family signaling | PathwayId: R-HSA-446652
NodeType: Pathway | PathwayName: Interleukin-1 processing | PathwayId: R-HSA-448706
NodeType: Pathway | PathwayName: Interleukin-1 signaling | PathwayId: R-HSA-9020702
NodeType: Pathway | PathwayName: Interleukin-10 signaling | PathwayId: R-HSA-6783783
NodeType: Pathway | PathwayName: Interleukin-12 family signaling | PathwayId: R-HSA-447115
NodeType: Pathway | PathwayName: Interleukin-12 signaling | PathwayId: R-HSA-9020591
NodeType: Pathway | PathwayName: Interleukin-15 signaling | PathwayId: R-HSA-8983432
NodeType: Pathway | PathwayName: Interleukin-17 signaling | PathwayId: R-HSA-448424
NodeType: Pathway | PathwayName: Interleukin-18 signaling | PathwayId: R-HSA-9012546
NodeType: Pathway | PathwayName: Interleukin-2 family signaling | PathwayId: R-HSA-451927
NodeType: Pathway | PathwayName: Interleukin-2 signaling | PathwayId: R-HSA-9020558
NodeType: Pathway | PathwayName: Interleukin-20 family signaling | PathwayId: R-HSA-8854691
NodeType: Pathway | PathwayName: Interleukin-21 signaling | PathwayId: R-HSA-9020958
NodeType: Pathway | PathwayName: Interleukin-23 signaling | PathwayId: R-HSA-9020933
NodeType: Pathway | PathwayName: Interleukin-27 signaling | PathwayId: R-HSA-9020956
NodeType: Pathway | PathwayName: Interleukin-3, Interleukin-5 and GM-CSF signaling | PathwayId: R-HSA-512988
NodeType: Pathway | PathwayName: Interleukin-33 signaling | PathwayId: R-HSA-9014843
NodeType: Pathway | PathwayName: Interleukin-35 Signalling | PathwayId: R-HSA-8984722
NodeType: Pathway | PathwayName: Interleukin-36 pathway | PathwayId: R-HSA-9014826
NodeType: Pathway | PathwayName: Interleukin-37 signaling | PathwayId: R-HSA-9008059
NodeType: Pathway | PathwayName: Interleukin-38 signaling | PathwayId: R-HSA-9007892
NodeType: Pathway | PathwayName: Interleukin-4 and Interleukin-13 signaling | PathwayId: R-HSA-6785807
NodeType: Pathway | PathwayName: Interleukin-6 family signaling | PathwayId: R-HSA-6783589
NodeType: Pathway | PathwayName: Interleukin-6 signaling | PathwayId: R-HSA-1059683
NodeType: Pathway | PathwayName: Interleukin-7 signaling | PathwayId: R-HSA-1266695
NodeType: Pathway | PathwayName: Interleukin-9 signaling | PathwayId: R-HSA-8985947
NodeType: Pathway | PathwayName: Intestinal absorption | PathwayId: R-HSA-8963676
NodeType: Pathway | PathwayName: Intestinal hexose absorption | PathwayId: R-HSA-8981373
NodeType: Pathway | PathwayName: Intestinal infectious diseases | PathwayId: R-HSA-8942233
NodeType: Pathway | PathwayName: Intestinal lipid absorption | PathwayId: R-HSA-8963678
NodeType: Pathway | PathwayName: Intestinal saccharidase deficiencies | PathwayId: R-HSA-5659898
NodeType: Pathway | PathwayName: Intra-Golgi and retrograde Golgi-to-ER traffic | PathwayId: R-HSA-6811442
NodeType: Pathway | PathwayName: Intra-Golgi traffic | PathwayId: R-HSA-6811438
NodeType: Pathway | PathwayName: Intracellular metabolism of fatty acids regulates insulin secretion | PathwayId: R-HSA-434313
NodeType: Pathway | PathwayName: Intracellular oxygen transport | PathwayId: R-HSA-8981607
NodeType: Pathway | PathwayName: Intracellular signaling by second messengers | PathwayId: R-HSA-9006925
NodeType: Pathway | PathwayName: Intraflagellar transport | PathwayId: R-HSA-5620924
NodeType: Pathway | PathwayName: Intrinsic Pathway for Apoptosis | PathwayId: R-HSA-109606
NodeType: Pathway | PathwayName: Intrinsic Pathway of Fibrin Clot Formation | PathwayId: R-HSA-140837
NodeType: Pathway | PathwayName: Invadopodia formation | PathwayId: R-HSA-8941237
NodeType: Pathway | PathwayName: Inwardly rectifying K+ channels | PathwayId: R-HSA-1296065
NodeType: Pathway | PathwayName: Ion channel transport | PathwayId: R-HSA-983712
NodeType: Pathway | PathwayName: Ion homeostasis | PathwayId: R-HSA-5578775
NodeType: Pathway | PathwayName: Ion influx/efflux at host-pathogen interface | PathwayId: R-HSA-6803544
NodeType: Pathway | PathwayName: Ion transport by P-type ATPases | PathwayId: R-HSA-936837
NodeType: Pathway | PathwayName: Ionotropic activity of kainate receptors | PathwayId: R-HSA-451306
NodeType: Pathway | PathwayName: Iron uptake and transport | PathwayId: R-HSA-917937
NodeType: Pathway | PathwayName: JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1 | PathwayId: R-HSA-450321
NodeType: Pathway | PathwayName: Josephin domain DUBs | PathwayId: R-HSA-5689877
NodeType: Pathway | PathwayName: KEAP1-NFE2L2 pathway | PathwayId: R-HSA-9755511
NodeType: Pathway | PathwayName: KIT mutants bind TKIs | PathwayId: R-HSA-9669921
NodeType: Pathway | PathwayName: KSRP (KHSRP) binds and destabilizes mRNA | PathwayId: R-HSA-450604
NodeType: Pathway | PathwayName: KW2449-resistant FLT3 mutants | PathwayId: R-HSA-9702569
NodeType: Pathway | PathwayName: Keratan sulfate biosynthesis | PathwayId: R-HSA-2022854
NodeType: Pathway | PathwayName: Keratan sulfate degradation | PathwayId: R-HSA-2022857
NodeType: Pathway | PathwayName: Keratan sulfate/keratin metabolism | PathwayId: R-HSA-1638074
NodeType: Pathway | PathwayName: Keratinization | PathwayId: R-HSA-6805567
NodeType: Pathway | PathwayName: Ketone body metabolism | PathwayId: R-HSA-74182
NodeType: Pathway | PathwayName: Kidney development | PathwayId: R-HSA-9830369
NodeType: Pathway | PathwayName: Killing mechanisms | PathwayId: R-HSA-9664420
NodeType: Pathway | PathwayName: Kinesins | PathwayId: R-HSA-983189
NodeType: Pathway | PathwayName: L13a-mediated translational silencing of Ceruloplasmin expression | PathwayId: R-HSA-156827
NodeType: Pathway | PathwayName: L1CAM interactions | PathwayId: R-HSA-373760
NodeType: Pathway | PathwayName: LDL clearance | PathwayId: R-HSA-8964038
NodeType: Pathway | PathwayName: LDL remodeling | PathwayId: R-HSA-8964041
NodeType: Pathway | PathwayName: LGI-ADAM interactions | PathwayId: R-HSA-5682910
NodeType: Pathway | PathwayName: LGK974 inhibits PORCN | PathwayId: R-HSA-5340573
NodeType: Pathway | PathwayName: LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | PathwayId: R-HSA-3134973
NodeType: Pathway | PathwayName: LTC4-CYSLTR mediated IL4 production | PathwayId: R-HSA-9664535
NodeType: Pathway | PathwayName: Lactose synthesis | PathwayId: R-HSA-5653890
NodeType: Pathway | PathwayName: Lagging Strand Synthesis | PathwayId: R-HSA-69186
NodeType: Pathway | PathwayName: Laminin interactions | PathwayId: R-HSA-3000157
NodeType: Pathway | PathwayName: Late Phase of HIV Life Cycle | PathwayId: R-HSA-162599
NodeType: Pathway | PathwayName: Late SARS-CoV-2 Infection Events | PathwayId: R-HSA-9772573
NodeType: Pathway | PathwayName: Late endosomal microautophagy | PathwayId: R-HSA-9615710
NodeType: Pathway | PathwayName: Latent infection - Other responses of Mtb to phagocytosis | PathwayId: R-HSA-1222499
NodeType: Pathway | PathwayName: Leading Strand Synthesis | PathwayId: R-HSA-69109
NodeType: Pathway | PathwayName: Lectin pathway of complement activation | PathwayId: R-HSA-166662
NodeType: Pathway | PathwayName: Leishmania infection | PathwayId: R-HSA-9658195
NodeType: Pathway | PathwayName: Leishmania parasite growth and survival | PathwayId: R-HSA-9664433
NodeType: Pathway | PathwayName: Leishmania phagocytosis | PathwayId: R-HSA-9664417
NodeType: Pathway | PathwayName: Leukotriene receptors | PathwayId: R-HSA-391906
NodeType: Pathway | PathwayName: Lewis blood group biosynthesis | PathwayId: R-HSA-9037629
NodeType: Pathway | PathwayName: Ligand-receptor interactions | PathwayId: R-HSA-5632681
NodeType: Pathway | PathwayName: Linoleic acid (LA) metabolism | PathwayId: R-HSA-2046105
NodeType: Pathway | PathwayName: Lipid particle organization | PathwayId: R-HSA-8964572
NodeType: Pathway | PathwayName: Lipophagy | PathwayId: R-HSA-9613354
NodeType: Pathway | PathwayName: Listeria monocytogenes entry into host cells | PathwayId: R-HSA-8876384
NodeType: Pathway | PathwayName: Localization of the PINCH-ILK-PARVIN complex to focal adhesions | PathwayId: R-HSA-446343
NodeType: Pathway | PathwayName: Long-term potentiation | PathwayId: R-HSA-9620244
NodeType: Pathway | PathwayName: Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling | PathwayId: R-HSA-2644607
NodeType: Pathway | PathwayName: Loss of Function of SMAD2/3 in Cancer | PathwayId: R-HSA-3304349
NodeType: Pathway | PathwayName: Loss of Function of SMAD4 in Cancer | PathwayId: R-HSA-3304347
NodeType: Pathway | PathwayName: Loss of Function of TGFBR1 in Cancer | PathwayId: R-HSA-3656534
NodeType: Pathway | PathwayName: Loss of Function of TGFBR2 in Cancer | PathwayId: R-HSA-3642278
NodeType: Pathway | PathwayName: Loss of Function of TP53 in Cancer | PathwayId: R-HSA-9723907
NodeType: Pathway | PathwayName: Loss of MECP2 binding ability to 5hmC-DNA | PathwayId: R-HSA-9022534
NodeType: Pathway | PathwayName: Loss of MECP2 binding ability to 5mC-DNA | PathwayId: R-HSA-9022538
NodeType: Pathway | PathwayName: Loss of MECP2 binding ability to the NCoR/SMRT complex | PathwayId: R-HSA-9022537
NodeType: Pathway | PathwayName: Loss of Nlp from mitotic centrosomes | PathwayId: R-HSA-380259
NodeType: Pathway | PathwayName: Loss of function of MECP2 in Rett syndrome | PathwayId: R-HSA-9005891
NodeType: Pathway | PathwayName: Loss of function of TP53 in cancer due to loss of tetramerization ability | PathwayId: R-HSA-9723905
NodeType: Pathway | PathwayName: Loss of phosphorylation of MECP2 at T308 | PathwayId: R-HSA-9022535
NodeType: Pathway | PathwayName: Loss of proteins required for interphase microtubule organization from the centrosome | PathwayId: R-HSA-380284
NodeType: Pathway | PathwayName: Lysine catabolism | PathwayId: R-HSA-71064
NodeType: Pathway | PathwayName: Lysosomal oligosaccharide catabolism | PathwayId: R-HSA-8853383
NodeType: Pathway | PathwayName: Lysosome Vesicle Biogenesis | PathwayId: R-HSA-432720
NodeType: Pathway | PathwayName: Lysosphingolipid and LPA receptors | PathwayId: R-HSA-419408
NodeType: Pathway | PathwayName: M Phase | PathwayId: R-HSA-68886
NodeType: Pathway | PathwayName: M-decay: degradation of maternal mRNAs by maternally stored factors | PathwayId: R-HSA-9820841
NodeType: Pathway | PathwayName: MAP kinase activation | PathwayId: R-HSA-450294
NodeType: Pathway | PathwayName: MAP2K and MAPK activation | PathwayId: R-HSA-5674135
NodeType: Pathway | PathwayName: MAP3K8 (TPL2)-dependent MAPK1/3 activation | PathwayId: R-HSA-5684264
NodeType: Pathway | PathwayName: MAPK family signaling cascades | PathwayId: R-HSA-5683057
NodeType: Pathway | PathwayName: MAPK targets/ Nuclear events mediated by MAP kinases | PathwayId: R-HSA-450282
NodeType: Pathway | PathwayName: MAPK1 (ERK2) activation | PathwayId: R-HSA-112411
NodeType: Pathway | PathwayName: MAPK1/MAPK3 signaling | PathwayId: R-HSA-5684996
NodeType: Pathway | PathwayName: MAPK3 (ERK1) activation | PathwayId: R-HSA-110056
NodeType: Pathway | PathwayName: MAPK6/MAPK4 signaling | PathwayId: R-HSA-5687128
NodeType: Pathway | PathwayName: MASTL Facilitates Mitotic Progression | PathwayId: R-HSA-2465910
NodeType: Pathway | PathwayName: MDK and PTN in ALK signaling | PathwayId: R-HSA-9851151
NodeType: Pathway | PathwayName: MECP2 regulates neuronal receptors and channels | PathwayId: R-HSA-9022699
NodeType: Pathway | PathwayName: MECP2 regulates transcription factors | PathwayId: R-HSA-9022707
NodeType: Pathway | PathwayName: MECP2 regulates transcription of genes involved in GABA signaling | PathwayId: R-HSA-9022927
NodeType: Pathway | PathwayName: MECP2 regulates transcription of neuronal ligands | PathwayId: R-HSA-9022702
NodeType: Pathway | PathwayName: MET Receptor Activation | PathwayId: R-HSA-6806942
NodeType: Pathway | PathwayName: MET activates PI3K/AKT signaling | PathwayId: R-HSA-8851907
NodeType: Pathway | PathwayName: MET activates PTK2 signaling | PathwayId: R-HSA-8874081
NodeType: Pathway | PathwayName: MET activates PTPN11 | PathwayId: R-HSA-8865999
NodeType: Pathway | PathwayName: MET activates RAP1 and RAC1 | PathwayId: R-HSA-8875555
NodeType: Pathway | PathwayName: MET activates RAS signaling | PathwayId: R-HSA-8851805
NodeType: Pathway | PathwayName: MET activates STAT3 | PathwayId: R-HSA-8875791
NodeType: Pathway | PathwayName: MET interacts with TNS proteins | PathwayId: R-HSA-8875513
NodeType: Pathway | PathwayName: MET promotes cell motility | PathwayId: R-HSA-8875878
NodeType: Pathway | PathwayName: MET receptor recycling | PathwayId: R-HSA-8875656
NodeType: Pathway | PathwayName: MGMT-mediated DNA damage reversal | PathwayId: R-HSA-5657655
NodeType: Pathway | PathwayName: MHC class II antigen presentation | PathwayId: R-HSA-2132295
NodeType: Pathway | PathwayName: MITF-M-dependent gene expression | PathwayId: R-HSA-9856651
NodeType: Pathway | PathwayName: MITF-M-regulated melanocyte development | PathwayId: R-HSA-9730414
NodeType: Pathway | PathwayName: MPS I - Hurler syndrome | PathwayId: R-HSA-2206302
NodeType: Pathway | PathwayName: MPS II - Hunter syndrome | PathwayId: R-HSA-2206296
NodeType: Pathway | PathwayName: MPS IIIA - Sanfilippo syndrome A | PathwayId: R-HSA-2206307
NodeType: Pathway | PathwayName: MPS IIIB - Sanfilippo syndrome B | PathwayId: R-HSA-2206282
NodeType: Pathway | PathwayName: MPS IIIC - Sanfilippo syndrome C | PathwayId: R-HSA-2206291
NodeType: Pathway | PathwayName: MPS IIID - Sanfilippo syndrome D | PathwayId: R-HSA-2206305
NodeType: Pathway | PathwayName: MPS IV - Morquio syndrome A | PathwayId: R-HSA-2206290
NodeType: Pathway | PathwayName: MPS IV - Morquio syndrome B | PathwayId: R-HSA-2206308
NodeType: Pathway | PathwayName: MPS IX - Natowicz syndrome | PathwayId: R-HSA-2206280
NodeType: Pathway | PathwayName: MPS VI - Maroteaux-Lamy syndrome | PathwayId: R-HSA-2206285
NodeType: Pathway | PathwayName: MPS VII - Sly syndrome | PathwayId: R-HSA-2206292
NodeType: Pathway | PathwayName: MTF1 activates gene expression | PathwayId: R-HSA-5660489
NodeType: Pathway | PathwayName: MTOR signalling | PathwayId: R-HSA-165159
NodeType: Pathway | PathwayName: Macroautophagy | PathwayId: R-HSA-1632852
NodeType: Pathway | PathwayName: Major pathway of rRNA processing in the nucleolus and cytosol | PathwayId: R-HSA-6791226
NodeType: Pathway | PathwayName: Malate-aspartate shuttle | PathwayId: R-HSA-9856872
NodeType: Pathway | PathwayName: Manipulation of host energy metabolism | PathwayId: R-HSA-9636667
NodeType: Pathway | PathwayName: Masitinib-resistant KIT mutants | PathwayId: R-HSA-9669924
NodeType: Pathway | PathwayName: Maternal to zygotic transition (MZT) | PathwayId: R-HSA-9816359
NodeType: Pathway | PathwayName: Maturation of TCA enzymes and regulation of TCA cycle | PathwayId: R-HSA-9854311
NodeType: Pathway | PathwayName: Maturation of hRSV A proteins | PathwayId: R-HSA-9828806
NodeType: Pathway | PathwayName: Maturation of nucleoprotein | PathwayId: R-HSA-9683610
NodeType: Pathway | PathwayName: Maturation of nucleoprotein | PathwayId: R-HSA-9694631
NodeType: Pathway | PathwayName: Maturation of protein 3a | PathwayId: R-HSA-9683673
NodeType: Pathway | PathwayName: Maturation of protein 3a | PathwayId: R-HSA-9694719
NodeType: Pathway | PathwayName: Maturation of protein E | PathwayId: R-HSA-9683683
NodeType: Pathway | PathwayName: Maturation of protein E | PathwayId: R-HSA-9694493
NodeType: Pathway | PathwayName: Maturation of protein M | PathwayId: R-HSA-9683612
NodeType: Pathway | PathwayName: Maturation of protein M | PathwayId: R-HSA-9694594
NodeType: Pathway | PathwayName: Maturation of replicase proteins | PathwayId: R-HSA-9684325
NodeType: Pathway | PathwayName: Maturation of replicase proteins | PathwayId: R-HSA-9694301
NodeType: Pathway | PathwayName: Maturation of spike protein | PathwayId: R-HSA-9683686
NodeType: Pathway | PathwayName: Maturation of spike protein | PathwayId: R-HSA-9694548
NodeType: Pathway | PathwayName: Meiosis | PathwayId: R-HSA-1500620
NodeType: Pathway | PathwayName: Meiotic recombination | PathwayId: R-HSA-912446
NodeType: Pathway | PathwayName: Meiotic synapsis | PathwayId: R-HSA-1221632
NodeType: Pathway | PathwayName: Melanin biosynthesis | PathwayId: R-HSA-5662702
NodeType: Pathway | PathwayName: Membrane Trafficking | PathwayId: R-HSA-199991
NodeType: Pathway | PathwayName: Membrane binding and targetting of GAG proteins | PathwayId: R-HSA-174490
NodeType: Pathway | PathwayName: Metabolic disorders of biological oxidation enzymes | PathwayId: R-HSA-5579029
NodeType: Pathway | PathwayName: Metabolism | PathwayId: R-HSA-1430728
NodeType: Pathway | PathwayName: Metabolism of Angiotensinogen to Angiotensins | PathwayId: R-HSA-2022377
NodeType: Pathway | PathwayName: Metabolism of RNA | PathwayId: R-HSA-8953854
NodeType: Pathway | PathwayName: Metabolism of amine-derived hormones | PathwayId: R-HSA-209776
NodeType: Pathway | PathwayName: Metabolism of amino acids and derivatives | PathwayId: R-HSA-71291
NodeType: Pathway | PathwayName: Metabolism of carbohydrates | PathwayId: R-HSA-71387
NodeType: Pathway | PathwayName: Metabolism of cofactors | PathwayId: R-HSA-8978934
NodeType: Pathway | PathwayName: Metabolism of fat-soluble vitamins | PathwayId: R-HSA-6806667
NodeType: Pathway | PathwayName: Metabolism of folate and pterines | PathwayId: R-HSA-196757
NodeType: Pathway | PathwayName: Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | PathwayId: R-HSA-2408550
NodeType: Pathway | PathwayName: Metabolism of ingested MeSeO2H into MeSeH | PathwayId: R-HSA-5263617
NodeType: Pathway | PathwayName: Metabolism of ingested SeMet, Sec, MeSec into H2Se | PathwayId: R-HSA-2408508
NodeType: Pathway | PathwayName: Metabolism of lipids | PathwayId: R-HSA-556833
NodeType: Pathway | PathwayName: Metabolism of nitric oxide: NOS3 activation and regulation | PathwayId: R-HSA-202131
NodeType: Pathway | PathwayName: Metabolism of non-coding RNA | PathwayId: R-HSA-194441
NodeType: Pathway | PathwayName: Metabolism of nucleotides | PathwayId: R-HSA-15869
NodeType: Pathway | PathwayName: Metabolism of polyamines | PathwayId: R-HSA-351202
NodeType: Pathway | PathwayName: Metabolism of porphyrins | PathwayId: R-HSA-189445
NodeType: Pathway | PathwayName: Metabolism of proteins | PathwayId: R-HSA-392499
NodeType: Pathway | PathwayName: Metabolism of serotonin | PathwayId: R-HSA-380612
NodeType: Pathway | PathwayName: Metabolism of steroid hormones | PathwayId: R-HSA-196071
NodeType: Pathway | PathwayName: Metabolism of steroids | PathwayId: R-HSA-8957322
NodeType: Pathway | PathwayName: Metabolism of vitamin K | PathwayId: R-HSA-6806664
NodeType: Pathway | PathwayName: Metabolism of vitamins and cofactors | PathwayId: R-HSA-196854
NodeType: Pathway | PathwayName: Metabolism of water-soluble vitamins and cofactors | PathwayId: R-HSA-196849
NodeType: Pathway | PathwayName: Metal ion SLC transporters | PathwayId: R-HSA-425410
NodeType: Pathway | PathwayName: Metal sequestration by antimicrobial proteins | PathwayId: R-HSA-6799990
NodeType: Pathway | PathwayName: Metalloprotease DUBs | PathwayId: R-HSA-5689901
NodeType: Pathway | PathwayName: Metallothioneins bind metals | PathwayId: R-HSA-5661231
NodeType: Pathway | PathwayName: Methionine salvage pathway | PathwayId: R-HSA-1237112
NodeType: Pathway | PathwayName: Methylation | PathwayId: R-HSA-156581
NodeType: Pathway | PathwayName: Methylation of MeSeH for excretion | PathwayId: R-HSA-2408552
NodeType: Pathway | PathwayName: MicroRNA (miRNA) biogenesis | PathwayId: R-HSA-203927
NodeType: Pathway | PathwayName: Microbial modulation of RIPK1-mediated regulated necrosis | PathwayId: R-HSA-9686347
NodeType: Pathway | PathwayName: Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | PathwayId: R-HSA-190840
NodeType: Pathway | PathwayName: Mineralocorticoid biosynthesis | PathwayId: R-HSA-193993
NodeType: Pathway | PathwayName: Minus-strand DNA synthesis | PathwayId: R-HSA-164516
NodeType: Pathway | PathwayName: Miro GTPase Cycle | PathwayId: R-HSA-9715370
NodeType: Pathway | PathwayName: Miscellaneous substrates | PathwayId: R-HSA-211958
NodeType: Pathway | PathwayName: Miscellaneous transport and binding events | PathwayId: R-HSA-5223345
NodeType: Pathway | PathwayName: Mismatch Repair | PathwayId: R-HSA-5358508
NodeType: Pathway | PathwayName: Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | PathwayId: R-HSA-5358606
NodeType: Pathway | PathwayName: Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | PathwayId: R-HSA-5358565
NodeType: Pathway | PathwayName: Mitochondrial ABC transporters | PathwayId: R-HSA-1369007
NodeType: Pathway | PathwayName: Mitochondrial Fatty Acid Beta-Oxidation | PathwayId: R-HSA-77289
NodeType: Pathway | PathwayName: Mitochondrial RNA degradation | PathwayId: R-HSA-9836573
NodeType: Pathway | PathwayName: Mitochondrial Uncoupling | PathwayId: R-HSA-166187
NodeType: Pathway | PathwayName: Mitochondrial biogenesis | PathwayId: R-HSA-1592230
NodeType: Pathway | PathwayName: Mitochondrial calcium ion transport | PathwayId: R-HSA-8949215
NodeType: Pathway | PathwayName: Mitochondrial iron-sulfur cluster biogenesis | PathwayId: R-HSA-1362409
NodeType: Pathway | PathwayName: Mitochondrial protein degradation | PathwayId: R-HSA-9837999
NodeType: Pathway | PathwayName: Mitochondrial protein import | PathwayId: R-HSA-1268020
NodeType: Pathway | PathwayName: Mitochondrial tRNA aminoacylation | PathwayId: R-HSA-379726
NodeType: Pathway | PathwayName: Mitochondrial transcription initiation | PathwayId: R-HSA-163282
NodeType: Pathway | PathwayName: Mitochondrial transcription termination | PathwayId: R-HSA-163316
NodeType: Pathway | PathwayName: Mitochondrial translation | PathwayId: R-HSA-5368287
NodeType: Pathway | PathwayName: Mitochondrial translation elongation | PathwayId: R-HSA-5389840
NodeType: Pathway | PathwayName: Mitochondrial translation initiation | PathwayId: R-HSA-5368286
NodeType: Pathway | PathwayName: Mitochondrial translation termination | PathwayId: R-HSA-5419276
NodeType: Pathway | PathwayName: Mitophagy | PathwayId: R-HSA-5205647
NodeType: Pathway | PathwayName: Mitotic Anaphase | PathwayId: R-HSA-68882
NodeType: Pathway | PathwayName: Mitotic G1 phase and G1/S transition | PathwayId: R-HSA-453279
NodeType: Pathway | PathwayName: Mitotic G2-G2/M phases | PathwayId: R-HSA-453274
NodeType: Pathway | PathwayName: Mitotic Metaphase and Anaphase | PathwayId: R-HSA-2555396
NodeType: Pathway | PathwayName: Mitotic Metaphase/Anaphase Transition | PathwayId: R-HSA-68881
NodeType: Pathway | PathwayName: Mitotic Prometaphase | PathwayId: R-HSA-68877
NodeType: Pathway | PathwayName: Mitotic Prophase | PathwayId: R-HSA-68875
NodeType: Pathway | PathwayName: Mitotic Spindle Checkpoint | PathwayId: R-HSA-69618
NodeType: Pathway | PathwayName: Mitotic Telophase/Cytokinesis | PathwayId: R-HSA-68884
NodeType: Pathway | PathwayName: Modulation by Mtb of host immune system | PathwayId: R-HSA-9637628
NodeType: Pathway | PathwayName: Molecules associated with elastic fibres | PathwayId: R-HSA-2129379
NodeType: Pathway | PathwayName: Molybdenum cofactor biosynthesis | PathwayId: R-HSA-947581
NodeType: Pathway | PathwayName: Mtb iron assimilation by chelation | PathwayId: R-HSA-1222449
NodeType: Pathway | PathwayName: Mucopolysaccharidoses | PathwayId: R-HSA-2206281
NodeType: Pathway | PathwayName: Multifunctional anion exchangers | PathwayId: R-HSA-427601
NodeType: Pathway | PathwayName: Muscarinic acetylcholine receptors | PathwayId: R-HSA-390648
NodeType: Pathway | PathwayName: Muscle contraction | PathwayId: R-HSA-397014
NodeType: Pathway | PathwayName: MyD88 cascade initiated on plasma membrane | PathwayId: R-HSA-975871
NodeType: Pathway | PathwayName: MyD88 deficiency (TLR2/4) | PathwayId: R-HSA-5602498
NodeType: Pathway | PathwayName: MyD88 deficiency (TLR5) | PathwayId: R-HSA-5602680
NodeType: Pathway | PathwayName: MyD88 dependent cascade initiated on endosome | PathwayId: R-HSA-975155
NodeType: Pathway | PathwayName: MyD88-independent TLR4 cascade | PathwayId: R-HSA-166166
NodeType: Pathway | PathwayName: MyD88:MAL(TIRAP) cascade initiated on plasma membrane | PathwayId: R-HSA-166058
NodeType: Pathway | PathwayName: Myoclonic epilepsy of Lafora | PathwayId: R-HSA-3785653
NodeType: Pathway | PathwayName: Myogenesis | PathwayId: R-HSA-525793
NodeType: Pathway | PathwayName: N-Glycan antennae elongation | PathwayId: R-HSA-975577
NodeType: Pathway | PathwayName: N-glycan antennae elongation in the medial/trans-Golgi | PathwayId: R-HSA-975576
NodeType: Pathway | PathwayName: N-glycan trimming and elongation in the cis-Golgi | PathwayId: R-HSA-964739
NodeType: Pathway | PathwayName: N-glycan trimming in the ER and Calnexin/Calreticulin cycle | PathwayId: R-HSA-532668
NodeType: Pathway | PathwayName: 2-LTR circle formation | PathwayId: R-HSA-164843
NodeType: Pathway | PathwayName: 5-Phosphoribose 1-diphosphate biosynthesis | PathwayId: R-HSA-73843
NodeType: Pathway | PathwayName: A tetrasaccharide linker sequence is required for GAG synthesis | PathwayId: R-HSA-1971475
NodeType: Pathway | PathwayName: ABC transporter disorders | PathwayId: R-HSA-5619084
NodeType: Pathway | PathwayName: ABC transporters in lipid homeostasis | PathwayId: R-HSA-1369062
NodeType: Pathway | PathwayName: ABC-family proteins mediated transport | PathwayId: R-HSA-382556
NodeType: Pathway | PathwayName: ABO blood group biosynthesis | PathwayId: R-HSA-9033807
NodeType: Pathway | PathwayName: ADORA2B mediated anti-inflammatory cytokines production | PathwayId: R-HSA-9660821
NodeType: Pathway | PathwayName: ADP signalling through P2Y purinoceptor 1 | PathwayId: R-HSA-418592
NodeType: Pathway | PathwayName: ADP signalling through P2Y purinoceptor 12 | PathwayId: R-HSA-392170
NodeType: Pathway | PathwayName: AKT phosphorylates targets in the cytosol | PathwayId: R-HSA-198323
NodeType: Pathway | PathwayName: AKT phosphorylates targets in the nucleus | PathwayId: R-HSA-198693
NodeType: Pathway | PathwayName: AKT-mediated inactivation of FOXO1A | PathwayId: R-HSA-211163
NodeType: Pathway | PathwayName: ALK mutants bind TKIs | PathwayId: R-HSA-9700645
NodeType: Pathway | PathwayName: ALKBH2 mediated reversal of alkylation damage | PathwayId: R-HSA-112122
NodeType: Pathway | PathwayName: ALKBH3 mediated reversal of alkylation damage | PathwayId: R-HSA-112126
NodeType: Pathway | PathwayName: AMPK inhibits chREBP transcriptional activation activity | PathwayId: R-HSA-163680
NodeType: Pathway | PathwayName: APC truncation mutants are not K63 polyubiquitinated | PathwayId: R-HSA-5467333
NodeType: Pathway | PathwayName: APC truncation mutants have impaired AXIN binding | PathwayId: R-HSA-5467337
NodeType: Pathway | PathwayName: APC-Cdc20 mediated degradation of Nek2A | PathwayId: R-HSA-179409
NodeType: Pathway | PathwayName: APC/C-mediated degradation of cell cycle proteins | PathwayId: R-HSA-174143
NodeType: Pathway | PathwayName: APC/C:Cdc20 mediated degradation of Cyclin B | PathwayId: R-HSA-174048
NodeType: Pathway | PathwayName: APC/C:Cdc20 mediated degradation of Securin | PathwayId: R-HSA-174154
NodeType: Pathway | PathwayName: APC/C:Cdc20 mediated degradation of mitotic proteins | PathwayId: R-HSA-176409
NodeType: Pathway | PathwayName: APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | PathwayId: R-HSA-174178
NodeType: Pathway | PathwayName: APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | PathwayId: R-HSA-179419
NodeType: Pathway | PathwayName: APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | PathwayId: R-HSA-5649702
NodeType: Pathway | PathwayName: APOBEC3G mediated resistance to HIV-1 infection | PathwayId: R-HSA-180689
NodeType: Pathway | PathwayName: ARL13B-mediated ciliary trafficking of INPP5E | PathwayId: R-HSA-5624958
NodeType: Pathway | PathwayName: ARMS-mediated activation | PathwayId: R-HSA-170984
NodeType: Pathway | PathwayName: ASP-3026-resistant ALK mutants | PathwayId: R-HSA-9717264
NodeType: Pathway | PathwayName: ATF4 activates genes in response to endoplasmic reticulum  stress | PathwayId: R-HSA-380994
NodeType: Pathway | PathwayName: ATF6 (ATF6-alpha) activates chaperone genes | PathwayId: R-HSA-381183
NodeType: Pathway | PathwayName: ATF6 (ATF6-alpha) activates chaperones | PathwayId: R-HSA-381033
NodeType: Pathway | PathwayName: ATF6B (ATF6-beta) activates chaperones | PathwayId: R-HSA-8874177
NodeType: Pathway | PathwayName: ATP sensitive Potassium channels | PathwayId: R-HSA-1296025
NodeType: Pathway | PathwayName: AUF1 (hnRNP D0) binds and destabilizes mRNA | PathwayId: R-HSA-450408
NodeType: Pathway | PathwayName: AURKA Activation by TPX2 | PathwayId: R-HSA-8854518
NodeType: Pathway | PathwayName: AXIN missense mutants destabilize the destruction complex | PathwayId: R-HSA-5467340
NodeType: Pathway | PathwayName: Abacavir ADME | PathwayId: R-HSA-2161522
NodeType: Pathway | PathwayName: Abacavir metabolism | PathwayId: R-HSA-2161541
NodeType: Pathway | PathwayName: Abacavir transmembrane transport | PathwayId: R-HSA-2161517
NodeType: Pathway | PathwayName: Abasic sugar-phosphate removal via the single-nucleotide replacement pathway | PathwayId: R-HSA-73930
NodeType: Pathway | PathwayName: Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | PathwayId: R-HSA-9659787
NodeType: Pathway | PathwayName: Aberrant regulation of mitotic cell cycle due to RB1 defects | PathwayId: R-HSA-9687139
NodeType: Pathway | PathwayName: Aberrant regulation of mitotic exit in cancer due to RB1 defects | PathwayId: R-HSA-9687136
NodeType: Pathway | PathwayName: Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate | PathwayId: R-HSA-2978092
NodeType: Pathway | PathwayName: Abortive elongation of HIV-1 transcript in the absence of Tat | PathwayId: R-HSA-167242
NodeType: Pathway | PathwayName: Acetylation | PathwayId: R-HSA-156582
NodeType: Pathway | PathwayName: Acetylcholine Neurotransmitter Release Cycle | PathwayId: R-HSA-264642
NodeType: Pathway | PathwayName: Acetylcholine binding and downstream events | PathwayId: R-HSA-181431
NodeType: Pathway | PathwayName: Acetylcholine inhibits contraction of outer hair cells | PathwayId: R-HSA-9667769
NodeType: Pathway | PathwayName: Acetylcholine regulates insulin secretion | PathwayId: R-HSA-399997
NodeType: Pathway | PathwayName: Acrosome Reaction and Sperm:Oocyte Membrane Binding | PathwayId: R-HSA-1300645
NodeType: Pathway | PathwayName: Activated NOTCH1 Transmits Signal to the Nucleus | PathwayId: R-HSA-2122948
NodeType: Pathway | PathwayName: Activated NTRK2 signals through CDK5 | PathwayId: R-HSA-9032845
NodeType: Pathway | PathwayName: Activated NTRK2 signals through FRS2 and FRS3 | PathwayId: R-HSA-9028731
NodeType: Pathway | PathwayName: Activated NTRK2 signals through FYN | PathwayId: R-HSA-9032500
NodeType: Pathway | PathwayName: Activated NTRK2 signals through PI3K | PathwayId: R-HSA-9028335
NodeType: Pathway | PathwayName: Activated NTRK2 signals through PLCG1 | PathwayId: R-HSA-9026527
NodeType: Pathway | PathwayName: Activated NTRK2 signals through RAS | PathwayId: R-HSA-9026519
NodeType: Pathway | PathwayName: Activated NTRK3 signals through PI3K | PathwayId: R-HSA-9603381
NodeType: Pathway | PathwayName: Activated NTRK3 signals through PLCG1 | PathwayId: R-HSA-9034793
NodeType: Pathway | PathwayName: Activated NTRK3 signals through RAS | PathwayId: R-HSA-9034864
NodeType: Pathway | PathwayName: Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | PathwayId: R-HSA-5625886
NodeType: Pathway | PathwayName: Activated point mutants of FGFR2 | PathwayId: R-HSA-2033519
NodeType: Pathway | PathwayName: Activation and oligomerization of BAK protein | PathwayId: R-HSA-111452
NodeType: Pathway | PathwayName: Activation of AKT2 | PathwayId: R-HSA-165158
NodeType: Pathway | PathwayName: Activation of AMPA receptors | PathwayId: R-HSA-399710
NodeType: Pathway | PathwayName: Activation of AMPK downstream of NMDARs | PathwayId: R-HSA-9619483
NodeType: Pathway | PathwayName: Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | PathwayId: R-HSA-176814
NodeType: Pathway | PathwayName: Activation of ATR in response to replication stress | PathwayId: R-HSA-176187
NodeType: Pathway | PathwayName: Activation of BAD and translocation to mitochondria | PathwayId: R-HSA-111447
NodeType: Pathway | PathwayName: Activation of BH3-only proteins | PathwayId: R-HSA-114452
NodeType: Pathway | PathwayName: Activation of BIM and translocation to mitochondria | PathwayId: R-HSA-111446
NodeType: Pathway | PathwayName: Activation of BMF and translocation to mitochondria | PathwayId: R-HSA-139910
NodeType: Pathway | PathwayName: Activation of C3 and C5 | PathwayId: R-HSA-174577
NodeType: Pathway | PathwayName: Activation of Ca-permeable Kainate Receptor | PathwayId: R-HSA-451308
NodeType: Pathway | PathwayName: Activation of G protein gated Potassium channels | PathwayId: R-HSA-1296041
NodeType: Pathway | PathwayName: Activation of GABAB receptors | PathwayId: R-HSA-991365
NodeType: Pathway | PathwayName: Activation of HOX genes during differentiation | PathwayId: R-HSA-5619507
NodeType: Pathway | PathwayName: Activation of IRF3, IRF7 mediated by TBK1, IKK (IKBKE) | PathwayId: R-HSA-936964
NodeType: Pathway | PathwayName: Activation of Matrix Metalloproteinases | PathwayId: R-HSA-1592389
NodeType: Pathway | PathwayName: Activation of NF-kappaB in B cells | PathwayId: R-HSA-1169091
NodeType: Pathway | PathwayName: Activation of NIMA Kinases NEK9, NEK6, NEK7 | PathwayId: R-HSA-2980767
NodeType: Pathway | PathwayName: Activation of NMDA receptors and postsynaptic events | PathwayId: R-HSA-442755
NodeType: Pathway | PathwayName: Activation of NOXA and translocation to mitochondria | PathwayId: R-HSA-111448
NodeType: Pathway | PathwayName: Activation of Na-permeable kainate receptors | PathwayId: R-HSA-451307
NodeType: Pathway | PathwayName: Activation of PPARGC1A (PGC-1alpha) by phosphorylation | PathwayId: R-HSA-2151209
NodeType: Pathway | PathwayName: Activation of PUMA and translocation to mitochondria | PathwayId: R-HSA-139915
NodeType: Pathway | PathwayName: Activation of RAC1 | PathwayId: R-HSA-428540
NodeType: Pathway | PathwayName: Activation of RAC1 downstream of NMDARs | PathwayId: R-HSA-9619229
NodeType: Pathway | PathwayName: Activation of RAS in B cells | PathwayId: R-HSA-1169092
NodeType: Pathway | PathwayName: Activation of SMO | PathwayId: R-HSA-5635838
NodeType: Pathway | PathwayName: Activation of TRKA receptors | PathwayId: R-HSA-187015
NodeType: Pathway | PathwayName: Activation of anterior HOX genes in hindbrain development during early embryogenesis | PathwayId: R-HSA-5617472
NodeType: Pathway | PathwayName: Activation of caspases through apoptosome-mediated cleavage | PathwayId: R-HSA-111459
NodeType: Pathway | PathwayName: Activation of gene expression by SREBF (SREBP) | PathwayId: R-HSA-2426168
NodeType: Pathway | PathwayName: Activation of kainate receptors upon glutamate binding | PathwayId: R-HSA-451326
NodeType: Pathway | PathwayName: Activation of the AP-1 family of transcription factors | PathwayId: R-HSA-450341
NodeType: Pathway | PathwayName: Activation of the TFAP2 (AP-2) family of transcription factors | PathwayId: R-HSA-8866907
NodeType: Pathway | PathwayName: Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | PathwayId: R-HSA-72662
NodeType: Pathway | PathwayName: Activation of the phototransduction cascade | PathwayId: R-HSA-2485179
NodeType: Pathway | PathwayName: Activation of the pre-replicative complex | PathwayId: R-HSA-68962
NodeType: Pathway | PathwayName: Activation, myristolyation of BID and translocation to mitochondria | PathwayId: R-HSA-75108
NodeType: Pathway | PathwayName: Activation, translocation and oligomerization of BAX | PathwayId: R-HSA-114294
NodeType: Pathway | PathwayName: Acyl chain remodeling of CL | PathwayId: R-HSA-1482798
NodeType: Pathway | PathwayName: Acyl chain remodeling of DAG and TAG | PathwayId: R-HSA-1482883
NodeType: Pathway | PathwayName: Acyl chain remodelling of PC | PathwayId: R-HSA-1482788
NodeType: Pathway | PathwayName: Acyl chain remodelling of PE | PathwayId: R-HSA-1482839
NodeType: Pathway | PathwayName: Acyl chain remodelling of PG | PathwayId: R-HSA-1482925
NodeType: Pathway | PathwayName: Acyl chain remodelling of PI | PathwayId: R-HSA-1482922
NodeType: Pathway | PathwayName: Acyl chain remodelling of PS | PathwayId: R-HSA-1482801
NodeType: Pathway | PathwayName: Adaptive Immune System | PathwayId: R-HSA-1280218
NodeType: Pathway | PathwayName: Adenosine P1 receptors | PathwayId: R-HSA-417973
NodeType: Pathway | PathwayName: Adenylate cyclase activating pathway | PathwayId: R-HSA-170660
NodeType: Pathway | PathwayName: Adenylate cyclase inhibitory pathway | PathwayId: R-HSA-170670
NodeType: Pathway | PathwayName: Adherens junctions interactions | PathwayId: R-HSA-418990
NodeType: Pathway | PathwayName: Adipogenesis | PathwayId: R-HSA-9843745
NodeType: Pathway | PathwayName: Adrenaline signalling through Alpha-2 adrenergic receptor | PathwayId: R-HSA-392023
NodeType: Pathway | PathwayName: Adrenaline,noradrenaline inhibits insulin secretion | PathwayId: R-HSA-400042
NodeType: Pathway | PathwayName: Adrenoceptors | PathwayId: R-HSA-390696
NodeType: Pathway | PathwayName: Advanced glycosylation endproduct receptor signaling | PathwayId: R-HSA-879415
NodeType: Pathway | PathwayName: Aerobic respiration and respiratory electron transport | PathwayId: R-HSA-1428517
NodeType: Pathway | PathwayName: Aflatoxin activation and detoxification | PathwayId: R-HSA-5423646
NodeType: Pathway | PathwayName: Aggrephagy | PathwayId: R-HSA-9646399
NodeType: Pathway | PathwayName: Agmatine biosynthesis | PathwayId: R-HSA-351143
NodeType: Pathway | PathwayName: Alanine metabolism | PathwayId: R-HSA-8964540
NodeType: Pathway | PathwayName: Alkylating DNA damage induced by chemotherapeutic drugs | PathwayId: R-HSA-9730737
NodeType: Pathway | PathwayName: Alpha-defensins | PathwayId: R-HSA-1462054
NodeType: Pathway | PathwayName: Alpha-oxidation of phytanate | PathwayId: R-HSA-389599
NodeType: Pathway | PathwayName: Alpha-protein kinase 1 signaling pathway | PathwayId: R-HSA-9645460
NodeType: Pathway | PathwayName: Alternative Lengthening of Telomeres (ALT) | PathwayId: R-HSA-9006821
NodeType: Pathway | PathwayName: Alternative complement activation | PathwayId: R-HSA-173736
NodeType: Pathway | PathwayName: Amine Oxidase reactions | PathwayId: R-HSA-140179
NodeType: Pathway | PathwayName: Amine ligand-binding receptors | PathwayId: R-HSA-375280
NodeType: Pathway | PathwayName: Amino Acid conjugation | PathwayId: R-HSA-156587
NodeType: Pathway | PathwayName: Amino acid transport across the plasma membrane | PathwayId: R-HSA-352230
NodeType: Pathway | PathwayName: Amino acids regulate mTORC1 | PathwayId: R-HSA-9639288
NodeType: Pathway | PathwayName: Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal | PathwayId: R-HSA-141444
NodeType: Pathway | PathwayName: Amplification of signal from the kinetochores | PathwayId: R-HSA-141424
NodeType: Pathway | PathwayName: Amyloid fiber formation | PathwayId: R-HSA-977225
NodeType: Pathway | PathwayName: Anchoring fibril formation | PathwayId: R-HSA-2214320
NodeType: Pathway | PathwayName: Anchoring of the basal body to the plasma membrane | PathwayId: R-HSA-5620912
NodeType: Pathway | PathwayName: Androgen biosynthesis | PathwayId: R-HSA-193048
NodeType: Pathway | PathwayName: Antagonism of Activin by Follistatin | PathwayId: R-HSA-2473224
NodeType: Pathway | PathwayName: Anti-inflammatory response favouring Leishmania parasite infection | PathwayId: R-HSA-9662851
NodeType: Pathway | PathwayName: Antigen Presentation: Folding, assembly and peptide loading of class I MHC | PathwayId: R-HSA-983170
NodeType: Pathway | PathwayName: Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | PathwayId: R-HSA-983695
NodeType: Pathway | PathwayName: Antigen processing-Cross presentation | PathwayId: R-HSA-1236975
NodeType: Pathway | PathwayName: Antigen processing: Ubiquitination & Proteasome degradation | PathwayId: R-HSA-983168
NodeType: Pathway | PathwayName: Antimicrobial action and antimicrobial resistance in Mtb | PathwayId: R-HSA-9639775
NodeType: Pathway | PathwayName: Antimicrobial peptides | PathwayId: R-HSA-6803157
NodeType: Pathway | PathwayName: Antiviral mechanism by IFN-stimulated genes | PathwayId: R-HSA-1169410
NodeType: Pathway | PathwayName: Apoptosis | PathwayId: R-HSA-109581
NodeType: Pathway | PathwayName: Apoptosis induced DNA fragmentation | PathwayId: R-HSA-140342
NodeType: Pathway | PathwayName: Apoptotic cleavage of cell adhesion  proteins | PathwayId: R-HSA-351906
NodeType: Pathway | PathwayName: Apoptotic cleavage of cellular proteins | PathwayId: R-HSA-111465
NodeType: Pathway | PathwayName: Apoptotic execution phase | PathwayId: R-HSA-75153
NodeType: Pathway | PathwayName: Apoptotic factor-mediated response | PathwayId: R-HSA-111471
NodeType: Pathway | PathwayName: Aquaporin-mediated transport | PathwayId: R-HSA-445717
NodeType: Pathway | PathwayName: Arachidonate production from DAG | PathwayId: R-HSA-426048
NodeType: Pathway | PathwayName: Arachidonic acid metabolism | PathwayId: R-HSA-2142753
NodeType: Pathway | PathwayName: Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2 | PathwayId: R-HSA-211957
NodeType: Pathway | PathwayName: Aryl hydrocarbon receptor signalling | PathwayId: R-HSA-8937144
NodeType: Pathway | PathwayName: Asparagine N-linked glycosylation | PathwayId: R-HSA-446203
NodeType: Pathway | PathwayName: Aspartate and asparagine metabolism | PathwayId: R-HSA-8963693
NodeType: Pathway | PathwayName: Aspirin ADME | PathwayId: R-HSA-9749641
NodeType: Pathway | PathwayName: Assembly Of The HIV Virion | PathwayId: R-HSA-175474
NodeType: Pathway | PathwayName: Assembly and cell surface presentation of NMDA receptors | PathwayId: R-HSA-9609736
NodeType: Pathway | PathwayName: Assembly and release of respiratory syncytial virus (RSV) virions | PathwayId: R-HSA-9820962
NodeType: Pathway | PathwayName: Assembly of Viral Components at the Budding Site | PathwayId: R-HSA-168316
NodeType: Pathway | PathwayName: Assembly of active LPL and LIPC lipase complexes | PathwayId: R-HSA-8963889
NodeType: Pathway | PathwayName: Assembly of collagen fibrils and other multimeric structures | PathwayId: R-HSA-2022090
NodeType: Pathway | PathwayName: Assembly of the ORC complex at the origin of replication | PathwayId: R-HSA-68616
NodeType: Pathway | PathwayName: Assembly of the SARS-CoV-1 Replication-Transcription Complex (RTC) | PathwayId: R-HSA-9683439
NodeType: Pathway | PathwayName: Assembly of the SARS-CoV-2 Replication-Transcription Complex (RTC) | PathwayId: R-HSA-9694271
NodeType: Pathway | PathwayName: Assembly of the pre-replicative complex | PathwayId: R-HSA-68867
NodeType: Pathway | PathwayName: Association of TriC/CCT with target proteins during biosynthesis | PathwayId: R-HSA-390471
NodeType: Pathway | PathwayName: Astrocytic Glutamate-Glutamine Uptake And Metabolism | PathwayId: R-HSA-210455
NodeType: Pathway | PathwayName: Asymmetric localization of PCP proteins | PathwayId: R-HSA-4608870
NodeType: Pathway | PathwayName: Atorvastatin ADME | PathwayId: R-HSA-9754706
NodeType: Pathway | PathwayName: Attachment and Entry | PathwayId: R-HSA-9678110
NodeType: Pathway | PathwayName: Attachment and Entry | PathwayId: R-HSA-9694614
NodeType: Pathway | PathwayName: Attachment of GPI anchor to uPAR | PathwayId: R-HSA-162791
NodeType: Pathway | PathwayName: Attenuation phase | PathwayId: R-HSA-3371568
NodeType: Pathway | PathwayName: Autodegradation of Cdh1 by Cdh1:APC/C | PathwayId: R-HSA-174084
NodeType: Pathway | PathwayName: Autodegradation of the E3 ubiquitin ligase COP1 | PathwayId: R-HSA-349425
NodeType: Pathway | PathwayName: Autointegration results in viral DNA circles | PathwayId: R-HSA-177539
NodeType: Pathway | PathwayName: Autophagy | PathwayId: R-HSA-9612973
NodeType: Pathway | PathwayName: Axon guidance | PathwayId: R-HSA-422475
NodeType: Pathway | PathwayName: Axonal growth inhibition (RHOA activation) | PathwayId: R-HSA-193634
NodeType: Pathway | PathwayName: Axonal growth stimulation | PathwayId: R-HSA-209563
NodeType: Pathway | PathwayName: Azathioprine ADME | PathwayId: R-HSA-9748787
NodeType: Pathway | PathwayName: B-WICH complex positively regulates rRNA expression | PathwayId: R-HSA-5250924
NodeType: Pathway | PathwayName: BBSome-mediated cargo-targeting to cilium | PathwayId: R-HSA-5620922
NodeType: Pathway | PathwayName: BCKDH synthesizes BCAA-CoA from KIC, KMVA, KIV | PathwayId: R-HSA-9859138
NodeType: Pathway | PathwayName: BDNF activates NTRK2 (TRKB) signaling | PathwayId: R-HSA-9024909
NodeType: Pathway | PathwayName: BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | PathwayId: R-HSA-111453
NodeType: Pathway | PathwayName: BMAL1:CLOCK,NPAS2 activates circadian gene expression | PathwayId: R-HSA-1368108
NodeType: Pathway | PathwayName: Bacterial Infection Pathways | PathwayId: R-HSA-9824439
NodeType: Pathway | PathwayName: Base Excision Repair | PathwayId: R-HSA-73884
NodeType: Pathway | PathwayName: Base-Excision Repair, AP Site Formation | PathwayId: R-HSA-73929
NodeType: Pathway | PathwayName: Basigin interactions | PathwayId: R-HSA-210991
NodeType: Pathway | PathwayName: Beta defensins | PathwayId: R-HSA-1461957
NodeType: Pathway | PathwayName: Beta oxidation of butanoyl-CoA to acetyl-CoA | PathwayId: R-HSA-77352
NodeType: Pathway | PathwayName: Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA | PathwayId: R-HSA-77346
NodeType: Pathway | PathwayName: Beta oxidation of hexanoyl-CoA to butanoyl-CoA | PathwayId: R-HSA-77350
NodeType: Pathway | PathwayName: Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA | PathwayId: R-HSA-77310
NodeType: Pathway | PathwayName: Beta oxidation of myristoyl-CoA to lauroyl-CoA | PathwayId: R-HSA-77285
NodeType: Pathway | PathwayName: Beta oxidation of octanoyl-CoA to hexanoyl-CoA | PathwayId: R-HSA-77348
NodeType: Pathway | PathwayName: Beta oxidation of palmitoyl-CoA to myristoyl-CoA | PathwayId: R-HSA-77305
NodeType: Pathway | PathwayName: Beta-catenin independent WNT signaling | PathwayId: R-HSA-3858494
NodeType: Pathway | PathwayName: Beta-catenin phosphorylation cascade | PathwayId: R-HSA-196299
NodeType: Pathway | PathwayName: Beta-oxidation of pristanoyl-CoA | PathwayId: R-HSA-389887
NodeType: Pathway | PathwayName: Beta-oxidation of very long chain fatty acids | PathwayId: R-HSA-390247
NodeType: Pathway | PathwayName: Bicarbonate transporters | PathwayId: R-HSA-425381
NodeType: Pathway | PathwayName: Bile acid and bile salt metabolism | PathwayId: R-HSA-194068
NodeType: Pathway | PathwayName: Binding and Uptake of Ligands by Scavenger Receptors | PathwayId: R-HSA-2173782
NodeType: Pathway | PathwayName: Binding and entry of HIV virion | PathwayId: R-HSA-173107
NodeType: Pathway | PathwayName: Binding of TCF/LEF:CTNNB1 to target gene promoters | PathwayId: R-HSA-4411364
NodeType: Pathway | PathwayName: Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB | PathwayId: R-HSA-141333
NodeType: Pathway | PathwayName: Biological oxidations | PathwayId: R-HSA-211859
NodeType: Pathway | PathwayName: Biosynthesis of A2E, implicated in retinal degradation | PathwayId: R-HSA-2466712
NodeType: Pathway | PathwayName: Biosynthesis of D-series resolvins | PathwayId: R-HSA-9018676
NodeType: Pathway | PathwayName: Biosynthesis of DHA-derived SPMs | PathwayId: R-HSA-9018677
NodeType: Pathway | PathwayName: Biosynthesis of DHA-derived sulfido conjugates | PathwayId: R-HSA-9026395
NodeType: Pathway | PathwayName: Biosynthesis of DPA-derived SPMs | PathwayId: R-HSA-9018683
NodeType: Pathway | PathwayName: Biosynthesis of DPAn-3 SPMs | PathwayId: R-HSA-9025094
NodeType: Pathway | PathwayName: Biosynthesis of DPAn-3-derived 13-series resolvins | PathwayId: R-HSA-9026403
NodeType: Pathway | PathwayName: Biosynthesis of DPAn-3-derived maresins | PathwayId: R-HSA-9026290
NodeType: Pathway | PathwayName: Biosynthesis of DPAn-3-derived protectins and resolvins | PathwayId: R-HSA-9026286
NodeType: Pathway | PathwayName: Biosynthesis of DPAn-6 SPMs | PathwayId: R-HSA-9025106
NodeType: Pathway | PathwayName: Biosynthesis of E-series 18(R)-resolvins | PathwayId: R-HSA-9023661
NodeType: Pathway | PathwayName: Biosynthesis of E-series 18(S)-resolvins | PathwayId: R-HSA-9018896
NodeType: Pathway | PathwayName: Biosynthesis of EPA-derived SPMs | PathwayId: R-HSA-9018679
NodeType: Pathway | PathwayName: Biosynthesis of aspirin-triggered D-series resolvins | PathwayId: R-HSA-9020265
NodeType: Pathway | PathwayName: Biosynthesis of electrophilic -3 PUFA oxo-derivatives | PathwayId: R-HSA-9027604
NodeType: Pathway | PathwayName: Biosynthesis of maresin conjugates in tissue regeneration (MCTR) | PathwayId: R-HSA-9026762
NodeType: Pathway | PathwayName: Biosynthesis of maresin-like SPMs | PathwayId: R-HSA-9027307
NodeType: Pathway | PathwayName: Biosynthesis of maresins | PathwayId: R-HSA-9018682
NodeType: Pathway | PathwayName: Biosynthesis of protectin and resolvin conjugates in tissue regeneration (PCTR and RCTR) | PathwayId: R-HSA-9026766
NodeType: Pathway | PathwayName: Biosynthesis of protectins | PathwayId: R-HSA-9018681
NodeType: Pathway | PathwayName: Biosynthesis of specialized proresolving mediators (SPMs) | PathwayId: R-HSA-9018678
NodeType: Pathway | PathwayName: Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | PathwayId: R-HSA-446193
NodeType: Pathway | PathwayName: Biotin transport and metabolism | PathwayId: R-HSA-196780
NodeType: Pathway | PathwayName: Blockage of phagosome acidification | PathwayId: R-HSA-9636467
NodeType: Pathway | PathwayName: Blood group systems biosynthesis | PathwayId: R-HSA-9033658
NodeType: Pathway | PathwayName: Branched-chain amino acid catabolism | PathwayId: R-HSA-70895
NodeType: Pathway | PathwayName: Breakdown of the nuclear lamina | PathwayId: R-HSA-352238
NodeType: Pathway | PathwayName: Budding | PathwayId: R-HSA-168302
NodeType: Pathway | PathwayName: Budding and maturation of HIV virion | PathwayId: R-HSA-162588
NodeType: Pathway | PathwayName: Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | PathwayId: R-HSA-450385
NodeType: Pathway | PathwayName: Butyrophilin (BTN) family interactions | PathwayId: R-HSA-8851680
NodeType: Pathway | PathwayName: C-type lectin receptors (CLRs) | PathwayId: R-HSA-5621481
NodeType: Pathway | PathwayName: C6 deamination of adenosine | PathwayId: R-HSA-75102
NodeType: Pathway | PathwayName: CASP8 activity is inhibited | PathwayId: R-HSA-5218900
NodeType: Pathway | PathwayName: CD163 mediating an anti-inflammatory response | PathwayId: R-HSA-9662834
NodeType: Pathway | PathwayName: CD209 (DC-SIGN) signaling | PathwayId: R-HSA-5621575
NodeType: Pathway | PathwayName: CD22 mediated BCR regulation | PathwayId: R-HSA-5690714
NodeType: Pathway | PathwayName: CD28 co-stimulation | PathwayId: R-HSA-389356
NodeType: Pathway | PathwayName: CD28 dependent PI3K/Akt signaling | PathwayId: R-HSA-389357
NodeType: Pathway | PathwayName: CD28 dependent Vav1 pathway | PathwayId: R-HSA-389359
NodeType: Pathway | PathwayName: CDC42 GTPase cycle | PathwayId: R-HSA-9013148
NodeType: Pathway | PathwayName: CDC6 association with the ORC:origin complex | PathwayId: R-HSA-68689
NodeType: Pathway | PathwayName: CDH11 homotypic and heterotypic interactions | PathwayId: R-HSA-9833576
NodeType: Pathway | PathwayName: CDK-mediated phosphorylation and removal of Cdc6 | PathwayId: R-HSA-69017
NodeType: Pathway | PathwayName: CHL1 interactions | PathwayId: R-HSA-447041
NodeType: Pathway | PathwayName: CLEC7A (Dectin-1) induces NFAT activation | PathwayId: R-HSA-5607763
NodeType: Pathway | PathwayName: CLEC7A (Dectin-1) signaling | PathwayId: R-HSA-5607764
NodeType: Pathway | PathwayName: CLEC7A/inflammasome pathway | PathwayId: R-HSA-5660668
NodeType: Pathway | PathwayName: COPI-dependent Golgi-to-ER retrograde traffic | PathwayId: R-HSA-6811434
NodeType: Pathway | PathwayName: COPI-independent Golgi-to-ER retrograde traffic | PathwayId: R-HSA-6811436
NodeType: Pathway | PathwayName: COPI-mediated anterograde transport | PathwayId: R-HSA-6807878
NodeType: Pathway | PathwayName: COPII-mediated vesicle transport | PathwayId: R-HSA-204005
NodeType: Pathway | PathwayName: COX reactions | PathwayId: R-HSA-140180
NodeType: Pathway | PathwayName: CREB phosphorylation | PathwayId: R-HSA-199920
NodeType: Pathway | PathwayName: CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | PathwayId: R-HSA-442742
NodeType: Pathway | PathwayName: CREB1 phosphorylation through the activation of Adenylate Cyclase | PathwayId: R-HSA-442720
NodeType: Pathway | PathwayName: CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | PathwayId: R-HSA-442729
NodeType: Pathway | PathwayName: CREB3 factors activate genes | PathwayId: R-HSA-8874211
NodeType: Pathway | PathwayName: CRMPs in Sema3A signaling | PathwayId: R-HSA-399956
NodeType: Pathway | PathwayName: CS/DS degradation | PathwayId: R-HSA-2024101
NodeType: Pathway | PathwayName: CTLA4 inhibitory signaling | PathwayId: R-HSA-389513
NodeType: Pathway | PathwayName: CTNNB1 S33 mutants aren't phosphorylated | PathwayId: R-HSA-5358747
NodeType: Pathway | PathwayName: CTNNB1 S37 mutants aren't phosphorylated | PathwayId: R-HSA-5358749
NodeType: Pathway | PathwayName: CTNNB1 S45 mutants aren't phosphorylated | PathwayId: R-HSA-5358751
NodeType: Pathway | PathwayName: CTNNB1 T41 mutants aren't phosphorylated | PathwayId: R-HSA-5358752
NodeType: Pathway | PathwayName: CYP2E1 reactions | PathwayId: R-HSA-211999
NodeType: Pathway | PathwayName: Ca-dependent events | PathwayId: R-HSA-111996
NodeType: Pathway | PathwayName: Ca2+ activated K+ channels | PathwayId: R-HSA-1296052
NodeType: Pathway | PathwayName: Ca2+ pathway | PathwayId: R-HSA-4086398
NodeType: Pathway | PathwayName: CaM pathway | PathwayId: R-HSA-111997
NodeType: Pathway | PathwayName: CaMK IV-mediated phosphorylation of CREB | PathwayId: R-HSA-111932
NodeType: Pathway | PathwayName: Calcineurin activates NFAT | PathwayId: R-HSA-2025928
NodeType: Pathway | PathwayName: Calcitonin-like ligand receptors | PathwayId: R-HSA-419812
NodeType: Pathway | PathwayName: Calmodulin induced events | PathwayId: R-HSA-111933
NodeType: Pathway | PathwayName: Calnexin/calreticulin cycle | PathwayId: R-HSA-901042
NodeType: Pathway | PathwayName: Cam-PDE 1 activation | PathwayId: R-HSA-111957
NodeType: Pathway | PathwayName: Cap-dependent Translation Initiation | PathwayId: R-HSA-72737
NodeType: Pathway | PathwayName: Carboxyterminal post-translational modifications of tubulin | PathwayId: R-HSA-8955332
NodeType: Pathway | PathwayName: Cardiac conduction | PathwayId: R-HSA-5576891
NodeType: Pathway | PathwayName: Cardiogenesis | PathwayId: R-HSA-9733709
NodeType: Pathway | PathwayName: Cargo concentration in the ER | PathwayId: R-HSA-5694530
NodeType: Pathway | PathwayName: Cargo recognition for clathrin-mediated endocytosis | PathwayId: R-HSA-8856825
NodeType: Pathway | PathwayName: Cargo trafficking to the periciliary membrane | PathwayId: R-HSA-5620920
NodeType: Pathway | PathwayName: Carnitine metabolism | PathwayId: R-HSA-200425
NodeType: Pathway | PathwayName: Carnitine synthesis | PathwayId: R-HSA-71262
NodeType: Pathway | PathwayName: Caspase activation via Death Receptors in the presence of ligand | PathwayId: R-HSA-140534
NodeType: Pathway | PathwayName: Caspase activation via Dependence Receptors in the absence of ligand | PathwayId: R-HSA-418889
NodeType: Pathway | PathwayName: Caspase activation via extrinsic apoptotic signalling pathway | PathwayId: R-HSA-5357769
NodeType: Pathway | PathwayName: Caspase-mediated cleavage of cytoskeletal proteins | PathwayId: R-HSA-264870
NodeType: Pathway | PathwayName: Catecholamine biosynthesis | PathwayId: R-HSA-209905
NodeType: Pathway | PathwayName: Cation-coupled Chloride cotransporters | PathwayId: R-HSA-426117
NodeType: Pathway | PathwayName: Cdc20:Phospho-APC/C mediated degradation of Cyclin A | PathwayId: R-HSA-174184
NodeType: Pathway | PathwayName: Cell Cycle | PathwayId: R-HSA-1640170
NodeType: Pathway | PathwayName: Cell Cycle Checkpoints | PathwayId: R-HSA-69620
NodeType: Pathway | PathwayName: Cell Cycle, Mitotic | PathwayId: R-HSA-69278
NodeType: Pathway | PathwayName: Cell death signalling via NRAGE, NRIF and NADE | PathwayId: R-HSA-204998
NodeType: Pathway | PathwayName: Cell junction organization | PathwayId: R-HSA-446728
NodeType: Pathway | PathwayName: Cell recruitment (pro-inflammatory response) | PathwayId: R-HSA-9664424
NodeType: Pathway | PathwayName: Cell redox homeostasis | PathwayId: R-HSA-1222541
NodeType: Pathway | PathwayName: Cell surface interactions at the vascular wall | PathwayId: R-HSA-202733
NodeType: Pathway | PathwayName: Cell-Cell communication | PathwayId: R-HSA-1500931
NodeType: Pathway | PathwayName: Cell-cell junction organization | PathwayId: R-HSA-421270
NodeType: Pathway | PathwayName: Cell-extracellular matrix interactions | PathwayId: R-HSA-446353
NodeType: Pathway | PathwayName: Cellular Senescence | PathwayId: R-HSA-2559583
NodeType: Pathway | PathwayName: Cellular hexose transport | PathwayId: R-HSA-189200
NodeType: Pathway | PathwayName: Cellular response to chemical stress | PathwayId: R-HSA-9711123
NodeType: Pathway | PathwayName: Cellular response to heat stress | PathwayId: R-HSA-3371556
NodeType: Pathway | PathwayName: Cellular response to hypoxia | PathwayId: R-HSA-1234174
NodeType: Pathway | PathwayName: Cellular response to mitochondrial stress | PathwayId: R-HSA-9840373
NodeType: Pathway | PathwayName: Cellular response to starvation | PathwayId: R-HSA-9711097
NodeType: Pathway | PathwayName: Cellular responses to stimuli | PathwayId: R-HSA-8953897
NodeType: Pathway | PathwayName: Cellular responses to stress | PathwayId: R-HSA-2262752
NodeType: Pathway | PathwayName: Centrosome maturation | PathwayId: R-HSA-380287
NodeType: Pathway | PathwayName: Ceramide signalling | PathwayId: R-HSA-193681
NodeType: Pathway | PathwayName: ChREBP activates metabolic gene expression | PathwayId: R-HSA-163765
NodeType: Pathway | PathwayName: Chaperone Mediated Autophagy | PathwayId: R-HSA-9613829
NodeType: Pathway | PathwayName: Chaperonin-mediated protein folding | PathwayId: R-HSA-390466
NodeType: Pathway | PathwayName: Chemokine receptors bind chemokines | PathwayId: R-HSA-380108
NodeType: Pathway | PathwayName: Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | PathwayId: R-HSA-75035
NodeType: Pathway | PathwayName: Cholesterol biosynthesis | PathwayId: R-HSA-191273
NodeType: Pathway | PathwayName: Cholesterol biosynthesis via desmosterol | PathwayId: R-HSA-6807047
NodeType: Pathway | PathwayName: Cholesterol biosynthesis via lathosterol | PathwayId: R-HSA-6807062
NodeType: Pathway | PathwayName: Choline catabolism | PathwayId: R-HSA-6798163
NodeType: Pathway | PathwayName: Chondroitin sulfate biosynthesis | PathwayId: R-HSA-2022870
NodeType: Pathway | PathwayName: Chondroitin sulfate/dermatan sulfate metabolism | PathwayId: R-HSA-1793185
NodeType: Pathway | PathwayName: Chromatin modifications during the maternal to zygotic transition (MZT) | PathwayId: R-HSA-9821002
NodeType: Pathway | PathwayName: Chromatin modifying enzymes | PathwayId: R-HSA-3247509
NodeType: Pathway | PathwayName: Chromatin organization | PathwayId: R-HSA-4839726
NodeType: Pathway | PathwayName: Chromosome Maintenance | PathwayId: R-HSA-73886
NodeType: Pathway | PathwayName: Chylomicron assembly | PathwayId: R-HSA-8963888
NodeType: Pathway | PathwayName: Chylomicron clearance | PathwayId: R-HSA-8964026
NodeType: Pathway | PathwayName: Chylomicron remodeling | PathwayId: R-HSA-8963901
NodeType: Pathway | PathwayName: Cilium Assembly | PathwayId: R-HSA-5617833
NodeType: Pathway | PathwayName: Ciprofloxacin ADME | PathwayId: R-HSA-9793528
NodeType: Pathway | PathwayName: Circadian Clock | PathwayId: R-HSA-400253
NodeType: Pathway | PathwayName: Citric acid cycle (TCA cycle) | PathwayId: R-HSA-71403
NodeType: Pathway | PathwayName: Class A/1 (Rhodopsin-like receptors) | PathwayId: R-HSA-373076
NodeType: Pathway | PathwayName: Class B/2 (Secretin family receptors) | PathwayId: R-HSA-373080
NodeType: Pathway | PathwayName: Class C/3 (Metabotropic glutamate/pheromone receptors) | PathwayId: R-HSA-420499
NodeType: Pathway | PathwayName: Class I MHC mediated antigen processing & presentation | PathwayId: R-HSA-983169
NodeType: Pathway | PathwayName: Class I peroxisomal membrane protein import | PathwayId: R-HSA-9603798
NodeType: Pathway | PathwayName: Classical Kir channels | PathwayId: R-HSA-1296053
NodeType: Pathway | PathwayName: Classical antibody-mediated complement activation | PathwayId: R-HSA-173623
NodeType: Pathway | PathwayName: Clathrin-mediated endocytosis | PathwayId: R-HSA-8856828
NodeType: Pathway | PathwayName: Cleavage of the damaged purine | PathwayId: R-HSA-110331
NodeType: Pathway | PathwayName: Cleavage of the damaged pyrimidine | PathwayId: R-HSA-110329
NodeType: Pathway | PathwayName: Cobalamin (Cbl) metabolism | PathwayId: R-HSA-9759218
NodeType: Pathway | PathwayName: Cobalamin (Cbl, vitamin B12) transport and metabolism | PathwayId: R-HSA-196741
NodeType: Pathway | PathwayName: Coenzyme A biosynthesis | PathwayId: R-HSA-196783
NodeType: Pathway | PathwayName: Cohesin Loading onto Chromatin | PathwayId: R-HSA-2470946
NodeType: Pathway | PathwayName: Collagen biosynthesis and modifying enzymes | PathwayId: R-HSA-1650814
NodeType: Pathway | PathwayName: Collagen chain trimerization | PathwayId: R-HSA-8948216
NodeType: Pathway | PathwayName: Collagen degradation | PathwayId: R-HSA-1442490
NodeType: Pathway | PathwayName: Collagen formation | PathwayId: R-HSA-1474290
NodeType: Pathway | PathwayName: Common Pathway of Fibrin Clot Formation | PathwayId: R-HSA-140875
NodeType: Pathway | PathwayName: Competing endogenous RNAs (ceRNAs) regulate PTEN translation | PathwayId: R-HSA-8948700
NodeType: Pathway | PathwayName: Complement cascade | PathwayId: R-HSA-166658
NodeType: Pathway | PathwayName: Complex I biogenesis | PathwayId: R-HSA-6799198
NodeType: Pathway | PathwayName: Complex III assembly | PathwayId: R-HSA-9865881
NodeType: Pathway | PathwayName: Complex IV assembly | PathwayId: R-HSA-9864848
NodeType: Pathway | PathwayName: Condensation of Prometaphase Chromosomes | PathwayId: R-HSA-2514853
NodeType: Pathway | PathwayName: Condensation of Prophase Chromosomes | PathwayId: R-HSA-2299718
NodeType: Pathway | PathwayName: Conjugation of benzoate with glycine | PathwayId: R-HSA-177135
NodeType: Pathway | PathwayName: Conjugation of carboxylic acids | PathwayId: R-HSA-159424
NodeType: Pathway | PathwayName: Conjugation of phenylacetate with glutamine | PathwayId: R-HSA-177162
NodeType: Pathway | PathwayName: Conjugation of salicylate with glycine | PathwayId: R-HSA-177128
NodeType: Pathway | PathwayName: Constitutive Signaling by AKT1 E17K in Cancer | PathwayId: R-HSA-5674400
NodeType: Pathway | PathwayName: Constitutive Signaling by Aberrant PI3K in Cancer | PathwayId: R-HSA-2219530
NodeType: Pathway | PathwayName: Constitutive Signaling by EGFRvIII | PathwayId: R-HSA-5637810
NodeType: Pathway | PathwayName: Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | PathwayId: R-HSA-1236382
NodeType: Pathway | PathwayName: Constitutive Signaling by NOTCH1 HD Domain Mutants | PathwayId: R-HSA-2691232
NodeType: Pathway | PathwayName: Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | PathwayId: R-HSA-2894862
NodeType: Pathway | PathwayName: Constitutive Signaling by NOTCH1 PEST Domain Mutants | PathwayId: R-HSA-2644606
NodeType: Pathway | PathwayName: Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | PathwayId: R-HSA-2660826
NodeType: Pathway | PathwayName: Constitutive Signaling by Overexpressed ERBB2 | PathwayId: R-HSA-9634285
NodeType: Pathway | PathwayName: Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | PathwayId: R-HSA-176407
NodeType: Pathway | PathwayName: Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | PathwayId: R-HSA-6814122
NodeType: Pathway | PathwayName: Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding | PathwayId: R-HSA-389958
NodeType: Pathway | PathwayName: Costimulation by the CD28 family | PathwayId: R-HSA-388841
NodeType: Pathway | PathwayName: Creatine metabolism | PathwayId: R-HSA-71288
NodeType: Pathway | PathwayName: Creation of C4 and C2 activators | PathwayId: R-HSA-166786
NodeType: Pathway | PathwayName: Cristae formation | PathwayId: R-HSA-8949613
NodeType: Pathway | PathwayName: Cross-presentation of particulate exogenous antigens (phagosomes) | PathwayId: R-HSA-1236973
NodeType: Pathway | PathwayName: Cross-presentation of soluble exogenous antigens (endosomes) | PathwayId: R-HSA-1236978
NodeType: Pathway | PathwayName: Crosslinking of collagen fibrils | PathwayId: R-HSA-2243919
NodeType: Pathway | PathwayName: Cyclin A/B1/B2 associated events during G2/M transition | PathwayId: R-HSA-69273
NodeType: Pathway | PathwayName: Cyclin A:Cdk2-associated events at S phase entry | PathwayId: R-HSA-69656
NodeType: Pathway | PathwayName: Cyclin D associated events in G1 | PathwayId: R-HSA-69231
NodeType: Pathway | PathwayName: Cyclin E associated events during G1/S transition | PathwayId: R-HSA-69202
NodeType: Pathway | PathwayName: Cysteine formation from homocysteine | PathwayId: R-HSA-1614603
NodeType: Pathway | PathwayName: Cytochrome P450 - arranged by substrate type | PathwayId: R-HSA-211897
NodeType: Pathway | PathwayName: Cytochrome c-mediated apoptotic response | PathwayId: R-HSA-111461
NodeType: Pathway | PathwayName: Cytokine Signaling in Immune system | PathwayId: R-HSA-1280215
NodeType: Pathway | PathwayName: Cytoprotection by HMOX1 | PathwayId: R-HSA-9707564
NodeType: Pathway | PathwayName: Cytosolic iron-sulfur cluster assembly | PathwayId: R-HSA-2564830
NodeType: Pathway | PathwayName: Cytosolic sensors of pathogen-associated DNA | PathwayId: R-HSA-1834949
NodeType: Pathway | PathwayName: Cytosolic sulfonation of small molecules | PathwayId: R-HSA-156584
NodeType: Pathway | PathwayName: Cytosolic tRNA aminoacylation | PathwayId: R-HSA-379716
NodeType: Pathway | PathwayName: DAG and IP3 signaling | PathwayId: R-HSA-1489509
NodeType: Pathway | PathwayName: DAP12 interactions | PathwayId: R-HSA-2172127
NodeType: Pathway | PathwayName: DAP12 signaling | PathwayId: R-HSA-2424491
NodeType: Pathway | PathwayName: DARPP-32 events | PathwayId: R-HSA-180024
NodeType: Pathway | PathwayName: DCC mediated attractive signaling | PathwayId: R-HSA-418885
NodeType: Pathway | PathwayName: DDX58/IFIH1-mediated induction of interferon-alpha/beta | PathwayId: R-HSA-168928
NodeType: Pathway | PathwayName: DEx/H-box helicases activate type I IFN and inflammatory cytokines production | PathwayId: R-HSA-3134963
NodeType: Pathway | PathwayName: DNA Damage Bypass | PathwayId: R-HSA-73893
NodeType: Pathway | PathwayName: DNA Damage Recognition in GG-NER | PathwayId: R-HSA-5696394
NodeType: Pathway | PathwayName: DNA Damage Reversal | PathwayId: R-HSA-73942
NodeType: Pathway | PathwayName: DNA Damage/Telomere Stress Induced Senescence | PathwayId: R-HSA-2559586
NodeType: Pathway | PathwayName: DNA Double Strand Break Response | PathwayId: R-HSA-5693606
NodeType: Pathway | PathwayName: DNA Double-Strand Break Repair | PathwayId: R-HSA-5693532
NodeType: Pathway | PathwayName: DNA Repair | PathwayId: R-HSA-73894
NodeType: Pathway | PathwayName: DNA Replication | PathwayId: R-HSA-69306
NodeType: Pathway | PathwayName: DNA Replication Pre-Initiation | PathwayId: R-HSA-69002
NodeType: Pathway | PathwayName: DNA methylation | PathwayId: R-HSA-5334118
NodeType: Pathway | PathwayName: DNA replication initiation | PathwayId: R-HSA-68952
NodeType: Pathway | PathwayName: DNA strand elongation | PathwayId: R-HSA-69190
NodeType: Pathway | PathwayName: DSCAM interactions | PathwayId: R-HSA-376172
NodeType: Pathway | PathwayName: Dasatinib-resistant KIT mutants | PathwayId: R-HSA-9669914
NodeType: Pathway | PathwayName: Deactivation of the beta-catenin transactivating complex | PathwayId: R-HSA-3769402
NodeType: Pathway | PathwayName: Deadenylation of mRNA | PathwayId: R-HSA-429947
NodeType: Pathway | PathwayName: Deadenylation-dependent mRNA decay | PathwayId: R-HSA-429914
NodeType: Pathway | PathwayName: Death Receptor Signaling | PathwayId: R-HSA-73887
NodeType: Pathway | PathwayName: Dectin-1 mediated noncanonical NF-kB signaling | PathwayId: R-HSA-5607761
NodeType: Pathway | PathwayName: Dectin-2 family | PathwayId: R-HSA-5621480
NodeType: Pathway | PathwayName: Defective ABCA1 causes TGD | PathwayId: R-HSA-5682113
NodeType: Pathway | PathwayName: Defective ABCA12 causes ARCI4B | PathwayId: R-HSA-5682294
NodeType: Pathway | PathwayName: Defective ABCA3 causes SMDP3 | PathwayId: R-HSA-5688399
NodeType: Pathway | PathwayName: Defective ABCA3 causes SMDP3 | PathwayId: R-HSA-5683678
NodeType: Pathway | PathwayName: Defective ABCB11 causes PFIC2 and BRIC2 | PathwayId: R-HSA-5678520
NodeType: Pathway | PathwayName: Defective ABCB4 causes PFIC3, ICP3 and GBD1 | PathwayId: R-HSA-5678771
NodeType: Pathway | PathwayName: Defective ABCB6 causes MCOPCB7 | PathwayId: R-HSA-5683371
NodeType: Pathway | PathwayName: Defective ABCC2 causes DJS | PathwayId: R-HSA-5679001
NodeType: Pathway | PathwayName: Defective ABCC6 causes PXE | PathwayId: R-HSA-5690338
NodeType: Pathway | PathwayName: Defective ABCC8 can cause hypo- and hyper-glycemias | PathwayId: R-HSA-5683177
NodeType: Pathway | PathwayName: Defective ABCC9 causes CMD10, ATFB12 and Cantu syndrome | PathwayId: R-HSA-5678420
NodeType: Pathway | PathwayName: Defective ABCD1 causes ALD | PathwayId: R-HSA-5684045
NodeType: Pathway | PathwayName: Defective ABCD4 causes MAHCJ | PathwayId: R-HSA-5683329
NodeType: Pathway | PathwayName: Defective ABCG5 causes sitosterolemia | PathwayId: R-HSA-5679096
NodeType: Pathway | PathwayName: Defective ABCG8 causes GBD4 and sitosterolemia | PathwayId: R-HSA-5679090
NodeType: Pathway | PathwayName: Defective ACTH causes obesity and POMCD | PathwayId: R-HSA-5579031
NodeType: Pathway | PathwayName: Defective ACY1 causes encephalopathy | PathwayId: R-HSA-5579007
NodeType: Pathway | PathwayName: Defective ADA disrupts (deoxy)adenosine deamination | PathwayId: R-HSA-9734735
NodeType: Pathway | PathwayName: Defective AHCY causes HMAHCHD | PathwayId: R-HSA-5578997
NodeType: Pathway | PathwayName: Defective ALG1 causes CDG-1k | PathwayId: R-HSA-4549380
NodeType: Pathway | PathwayName: Defective ALG11 causes CDG-1p | PathwayId: R-HSA-4551295
NodeType: Pathway | PathwayName: Defective ALG12 causes CDG-1g | PathwayId: R-HSA-4720489
NodeType: Pathway | PathwayName: Defective ALG14 causes ALG14-CMS | PathwayId: R-HSA-5633231
NodeType: Pathway | PathwayName: Defective ALG2 causes CDG-1i | PathwayId: R-HSA-4549349
NodeType: Pathway | PathwayName: Defective ALG3 causes CDG-1d | PathwayId: R-HSA-4720475
NodeType: Pathway | PathwayName: Defective ALG6 causes CDG-1c | PathwayId: R-HSA-4724289
NodeType: Pathway | PathwayName: Defective ALG8 causes CDG-1h | PathwayId: R-HSA-4724325
NodeType: Pathway | PathwayName: Defective ALG9 causes CDG-1l | PathwayId: R-HSA-4720454
NodeType: Pathway | PathwayName: Defective AMN causes MGA1 | PathwayId: R-HSA-3359462
NodeType: Pathway | PathwayName: Defective APRT disrupts adenine salvage | PathwayId: R-HSA-9734195
NodeType: Pathway | PathwayName: Defective AVP does not bind AVPR1A,B and causes neurohypophyseal diabetes insipidus (NDI) | PathwayId: R-HSA-5619099
NodeType: Pathway | PathwayName: Defective AVP does not bind AVPR2 and causes neurohypophyseal diabetes insipidus (NDI) | PathwayId: R-HSA-9036092
NodeType: Pathway | PathwayName: Defective B3GALT6 causes EDSP2 and SEMDJL1 | PathwayId: R-HSA-4420332
NodeType: Pathway | PathwayName: Defective B3GALTL causes PpS | PathwayId: R-HSA-5083635
NodeType: Pathway | PathwayName: Defective B3GAT3 causes JDSSDHD | PathwayId: R-HSA-3560801
NodeType: Pathway | PathwayName: Defective B4GALT1 causes B4GALT1-CDG (CDG-2d) | PathwayId: R-HSA-3656244
NodeType: Pathway | PathwayName: Defective B4GALT1 causes CDG-2d | PathwayId: R-HSA-4793953
NodeType: Pathway | PathwayName: Defective B4GALT7 causes EDS, progeroid type | PathwayId: R-HSA-3560783
NodeType: Pathway | PathwayName: Defective BTD causes biotidinase deficiency | PathwayId: R-HSA-3371598
NodeType: Pathway | PathwayName: Defective Base Excision Repair Associated with MUTYH | PathwayId: R-HSA-9605310
NodeType: Pathway | PathwayName: Defective Base Excision Repair Associated with NEIL1 | PathwayId: R-HSA-9616334
NodeType: Pathway | PathwayName: Defective Base Excision Repair Associated with NEIL3 | PathwayId: R-HSA-9629232
NodeType: Pathway | PathwayName: Defective Base Excision Repair Associated with NTHL1 | PathwayId: R-HSA-9616333
NodeType: Pathway | PathwayName: Defective Base Excision Repair Associated with OGG1 | PathwayId: R-HSA-9656249
NodeType: Pathway | PathwayName: Defective C1GALT1C1 causes TNPS | PathwayId: R-HSA-5083632
NodeType: Pathway | PathwayName: Defective CBLIF causes IFD | PathwayId: R-HSA-3359457
NodeType: Pathway | PathwayName: Defective CD320 causes MMATC | PathwayId: R-HSA-3359485
NodeType: Pathway | PathwayName: Defective CFTR causes cystic fibrosis | PathwayId: R-HSA-5678895
NodeType: Pathway | PathwayName: Defective CHST14 causes EDS, musculocontractural type | PathwayId: R-HSA-3595174
NodeType: Pathway | PathwayName: Defective CHST3 causes SEDCJD | PathwayId: R-HSA-3595172
NodeType: Pathway | PathwayName: Defective CHST6 causes MCDC1 | PathwayId: R-HSA-3656225
NodeType: Pathway | PathwayName: Defective CHSY1 causes TPBS | PathwayId: R-HSA-3595177
NodeType: Pathway | PathwayName: Defective CP causes aceruloplasminemia (ACERULOP) | PathwayId: R-HSA-5619060
NodeType: Pathway | PathwayName: Defective CSF2RA causes SMDP4 | PathwayId: R-HSA-5688890
NodeType: Pathway | PathwayName: Defective CSF2RB causes SMDP5 | PathwayId: R-HSA-5688849
NodeType: Pathway | PathwayName: Defective CUBN causes MGA1 | PathwayId: R-HSA-3359463
NodeType: Pathway | PathwayName: Defective CYP11A1 causes AICSR | PathwayId: R-HSA-5579026
NodeType: Pathway | PathwayName: Defective CYP11B1 causes AH4 | PathwayId: R-HSA-5579017
NodeType: Pathway | PathwayName: Defective CYP11B2 causes CMO-1 deficiency | PathwayId: R-HSA-5579009
NodeType: Pathway | PathwayName: Defective CYP17A1 causes AH5 | PathwayId: R-HSA-5579028
NodeType: Pathway | PathwayName: Defective CYP19A1 causes AEXS | PathwayId: R-HSA-5579030
NodeType: Pathway | PathwayName: Defective CYP1B1 causes Glaucoma | PathwayId: R-HSA-5579000
NodeType: Pathway | PathwayName: Defective CYP21A2 causes AH3 | PathwayId: R-HSA-5579021
NodeType: Pathway | PathwayName: Defective CYP24A1 causes HCAI | PathwayId: R-HSA-5579010
NodeType: Pathway | PathwayName: Defective CYP26B1 causes RHFCA | PathwayId: R-HSA-5579015
NodeType: Pathway | PathwayName: Defective CYP26C1 causes FFDD4 | PathwayId: R-HSA-5579004
NodeType: Pathway | PathwayName: Defective CYP27A1 causes CTX | PathwayId: R-HSA-5578996
NodeType: Pathway | PathwayName: Defective CYP27B1 causes VDDR1A | PathwayId: R-HSA-5579014
NodeType: Pathway | PathwayName: Defective CYP27B1 causes VDDR1B | PathwayId: R-HSA-5579027
NodeType: Pathway | PathwayName: Defective CYP2U1 causes SPG56 | PathwayId: R-HSA-5579011
NodeType: Pathway | PathwayName: Defective CYP4F22 causes ARCI5 | PathwayId: R-HSA-5579005
NodeType: Pathway | PathwayName: Defective CYP7B1 causes SPG5A and CBAS3 | PathwayId: R-HSA-5579013
NodeType: Pathway | PathwayName: Defective DHDDS causes RP59 | PathwayId: R-HSA-4755609
NodeType: Pathway | PathwayName: Defective DNA double strand break response due to BARD1 loss of function | PathwayId: R-HSA-9699150
NodeType: Pathway | PathwayName: Defective DNA double strand break response due to BRCA1 loss of function | PathwayId: R-HSA-9663199
NodeType: Pathway | PathwayName: Defective DOLK causes DOLK-CDG | PathwayId: R-HSA-4755583
NodeType: Pathway | PathwayName: Defective DPAGT1 causes CDG-1j, CMSTA2 | PathwayId: R-HSA-4549356
NodeType: Pathway | PathwayName: Defective DPM1 causes DPM1-CDG | PathwayId: R-HSA-4717374
NodeType: Pathway | PathwayName: Defective DPM2 causes DPM2-CDG | PathwayId: R-HSA-4719377
NodeType: Pathway | PathwayName: Defective DPM3 causes DPM3-CDG | PathwayId: R-HSA-4719360
NodeType: Pathway | PathwayName: Defective EXT1 causes exostoses 1, TRPS2 and CHDS | PathwayId: R-HSA-3656253
NodeType: Pathway | PathwayName: Defective EXT2 causes exostoses 2 | PathwayId: R-HSA-3656237
NodeType: Pathway | PathwayName: Defective F8 accelerates dissociation of the A2 domain | PathwayId: R-HSA-9672387
NodeType: Pathway | PathwayName: Defective F8 binding to the cell membrane | PathwayId: R-HSA-9672395
NodeType: Pathway | PathwayName: Defective F8 binding to von Willebrand factor | PathwayId: R-HSA-9672393
NodeType: Pathway | PathwayName: Defective F8 cleavage by thrombin | PathwayId: R-HSA-9672391
NodeType: Pathway | PathwayName: Defective F8 secretion | PathwayId: R-HSA-9672397
NodeType: Pathway | PathwayName: Defective F8 sulfation at Y1699 | PathwayId: R-HSA-9674519
NodeType: Pathway | PathwayName: Defective F9 activation | PathwayId: R-HSA-9673221
NodeType: Pathway | PathwayName: Defective F9 secretion | PathwayId: R-HSA-9673218
NodeType: Pathway | PathwayName: Defective F9 variant does not activate FX | PathwayId: R-HSA-9673202
NodeType: Pathway | PathwayName: Defective FMO3 causes TMAU | PathwayId: R-HSA-5579019
NodeType: Pathway | PathwayName: Defective GALE causes EDG | PathwayId: R-HSA-5609977
NodeType: Pathway | PathwayName: Defective GALK1 causes GALCT2 | PathwayId: R-HSA-5609976
NodeType: Pathway | PathwayName: Defective GALNT12 causes CRCS1 | PathwayId: R-HSA-5083636
NodeType: Pathway | PathwayName: Defective GALNT3 causes HFTC | PathwayId: R-HSA-5083625
NodeType: Pathway | PathwayName: Defective GALT can cause GALCT | PathwayId: R-HSA-5609978
NodeType: Pathway | PathwayName: Defective GCK causes maturity-onset diabetes of the young 2 (MODY2) | PathwayId: R-HSA-5619073
NodeType: Pathway | PathwayName: Defective GCLC causes HAGGSD | PathwayId: R-HSA-5578999
NodeType: Pathway | PathwayName: Defective GFPT1 causes CMSTA1 | PathwayId: R-HSA-4085023
NodeType: Pathway | PathwayName: Defective GGT1 causes GLUTH | PathwayId: R-HSA-5579022
NodeType: Pathway | PathwayName: Defective GGT1 in aflatoxin detoxification causes GLUTH | PathwayId: R-HSA-9035968
NodeType: Pathway | PathwayName: Defective GNE causes sialuria, NK and IBM2 | PathwayId: R-HSA-4085011
NodeType: Pathway | PathwayName: Defective GSS causes GSS deficiency | PathwayId: R-HSA-5579006
NodeType: Pathway | PathwayName: Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | PathwayId: R-HSA-9704331
NodeType: Pathway | PathwayName: Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | PathwayId: R-HSA-9704646
NodeType: Pathway | PathwayName: Defective HEXA causes GM2G1 | PathwayId: R-HSA-3656234
NodeType: Pathway | PathwayName: Defective HEXB causes GM2G2 | PathwayId: R-HSA-3656248
NodeType: Pathway | PathwayName: Defective HK1 causes hexokinase deficiency (HK deficiency) | PathwayId: R-HSA-5619056
NodeType: Pathway | PathwayName: Defective HLCS causes multiple carboxylase deficiency | PathwayId: R-HSA-3371599
NodeType: Pathway | PathwayName: Defective HPRT1 disrupts guanine and hypoxanthine salvage | PathwayId: R-HSA-9734281
NodeType: Pathway | PathwayName: Defective Inhibition of DNA Recombination at Telomere | PathwayId: R-HSA-9670621
NodeType: Pathway | PathwayName: Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | PathwayId: R-HSA-9670615
NodeType: Pathway | PathwayName: Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | PathwayId: R-HSA-9670613
NodeType: Pathway | PathwayName: Defective Intrinsic Pathway for Apoptosis | PathwayId: R-HSA-9734009
NodeType: Pathway | PathwayName: Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function | PathwayId: R-HSA-9645722
NodeType: Pathway | PathwayName: Defective LARGE causes MDDGA6 and MDDGB6 | PathwayId: R-HSA-5083627
NodeType: Pathway | PathwayName: Defective LFNG causes SCDO3 | PathwayId: R-HSA-5083630
NodeType: Pathway | PathwayName: Defective MAN1B1 causes MRT15 | PathwayId: R-HSA-4793950
NodeType: Pathway | PathwayName: Defective MAOA causes BRUNS | PathwayId: R-HSA-5579012
NodeType: Pathway | PathwayName: Defective MAT1A causes MATD | PathwayId: R-HSA-5579024
NodeType: Pathway | PathwayName: Defective MGAT2 causes CDG-2a | PathwayId: R-HSA-4793952
NodeType: Pathway | PathwayName: Defective MMAA causes MMA, cblA type | PathwayId: R-HSA-3359475
NodeType: Pathway | PathwayName: Defective MMAB causes MMA, cblB type | PathwayId: R-HSA-3359471
NodeType: Pathway | PathwayName: Defective MMACHC causes MAHCC | PathwayId: R-HSA-3359474
NodeType: Pathway | PathwayName: Defective MMADHC causes MMAHCD | PathwayId: R-HSA-3359473
NodeType: Pathway | PathwayName: Defective MOGS causes CDG-2b | PathwayId: R-HSA-4793954
NodeType: Pathway | PathwayName: Defective MPDU1 causes CDG-1f | PathwayId: R-HSA-4687000
NodeType: Pathway | PathwayName: Defective MPI causes MPI-CDG | PathwayId: R-HSA-4043916
NodeType: Pathway | PathwayName: Defective MTR causes HMAG | PathwayId: R-HSA-3359469
NodeType: Pathway | PathwayName: Defective MTRR causes HMAE | PathwayId: R-HSA-3359467
NodeType: Pathway | PathwayName: Defective MUT causes MMAM | PathwayId: R-HSA-3359478
NodeType: Pathway | PathwayName: Defective MUTYH substrate binding | PathwayId: R-HSA-9608287
NodeType: Pathway | PathwayName: Defective MUTYH substrate processing | PathwayId: R-HSA-9608290
NodeType: Pathway | PathwayName: Defective Mismatch Repair Associated With MLH1 | PathwayId: R-HSA-5545483
NodeType: Pathway | PathwayName: Defective Mismatch Repair Associated With MSH2 | PathwayId: R-HSA-5632928
NodeType: Pathway | PathwayName: Defective Mismatch Repair Associated With MSH3 | PathwayId: R-HSA-5632927
NodeType: Pathway | PathwayName: Defective Mismatch Repair Associated With MSH6 | PathwayId: R-HSA-5632968
NodeType: Pathway | PathwayName: Defective Mismatch Repair Associated With PMS2 | PathwayId: R-HSA-5632987
NodeType: Pathway | PathwayName: Defective NEU1 causes sialidosis | PathwayId: R-HSA-4341670
NodeType: Pathway | PathwayName: Defective NTHL1 substrate binding | PathwayId: R-HSA-9630222
NodeType: Pathway | PathwayName: Defective NTHL1 substrate processing | PathwayId: R-HSA-9630221
NodeType: Pathway | PathwayName: Defective OGG1 Localization | PathwayId: R-HSA-9657050
NodeType: Pathway | PathwayName: Defective OGG1 Substrate Binding | PathwayId: R-HSA-9656255
NodeType: Pathway | PathwayName: Defective OGG1 Substrate Processing | PathwayId: R-HSA-9656256
NodeType: Pathway | PathwayName: Defective OPLAH causes OPLAHD | PathwayId: R-HSA-5578998
NodeType: Pathway | PathwayName: Defective PAPSS2 causes SEMD-PA | PathwayId: R-HSA-3560796
NodeType: Pathway | PathwayName: Defective PGM1 causes PGM1-CDG | PathwayId: R-HSA-5609974
NodeType: Pathway | PathwayName: Defective PMM2 causes PMM2-CDG | PathwayId: R-HSA-4043911
NodeType: Pathway | PathwayName: Defective PNP disrupts phosphorolysis of (deoxy)guanosine and (deoxy)inosine | PathwayId: R-HSA-9735763
NodeType: Pathway | PathwayName: Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3 | PathwayId: R-HSA-5083628
NodeType: Pathway | PathwayName: Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1 | PathwayId: R-HSA-5083633
NodeType: Pathway | PathwayName: Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2 | PathwayId: R-HSA-5083629
NodeType: Pathway | PathwayName: Defective RFT1 causes CDG-1n | PathwayId: R-HSA-4570571
NodeType: Pathway | PathwayName: Defective RHAG causes regulator type Rh-null hemolytic anemia (RHN) | PathwayId: R-HSA-5619042
NodeType: Pathway | PathwayName: Defective RIPK1-mediated regulated necrosis | PathwayId: R-HSA-9693928
NodeType: Pathway | PathwayName: Defective SERPING1 causes hereditary angioedema | PathwayId: R-HSA-9657689
NodeType: Pathway | PathwayName: Defective SFTPA2 causes IPF | PathwayId: R-HSA-5687868
NodeType: Pathway | PathwayName: Defective SLC11A2 causes hypochromic microcytic anemia, with iron overload 1 (AHMIO1) | PathwayId: R-HSA-5619048
NodeType: Pathway | PathwayName: Defective SLC12A1 causes Bartter syndrome 1 (BS1) | PathwayId: R-HSA-5619104
NodeType: Pathway | PathwayName: Defective SLC12A3 causes Gitelman syndrome (GS) | PathwayId: R-HSA-5619087
NodeType: Pathway | PathwayName: Defective SLC12A6 causes agenesis of the corpus callosum, with peripheral neuropathy (ACCPN) | PathwayId: R-HSA-5619039
NodeType: Pathway | PathwayName: Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT) | PathwayId: R-HSA-5619070
NodeType: Pathway | PathwayName: Defective SLC17A5 causes Salla disease (SD) and ISSD | PathwayId: R-HSA-5619035
NodeType: Pathway | PathwayName: Defective SLC17A8 causes autosomal dominant deafness 25 (DFNA25) | PathwayId: R-HSA-5619076
NodeType: Pathway | PathwayName: Defective SLC1A1 is implicated in schizophrenia 18 (SCZD18) and dicarboxylic aminoaciduria (DCBXA) | PathwayId: R-HSA-5619067
NodeType: Pathway | PathwayName: Defective SLC1A3 causes episodic ataxia 6 (EA6) | PathwayId: R-HSA-5619062
NodeType: Pathway | PathwayName: Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) | PathwayId: R-HSA-5619111
NodeType: Pathway | PathwayName: Defective SLC22A12 causes renal hypouricemia 1 (RHUC1) | PathwayId: R-HSA-5619071
NodeType: Pathway | PathwayName: Defective SLC22A18 causes lung cancer (LNCR) and embryonal rhabdomyosarcoma 1 (RMSE1) | PathwayId: R-HSA-5619066
NodeType: Pathway | PathwayName: Defective SLC22A5 causes systemic primary carnitine deficiency (CDSP) | PathwayId: R-HSA-5619053
NodeType: Pathway | PathwayName: Defective SLC24A1 causes congenital stationary night blindness 1D (CSNB1D) | PathwayId: R-HSA-5619077
NodeType: Pathway | PathwayName: Defective SLC24A4 causes hypomineralized amelogenesis imperfecta (AI) | PathwayId: R-HSA-5619055
NodeType: Pathway | PathwayName: Defective SLC24A5 causes oculocutaneous albinism 6 (OCA6) | PathwayId: R-HSA-5619036
NodeType: Pathway | PathwayName: Defective SLC26A2 causes chondrodysplasias | PathwayId: R-HSA-3560792
NodeType: Pathway | PathwayName: Defective SLC26A3 causes congenital secretory chloride diarrhea 1 (DIAR1) | PathwayId: R-HSA-5619085
NodeType: Pathway | PathwayName: Defective SLC26A4 causes Pendred syndrome (PDS) | PathwayId: R-HSA-5619046
NodeType: Pathway | PathwayName: Defective SLC27A4 causes ichthyosis prematurity syndrome (IPS) | PathwayId: R-HSA-5619108
NodeType: Pathway | PathwayName: Defective SLC29A3 causes histiocytosis-lymphadenopathy plus syndrome (HLAS) | PathwayId: R-HSA-5619063
NodeType: Pathway | PathwayName: Defective SLC2A1 causes GLUT1 deficiency syndrome 1 (GLUT1DS1) | PathwayId: R-HSA-5619043
NodeType: Pathway | PathwayName: Defective SLC2A10 causes arterial tortuosity syndrome (ATS) | PathwayId: R-HSA-5619068
NodeType: Pathway | PathwayName: Defective SLC2A2 causes Fanconi-Bickel syndrome (FBS) | PathwayId: R-HSA-5619098
NodeType: Pathway | PathwayName: Defective SLC2A9 causes hypouricemia renal 2 (RHUC2) | PathwayId: R-HSA-5619047
NodeType: Pathway | PathwayName: Defective SLC33A1 causes spastic paraplegia 42 (SPG42) | PathwayId: R-HSA-5619061
NodeType: Pathway | PathwayName: Defective SLC34A1 causes hypophosphatemic nephrolithiasis/osteoporosis 1 (NPHLOP1) | PathwayId: R-HSA-5619040
NodeType: Pathway | PathwayName: Defective SLC34A2 causes PALM | PathwayId: R-HSA-5687583
NodeType: Pathway | PathwayName: Defective SLC34A2 causes pulmonary alveolar microlithiasis (PALM) | PathwayId: R-HSA-5619045
NodeType: Pathway | PathwayName: Defective SLC34A3 causes Hereditary hypophosphatemic rickets with hypercalciuria (HHRH) | PathwayId: R-HSA-5619097
NodeType: Pathway | PathwayName: Defective SLC35A1 causes congenital disorder of glycosylation 2F (CDG2F) | PathwayId: R-HSA-5619037
NodeType: Pathway | PathwayName: Defective SLC35A1 causes congenital disorder of glycosylation 2F (CDG2F) | PathwayId: R-HSA-5663020
NodeType: Pathway | PathwayName: Defective SLC35A2 causes congenital disorder of glycosylation 2M (CDG2M) | PathwayId: R-HSA-5619072
NodeType: Pathway | PathwayName: Defective SLC35A3 causes arthrogryposis, mental retardation, and seizures (AMRS) | PathwayId: R-HSA-5619083
NodeType: Pathway | PathwayName: Defective SLC35C1 causes congenital disorder of glycosylation 2C (CDG2C) | PathwayId: R-HSA-5619078
NodeType: Pathway | PathwayName: Defective SLC35D1 causes SCHBCKD | PathwayId: R-HSA-5579020
NodeType: Pathway | PathwayName: Defective SLC36A2 causes iminoglycinuria (IG) and hyperglycinuria (HG) | PathwayId: R-HSA-5619041
NodeType: Pathway | PathwayName: Defective SLC39A4 causes acrodermatitis enteropathica, zinc-deficiency type (AEZ) | PathwayId: R-HSA-5619088
NodeType: Pathway | PathwayName: Defective SLC3A1 causes cystinuria (CSNU) | PathwayId: R-HSA-5619113
NodeType: Pathway | PathwayName: Defective SLC40A1 causes hemochromatosis 4 (HFE4) (duodenum) | PathwayId: R-HSA-5655799
NodeType: Pathway | PathwayName: Defective SLC40A1 causes hemochromatosis 4 (HFE4) (macrophages) | PathwayId: R-HSA-5619049
NodeType: Pathway | PathwayName: Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4),  distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | PathwayId: R-HSA-5619050
NodeType: Pathway | PathwayName: Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | PathwayId: R-HSA-5619054
NodeType: Pathway | PathwayName: Defective SLC5A1 causes congenital glucose/galactose malabsorption (GGM) | PathwayId: R-HSA-5656364
NodeType: Pathway | PathwayName: Defective SLC5A2 causes renal glucosuria (GLYS1) | PathwayId: R-HSA-5658208
NodeType: Pathway | PathwayName: Defective SLC5A5 causes thyroid dyshormonogenesis 1 (TDH1) | PathwayId: R-HSA-5619096
NodeType: Pathway | PathwayName: Defective SLC5A7 causes distal hereditary motor neuronopathy 7A (HMN7A) | PathwayId: R-HSA-5658471
NodeType: Pathway | PathwayName: Defective SLC5A7 causes distal hereditary motor neuronopathy 7A (HMN7A) | PathwayId: R-HSA-5619114
NodeType: Pathway | PathwayName: Defective SLC6A18 may confer susceptibility to iminoglycinuria and/or hyperglycinuria | PathwayId: R-HSA-5659729
NodeType: Pathway | PathwayName: Defective SLC6A18 may confer susceptibility to iminoglycinuria and/or hyperglycinuria | PathwayId: R-HSA-5619079
NodeType: Pathway | PathwayName: Defective SLC6A19 causes Hartnup disorder (HND) | PathwayId: R-HSA-5659735
NodeType: Pathway | PathwayName: Defective SLC6A19 causes Hartnup disorder (HND) | PathwayId: R-HSA-5619044
NodeType: Pathway | PathwayName: Defective SLC6A2 causes orthostatic intolerance (OI) | PathwayId: R-HSA-5619109
NodeType: Pathway | PathwayName: Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | PathwayId: R-HSA-5619081
NodeType: Pathway | PathwayName: Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | PathwayId: R-HSA-5660724
NodeType: Pathway | PathwayName: Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | PathwayId: R-HSA-5619089
NodeType: Pathway | PathwayName: Defective SLC7A7 causes lysinuric protein intolerance (LPI) | PathwayId: R-HSA-5660862
NodeType: Pathway | PathwayName: Defective SLC7A9 causes cystinuria (CSNU) | PathwayId: R-HSA-5660883
NodeType: Pathway | PathwayName: Defective SLC9A6 causes  X-linked, syndromic mental retardation,, Christianson type (MRXSCH) | PathwayId: R-HSA-5619092
NodeType: Pathway | PathwayName: Defective SLC9A9 causes autism 16 (AUTS16) | PathwayId: R-HSA-5619052
NodeType: Pathway | PathwayName: Defective SLCO1B1 causes hyperbilirubinemia, Rotor type (HBLRR) | PathwayId: R-HSA-5619110
NodeType: Pathway | PathwayName: Defective SLCO1B3 causes hyperbilirubinemia, Rotor type (HBLRR) | PathwayId: R-HSA-5619058
NodeType: Pathway | PathwayName: Defective SLCO2A1 causes primary, autosomal recessive hypertrophic osteoarthropathy 2 (PHOAR2) | PathwayId: R-HSA-5619095
NodeType: Pathway | PathwayName: Defective SRD5A3 causes SRD5A3-CDG, KHRZ | PathwayId: R-HSA-4755579
NodeType: Pathway | PathwayName: Defective ST3GAL3 causes MCT12 and EIEE15 | PathwayId: R-HSA-3656243
NodeType: Pathway | PathwayName: Defective TBXAS1 causes GHDD | PathwayId: R-HSA-5579032
NodeType: Pathway | PathwayName: Defective TCN2 causes TCN2 deficiency | PathwayId: R-HSA-3359454
NodeType: Pathway | PathwayName: Defective TPMT causes TPMT deficiency | PathwayId: R-HSA-5578995
NodeType: Pathway | PathwayName: Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | PathwayId: R-HSA-5619107
NodeType: Pathway | PathwayName: Defective UGT1A1 causes hyperbilirubinemia | PathwayId: R-HSA-5579002
NodeType: Pathway | PathwayName: Defective UGT1A4 causes hyperbilirubinemia | PathwayId: R-HSA-5579016
NodeType: Pathway | PathwayName: Defective VWF binding to collagen type I | PathwayId: R-HSA-9845622
NodeType: Pathway | PathwayName: Defective VWF cleavage by ADAMTS13 variant | PathwayId: R-HSA-9845621
NodeType: Pathway | PathwayName: Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | PathwayId: R-HSA-9661069
NodeType: Pathway | PathwayName: Defective binding of VWF variant to GPIb:IX:V | PathwayId: R-HSA-9846298
NodeType: Pathway | PathwayName: Defective cofactor function of FVIIIa variant | PathwayId: R-HSA-9672396
NodeType: Pathway | PathwayName: Defective factor IX causes hemophilia B | PathwayId: R-HSA-9668250
NodeType: Pathway | PathwayName: Defective factor IX causes thrombophilia | PathwayId: R-HSA-9672383
NodeType: Pathway | PathwayName: Defective factor VIII causes hemophilia A | PathwayId: R-HSA-9662001
NodeType: Pathway | PathwayName: Defective factor XII causes hereditary angioedema | PathwayId: R-HSA-9657688
NodeType: Pathway | PathwayName: Defective gamma-carboxylation of F9 | PathwayId: R-HSA-9673240
NodeType: Pathway | PathwayName: Defective homologous recombination repair (HRR) due to BRCA1 loss of function | PathwayId: R-HSA-9701192
NodeType: Pathway | PathwayName: Defective homologous recombination repair (HRR) due to BRCA2 loss of function | PathwayId: R-HSA-9701190
NodeType: Pathway | PathwayName: Defective homologous recombination repair (HRR) due to PALB2 loss of function | PathwayId: R-HSA-9701193
NodeType: Pathway | PathwayName: Defective pro-SFTPB causes SMDP1 and RDS | PathwayId: R-HSA-5688031
NodeType: Pathway | PathwayName: Defective pro-SFTPC causes SMDP2 and RDS | PathwayId: R-HSA-5688354
NodeType: Pathway | PathwayName: Defective pyroptosis | PathwayId: R-HSA-9710421
NodeType: Pathway | PathwayName: Defective regulation of TLR7 by endogenous ligand | PathwayId: R-HSA-9824856
NodeType: Pathway | PathwayName: Defective translocation of RB1 mutants to the nucleus | PathwayId: R-HSA-9661070
NodeType: Pathway | PathwayName: Defects in biotin (Btn) metabolism | PathwayId: R-HSA-3323169
NodeType: Pathway | PathwayName: Defects in cobalamin (B12) metabolism | PathwayId: R-HSA-3296469
NodeType: Pathway | PathwayName: Defects in vitamin and cofactor metabolism | PathwayId: R-HSA-3296482
NodeType: Pathway | PathwayName: Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | PathwayId: R-HSA-9651496
NodeType: Pathway | PathwayName: Defects of platelet adhesion to exposed collagen | PathwayId: R-HSA-9823587
NodeType: Pathway | PathwayName: Defensins | PathwayId: R-HSA-1461973
NodeType: Pathway | PathwayName: Degradation of AXIN | PathwayId: R-HSA-4641257
NodeType: Pathway | PathwayName: Degradation of DVL | PathwayId: R-HSA-4641258
NodeType: Pathway | PathwayName: Degradation of GABA | PathwayId: R-HSA-916853
NodeType: Pathway | PathwayName: Degradation of GLI1 by the proteasome | PathwayId: R-HSA-5610780
NodeType: Pathway | PathwayName: Degradation of GLI2 by the proteasome | PathwayId: R-HSA-5610783
NodeType: Pathway | PathwayName: Degradation of beta-catenin by the destruction complex | PathwayId: R-HSA-195253
NodeType: Pathway | PathwayName: Degradation of cysteine and homocysteine | PathwayId: R-HSA-1614558
NodeType: Pathway | PathwayName: Degradation of the extracellular matrix | PathwayId: R-HSA-1474228
NodeType: Pathway | PathwayName: Deletions in the AMER1 gene destabilize the destruction complex | PathwayId: R-HSA-5467343
NodeType: Pathway | PathwayName: Deletions in the AXIN1 gene destabilize the destruction complex | PathwayId: R-HSA-5467345
NodeType: Pathway | PathwayName: Depolymerization of the Nuclear Lamina | PathwayId: R-HSA-4419969
NodeType: Pathway | PathwayName: Deposition of new CENPA-containing nucleosomes at the centromere | PathwayId: R-HSA-606279
NodeType: Pathway | PathwayName: Depurination | PathwayId: R-HSA-73927
NodeType: Pathway | PathwayName: Depyrimidination | PathwayId: R-HSA-73928
NodeType: Pathway | PathwayName: Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | PathwayId: R-HSA-8862803
NodeType: Pathway | PathwayName: Dermatan sulfate biosynthesis | PathwayId: R-HSA-2022923
NodeType: Pathway | PathwayName: Detoxification of Reactive Oxygen Species | PathwayId: R-HSA-3299685
NodeType: Pathway | PathwayName: Deubiquitination | PathwayId: R-HSA-5688426
NodeType: Pathway | PathwayName: Developmental Biology | PathwayId: R-HSA-1266738
NodeType: Pathway | PathwayName: Developmental Cell Lineages | PathwayId: R-HSA-9734767
NodeType: Pathway | PathwayName: Differentiation of keratinocytes in interfollicular epidermis in mammalian skin | PathwayId: R-HSA-9725554
NodeType: Pathway | PathwayName: Digestion | PathwayId: R-HSA-8935690
NodeType: Pathway | PathwayName: Digestion and absorption | PathwayId: R-HSA-8963743
NodeType: Pathway | PathwayName: Digestion of dietary carbohydrate | PathwayId: R-HSA-189085
NodeType: Pathway | PathwayName: Digestion of dietary lipid | PathwayId: R-HSA-192456
NodeType: Pathway | PathwayName: Dimerization of procaspase-8 | PathwayId: R-HSA-69416
NodeType: Pathway | PathwayName: Disassembly of the destruction complex and recruitment of AXIN to the membrane | PathwayId: R-HSA-4641262
NodeType: Pathway | PathwayName: Disease | PathwayId: R-HSA-1643685
NodeType: Pathway | PathwayName: Diseases associated with N-glycosylation of proteins | PathwayId: R-HSA-3781860
NodeType: Pathway | PathwayName: Diseases associated with O-glycosylation of proteins | PathwayId: R-HSA-3906995
NodeType: Pathway | PathwayName: Diseases associated with glycosaminoglycan metabolism | PathwayId: R-HSA-3560782
NodeType: Pathway | PathwayName: Diseases associated with glycosylation precursor biosynthesis | PathwayId: R-HSA-5609975
NodeType: Pathway | PathwayName: Diseases associated with surfactant metabolism | PathwayId: R-HSA-5687613
NodeType: Pathway | PathwayName: Diseases associated with the TLR signaling cascade | PathwayId: R-HSA-5602358
NodeType: Pathway | PathwayName: Diseases associated with visual transduction | PathwayId: R-HSA-2474795
NodeType: Pathway | PathwayName: Diseases of Base Excision Repair | PathwayId: R-HSA-9605308
NodeType: Pathway | PathwayName: Diseases of Cellular Senescence | PathwayId: R-HSA-9630747
NodeType: Pathway | PathwayName: Diseases of DNA Double-Strand Break Repair | PathwayId: R-HSA-9675136
NodeType: Pathway | PathwayName: Diseases of DNA repair | PathwayId: R-HSA-9675135
NodeType: Pathway | PathwayName: Diseases of Immune System | PathwayId: R-HSA-5260271
NodeType: Pathway | PathwayName: Diseases of Mismatch Repair (MMR) | PathwayId: R-HSA-5423599
NodeType: Pathway | PathwayName: Diseases of Telomere Maintenance | PathwayId: R-HSA-9673013
NodeType: Pathway | PathwayName: Diseases of carbohydrate metabolism | PathwayId: R-HSA-5663084
NodeType: Pathway | PathwayName: Diseases of cellular response to stress | PathwayId: R-HSA-9675132
NodeType: Pathway | PathwayName: Diseases of glycosylation | PathwayId: R-HSA-3781865
NodeType: Pathway | PathwayName: Diseases of hemostasis | PathwayId: R-HSA-9671793
NodeType: Pathway | PathwayName: Diseases of metabolism | PathwayId: R-HSA-5668914
NodeType: Pathway | PathwayName: Diseases of mitochondrial beta oxidation | PathwayId: R-HSA-9759774
NodeType: Pathway | PathwayName: Diseases of mitotic cell cycle | PathwayId: R-HSA-9675126
NodeType: Pathway | PathwayName: Diseases of nucleotide metabolism | PathwayId: R-HSA-9735804
NodeType: Pathway | PathwayName: Diseases of programmed cell death | PathwayId: R-HSA-9645723
NodeType: Pathway | PathwayName: Diseases of propionyl-CoA catabolism | PathwayId: R-HSA-9759785
NodeType: Pathway | PathwayName: Diseases of signal transduction by growth factor receptors and second messengers | PathwayId: R-HSA-5663202
NodeType: Pathway | PathwayName: Diseases of the neuronal system | PathwayId: R-HSA-9675143
NodeType: Pathway | PathwayName: Disinhibition of SNARE formation | PathwayId: R-HSA-114516
NodeType: Pathway | PathwayName: Disorders of Developmental Biology | PathwayId: R-HSA-9675151
NodeType: Pathway | PathwayName: Disorders of Nervous System Development | PathwayId: R-HSA-9697154
NodeType: Pathway | PathwayName: Disorders of transmembrane transporters | PathwayId: R-HSA-5619115
NodeType: Pathway | PathwayName: Displacement of DNA glycosylase by APEX1 | PathwayId: R-HSA-110357
NodeType: Pathway | PathwayName: Dissolution of Fibrin Clot | PathwayId: R-HSA-75205
NodeType: Pathway | PathwayName: Dopamine Neurotransmitter Release Cycle | PathwayId: R-HSA-212676
NodeType: Pathway | PathwayName: Dopamine clearance from the synaptic cleft | PathwayId: R-HSA-379401
NodeType: Pathway | PathwayName: Dopamine receptors | PathwayId: R-HSA-390651
NodeType: Pathway | PathwayName: Downregulation of ERBB2 signaling | PathwayId: R-HSA-8863795
NodeType: Pathway | PathwayName: Downregulation of ERBB2:ERBB3 signaling | PathwayId: R-HSA-1358803
NodeType: Pathway | PathwayName: Downregulation of ERBB4 signaling | PathwayId: R-HSA-1253288
NodeType: Pathway | PathwayName: Downregulation of SMAD2/3:SMAD4 transcriptional activity | PathwayId: R-HSA-2173795
NodeType: Pathway | PathwayName: Downregulation of TGF-beta receptor signaling | PathwayId: R-HSA-2173788
NodeType: Pathway | PathwayName: Downstream TCR signaling | PathwayId: R-HSA-202424
NodeType: Pathway | PathwayName: Downstream signal transduction | PathwayId: R-HSA-186763
NodeType: Pathway | PathwayName: Downstream signaling events of B Cell Receptor (BCR) | PathwayId: R-HSA-1168372
NodeType: Pathway | PathwayName: Downstream signaling of activated FGFR1 | PathwayId: R-HSA-5654687
NodeType: Pathway | PathwayName: Downstream signaling of activated FGFR2 | PathwayId: R-HSA-5654696
NodeType: Pathway | PathwayName: Downstream signaling of activated FGFR3 | PathwayId: R-HSA-5654708
NodeType: Pathway | PathwayName: Downstream signaling of activated FGFR4 | PathwayId: R-HSA-5654716
NodeType: Pathway | PathwayName: Drug ADME | PathwayId: R-HSA-9748784
NodeType: Pathway | PathwayName: Drug resistance in ERBB2 KD mutants | PathwayId: R-HSA-9665230
NodeType: Pathway | PathwayName: Drug resistance in ERBB2 TMD/JMD mutants | PathwayId: R-HSA-9665737
NodeType: Pathway | PathwayName: Drug resistance of ALK mutants | PathwayId: R-HSA-9700649
NodeType: Pathway | PathwayName: Drug resistance of FLT3 mutants | PathwayId: R-HSA-9702506
NodeType: Pathway | PathwayName: Drug resistance of KIT mutants | PathwayId: R-HSA-9669937
NodeType: Pathway | PathwayName: Drug resistance of PDGFR mutants | PathwayId: R-HSA-9674415
NodeType: Pathway | PathwayName: Drug-induced formation of DNA interstrand crosslinks | PathwayId: R-HSA-9750126
NodeType: Pathway | PathwayName: Drug-mediated inhibition of CDK4/CDK6 activity | PathwayId: R-HSA-9754119
NodeType: Pathway | PathwayName: Drug-mediated inhibition of ERBB2 signaling | PathwayId: R-HSA-9652282
NodeType: Pathway | PathwayName: Drug-mediated inhibition of MET activation | PathwayId: R-HSA-9734091
NodeType: Pathway | PathwayName: Dual Incision in GG-NER | PathwayId: R-HSA-5696400
NodeType: Pathway | PathwayName: Dual incision in TC-NER | PathwayId: R-HSA-6782135
NodeType: Pathway | PathwayName: E2F mediated regulation of DNA replication | PathwayId: R-HSA-113510
NodeType: Pathway | PathwayName: E2F-enabled inhibition of pre-replication complex formation | PathwayId: R-HSA-113507
NodeType: Pathway | PathwayName: E3 ubiquitin ligases ubiquitinate target proteins | PathwayId: R-HSA-8866654
NodeType: Pathway | PathwayName: ECM proteoglycans | PathwayId: R-HSA-3000178
NodeType: Pathway | PathwayName: EGFR Transactivation by Gastrin | PathwayId: R-HSA-2179392
NodeType: Pathway | PathwayName: EGFR downregulation | PathwayId: R-HSA-182971
NodeType: Pathway | PathwayName: EGFR interacts with phospholipase C-gamma | PathwayId: R-HSA-212718
NodeType: Pathway | PathwayName: EGR2 and SOX10-mediated initiation of Schwann cell myelination | PathwayId: R-HSA-9619665
NodeType: Pathway | PathwayName: EML4 and NUDC in mitotic spindle formation | PathwayId: R-HSA-9648025
NodeType: Pathway | PathwayName: EPH-Ephrin signaling | PathwayId: R-HSA-2682334
NodeType: Pathway | PathwayName: EPH-ephrin mediated repulsion of cells | PathwayId: R-HSA-3928665
NodeType: Pathway | PathwayName: EPHA-mediated growth cone collapse | PathwayId: R-HSA-3928663
NodeType: Pathway | PathwayName: EPHB-mediated forward signaling | PathwayId: R-HSA-3928662
NodeType: Pathway | PathwayName: ER Quality Control Compartment (ERQC) | PathwayId: R-HSA-901032
NodeType: Pathway | PathwayName: ER to Golgi Anterograde Transport | PathwayId: R-HSA-199977
NodeType: Pathway | PathwayName: ER-Phagosome pathway | PathwayId: R-HSA-1236974
NodeType: Pathway | PathwayName: ERBB2 Activates PTK6 Signaling | PathwayId: R-HSA-8847993
NodeType: Pathway | PathwayName: ERBB2 Regulates Cell Motility | PathwayId: R-HSA-6785631
NodeType: Pathway | PathwayName: ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | PathwayId: R-HSA-427389
NodeType: Pathway | PathwayName: ERK/MAPK targets | PathwayId: R-HSA-198753
NodeType: Pathway | PathwayName: ERKs are inactivated | PathwayId: R-HSA-202670
NodeType: Pathway | PathwayName: ESR-mediated signaling | PathwayId: R-HSA-8939211
NodeType: Pathway | PathwayName: Early Phase of HIV Life Cycle | PathwayId: R-HSA-162594
NodeType: Pathway | PathwayName: Early SARS-CoV-2 Infection Events | PathwayId: R-HSA-9772572
NodeType: Pathway | PathwayName: Effects of PIP2 hydrolysis | PathwayId: R-HSA-114508
NodeType: Pathway | PathwayName: Eicosanoid ligand-binding receptors | PathwayId: R-HSA-391903
NodeType: Pathway | PathwayName: Eicosanoids | PathwayId: R-HSA-211979
NodeType: Pathway | PathwayName: Elastic fibre formation | PathwayId: R-HSA-1566948
NodeType: Pathway | PathwayName: Electric Transmission Across Gap Junctions | PathwayId: R-HSA-112303
NodeType: Pathway | PathwayName: Electron transport from NADPH to Ferredoxin | PathwayId: R-HSA-2395516
NodeType: Pathway | PathwayName: Elevation of cytosolic Ca2+ levels | PathwayId: R-HSA-139853
NodeType: Pathway | PathwayName: Endogenous sterols | PathwayId: R-HSA-211976
NodeType: Pathway | PathwayName: Endosomal Sorting Complex Required For Transport (ESCRT) | PathwayId: R-HSA-917729
NodeType: Pathway | PathwayName: Endosomal/Vacuolar pathway | PathwayId: R-HSA-1236977
NodeType: Pathway | PathwayName: Energy dependent regulation of mTOR by LKB1-AMPK | PathwayId: R-HSA-380972
NodeType: Pathway | PathwayName: Enhanced binding of GP1BA variant to VWF multimer:collagen | PathwayId: R-HSA-9845620
NodeType: Pathway | PathwayName: Enhanced cleavage of VWF variant by ADAMTS13 | PathwayId: R-HSA-9845619
NodeType: Pathway | PathwayName: Entry of Influenza Virion into Host Cell via Endocytosis | PathwayId: R-HSA-168275
NodeType: Pathway | PathwayName: Enzymatic degradation of Dopamine by monoamine oxidase | PathwayId: R-HSA-379398
NodeType: Pathway | PathwayName: Enzymatic degradation of dopamine by COMT | PathwayId: R-HSA-379397
NodeType: Pathway | PathwayName: Ephrin signaling | PathwayId: R-HSA-3928664
NodeType: Pathway | PathwayName: Epigenetic regulation of gene expression | PathwayId: R-HSA-212165
NodeType: Pathway | PathwayName: Epithelial-Mesenchymal Transition (EMT) during gastrulation | PathwayId: R-HSA-9758919
NodeType: Pathway | PathwayName: Erythrocytes take up carbon dioxide and release oxygen | PathwayId: R-HSA-1237044
NodeType: Pathway | PathwayName: Erythrocytes take up oxygen and release carbon dioxide | PathwayId: R-HSA-1247673
NodeType: Pathway | PathwayName: Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | PathwayId: R-HSA-9027276
NodeType: Pathway | PathwayName: Erythropoietin activates Phospholipase C gamma (PLCG) | PathwayId: R-HSA-9027277
NodeType: Pathway | PathwayName: Erythropoietin activates RAS | PathwayId: R-HSA-9027284
NodeType: Pathway | PathwayName: Erythropoietin activates STAT5 | PathwayId: R-HSA-9027283
NodeType: Pathway | PathwayName: Escape of Mtb from the phagocyte | PathwayId: R-HSA-9637679
NodeType: Pathway | PathwayName: Essential fructosuria | PathwayId: R-HSA-5657562
NodeType: Pathway | PathwayName: Essential pentosuria | PathwayId: R-HSA-5662853
NodeType: Pathway | PathwayName: Establishment of Sister Chromatid Cohesion | PathwayId: R-HSA-2468052
NodeType: Pathway | PathwayName: Estrogen biosynthesis | PathwayId: R-HSA-193144
NodeType: Pathway | PathwayName: Estrogen-dependent gene expression | PathwayId: R-HSA-9018519
NodeType: Pathway | PathwayName: Estrogen-dependent nuclear events downstream of ESR-membrane signaling | PathwayId: R-HSA-9634638
NodeType: Pathway | PathwayName: Estrogen-stimulated signaling through PRKCZ | PathwayId: R-HSA-9634635
NodeType: Pathway | PathwayName: Ethanol oxidation | PathwayId: R-HSA-71384
NodeType: Pathway | PathwayName: Eukaryotic Translation Elongation | PathwayId: R-HSA-156842
NodeType: Pathway | PathwayName: Eukaryotic Translation Initiation | PathwayId: R-HSA-72613
NodeType: Pathway | PathwayName: Eukaryotic Translation Termination | PathwayId: R-HSA-72764
NodeType: Pathway | PathwayName: Evasion by RSV of host interferon responses | PathwayId: R-HSA-9833109
NodeType: Pathway | PathwayName: Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 | PathwayId: R-HSA-9630791
NodeType: Pathway | PathwayName: Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | PathwayId: R-HSA-9630794
NodeType: Pathway | PathwayName: Evasion of Oncogene Induced Senescence Due to p14ARF Defects | PathwayId: R-HSA-9646303
NodeType: Pathway | PathwayName: Evasion of Oncogene Induced Senescence Due to p16INK4A Defects | PathwayId: R-HSA-9630750
NodeType: Pathway | PathwayName: Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 | PathwayId: R-HSA-9632697
NodeType: Pathway | PathwayName: Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | PathwayId: R-HSA-9632700
NodeType: Pathway | PathwayName: Evasion of Oxidative Stress Induced Senescence Due to p14ARF Defects | PathwayId: R-HSA-9646304
NodeType: Pathway | PathwayName: Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects | PathwayId: R-HSA-9632693
NodeType: Pathway | PathwayName: Events associated with phagocytolytic activity of PMN cells | PathwayId: R-HSA-8941413
NodeType: Pathway | PathwayName: Export of Viral Ribonucleoproteins from Nucleus | PathwayId: R-HSA-168274
NodeType: Pathway | PathwayName: Expression and Processing of Neurotrophins | PathwayId: R-HSA-9036866
NodeType: Pathway | PathwayName: Expression and translocation of olfactory receptors | PathwayId: R-HSA-9752946
NodeType: Pathway | PathwayName: Extension of Telomeres | PathwayId: R-HSA-180786
NodeType: Pathway | PathwayName: Extra-nuclear estrogen signaling | PathwayId: R-HSA-9009391
NodeType: Pathway | PathwayName: Extracellular matrix organization | PathwayId: R-HSA-1474244
NodeType: Pathway | PathwayName: Extrinsic Pathway of Fibrin Clot Formation | PathwayId: R-HSA-140834
NodeType: Pathway | PathwayName: FASTK family proteins regulate processing and stability of mitochondrial RNAs | PathwayId: R-HSA-9837092
NodeType: Pathway | PathwayName: FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | PathwayId: R-HSA-8854050
NodeType: Pathway | PathwayName: FBXW7 Mutants and NOTCH1 in Cancer | PathwayId: R-HSA-2644605
NodeType: Pathway | PathwayName: FCERI mediated Ca+2 mobilization | PathwayId: R-HSA-2871809
NodeType: Pathway | PathwayName: FCERI mediated MAPK activation | PathwayId: R-HSA-2871796
NodeType: Pathway | PathwayName: FCERI mediated NF-kB activation | PathwayId: R-HSA-2871837
NodeType: Pathway | PathwayName: FCGR activation | PathwayId: R-HSA-2029481
NodeType: Pathway | PathwayName: FCGR3A-mediated IL10 synthesis | PathwayId: R-HSA-9664323
NodeType: Pathway | PathwayName: FCGR3A-mediated phagocytosis | PathwayId: R-HSA-9664422
NodeType: Pathway | PathwayName: FGFR1 ligand binding and activation | PathwayId: R-HSA-190242
NodeType: Pathway | PathwayName: FGFR1 mutant receptor activation | PathwayId: R-HSA-1839124
NodeType: Pathway | PathwayName: FGFR1b ligand binding and activation | PathwayId: R-HSA-190370
NodeType: Pathway | PathwayName: FGFR1c and Klotho ligand binding and activation | PathwayId: R-HSA-190374
NodeType: Pathway | PathwayName: FGFR1c ligand binding and activation | PathwayId: R-HSA-190373
NodeType: Pathway | PathwayName: FGFR2 alternative splicing | PathwayId: R-HSA-6803529
NodeType: Pathway | PathwayName: FGFR2 ligand binding and activation | PathwayId: R-HSA-190241
NodeType: Pathway | PathwayName: FGFR2 mutant receptor activation | PathwayId: R-HSA-1839126
NodeType: Pathway | PathwayName: FGFR2b ligand binding and activation | PathwayId: R-HSA-190377
NodeType: Pathway | PathwayName: FGFR2c ligand binding and activation | PathwayId: R-HSA-190375
NodeType: Pathway | PathwayName: FGFR3 ligand binding and activation | PathwayId: R-HSA-190239
NodeType: Pathway | PathwayName: FGFR3 mutant receptor activation | PathwayId: R-HSA-2033514
NodeType: Pathway | PathwayName: FGFR3b ligand binding and activation | PathwayId: R-HSA-190371
NodeType: Pathway | PathwayName: FGFR3c ligand binding and activation | PathwayId: R-HSA-190372
NodeType: Pathway | PathwayName: FGFR4 ligand binding and activation | PathwayId: R-HSA-190322
NodeType: Pathway | PathwayName: FGFR4 mutant receptor activation | PathwayId: R-HSA-1839128
NodeType: Pathway | PathwayName: FGFRL1 modulation of FGFR1 signaling | PathwayId: R-HSA-5658623
NodeType: Pathway | PathwayName: FLT3 Signaling | PathwayId: R-HSA-9607240
NodeType: Pathway | PathwayName: FLT3 mutants bind TKIs | PathwayId: R-HSA-9702509
NodeType: Pathway | PathwayName: FLT3 signaling by CBL mutants | PathwayId: R-HSA-9706377
NodeType: Pathway | PathwayName: FLT3 signaling in disease | PathwayId: R-HSA-9682385
NodeType: Pathway | PathwayName: FLT3 signaling through SRC family kinases | PathwayId: R-HSA-9706374
NodeType: Pathway | PathwayName: FMO oxidises nucleophiles | PathwayId: R-HSA-217271
NodeType: Pathway | PathwayName: FOXO-mediated transcription | PathwayId: R-HSA-9614085
NodeType: Pathway | PathwayName: FOXO-mediated transcription of cell cycle genes | PathwayId: R-HSA-9617828
NodeType: Pathway | PathwayName: FOXO-mediated transcription of cell death genes | PathwayId: R-HSA-9614657
NodeType: Pathway | PathwayName: FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | PathwayId: R-HSA-9615017
NodeType: Pathway | PathwayName: FRS-mediated FGFR1 signaling | PathwayId: R-HSA-5654693
NodeType: Pathway | PathwayName: FRS-mediated FGFR2 signaling | PathwayId: R-HSA-5654700
NodeType: Pathway | PathwayName: FRS-mediated FGFR3 signaling | PathwayId: R-HSA-5654706
NodeType: Pathway | PathwayName: FRS-mediated FGFR4 signaling | PathwayId: R-HSA-5654712
NodeType: Pathway | PathwayName: Factors involved in megakaryocyte development and platelet production | PathwayId: R-HSA-983231
NodeType: Pathway | PathwayName: Fanconi Anemia Pathway | PathwayId: R-HSA-6783310
NodeType: Pathway | PathwayName: FasL/ CD95L signaling | PathwayId: R-HSA-75157
NodeType: Pathway | PathwayName: Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | PathwayId: R-HSA-434316
NodeType: Pathway | PathwayName: Fatty acid metabolism | PathwayId: R-HSA-8978868
NodeType: Pathway | PathwayName: Fatty acids | PathwayId: R-HSA-211935
NodeType: Pathway | PathwayName: Fatty acyl-CoA biosynthesis | PathwayId: R-HSA-75105
NodeType: Pathway | PathwayName: Fc epsilon receptor (FCERI) signaling | PathwayId: R-HSA-2454202
NodeType: Pathway | PathwayName: Fcgamma receptor (FCGR) dependent phagocytosis | PathwayId: R-HSA-2029480
NodeType: Pathway | PathwayName: Fertilization | PathwayId: R-HSA-1187000
NodeType: Pathway | PathwayName: Fibronectin matrix formation | PathwayId: R-HSA-1566977
NodeType: Pathway | PathwayName: Ficolins bind to repetitive carbohydrate structures on the target cell surface | PathwayId: R-HSA-2855086
NodeType: Pathway | PathwayName: Folding of actin by CCT/TriC | PathwayId: R-HSA-390450
NodeType: Pathway | PathwayName: Formation of ATP by chemiosmotic coupling | PathwayId: R-HSA-163210
NodeType: Pathway | PathwayName: Formation of Fibrin Clot (Clotting Cascade) | PathwayId: R-HSA-140877
NodeType: Pathway | PathwayName: Formation of HIV elongation complex in the absence of HIV Tat | PathwayId: R-HSA-167152
NodeType: Pathway | PathwayName: Formation of HIV-1 elongation complex containing HIV-1 Tat | PathwayId: R-HSA-167200
NodeType: Pathway | PathwayName: Formation of Incision Complex in GG-NER | PathwayId: R-HSA-5696395
NodeType: Pathway | PathwayName: Formation of RNA Pol II elongation complex | PathwayId: R-HSA-112382
NodeType: Pathway | PathwayName: Formation of Senescence-Associated Heterochromatin Foci (SAHF) | PathwayId: R-HSA-2559584
NodeType: Pathway | PathwayName: Formation of TC-NER Pre-Incision Complex | PathwayId: R-HSA-6781823
NodeType: Pathway | PathwayName: Formation of WDR5-containing histone-modifying complexes | PathwayId: R-HSA-9772755
NodeType: Pathway | PathwayName: Formation of a pool of free 40S subunits | PathwayId: R-HSA-72689
NodeType: Pathway | PathwayName: Formation of annular gap junctions | PathwayId: R-HSA-196025
NodeType: Pathway | PathwayName: Formation of apoptosome | PathwayId: R-HSA-111458
NodeType: Pathway | PathwayName: Formation of axial mesoderm | PathwayId: R-HSA-9796292
NodeType: Pathway | PathwayName: Formation of definitive endoderm | PathwayId: R-HSA-9823730
NodeType: Pathway | PathwayName: Formation of editosomes by ADAR proteins | PathwayId: R-HSA-77042
NodeType: Pathway | PathwayName: Formation of intermediate mesoderm | PathwayId: R-HSA-9761174
NodeType: Pathway | PathwayName: Formation of lateral plate mesoderm | PathwayId: R-HSA-9758920
NodeType: Pathway | PathwayName: Formation of paraxial mesoderm | PathwayId: R-HSA-9793380
NodeType: Pathway | PathwayName: Formation of selenosugars for excretion | PathwayId: R-HSA-2408499
NodeType: Pathway | PathwayName: Formation of the Early Elongation Complex | PathwayId: R-HSA-113418
NodeType: Pathway | PathwayName: Formation of the Editosome | PathwayId: R-HSA-75094
NodeType: Pathway | PathwayName: Formation of the HIV-1 Early Elongation Complex | PathwayId: R-HSA-167158
NodeType: Pathway | PathwayName: Formation of the active cofactor, UDP-glucuronate | PathwayId: R-HSA-173599
NodeType: Pathway | PathwayName: Formation of the anterior neural plate | PathwayId: R-HSA-9823739
NodeType: Pathway | PathwayName: Formation of the beta-catenin:TCF transactivating complex | PathwayId: R-HSA-201722
NodeType: Pathway | PathwayName: Formation of the cornified envelope | PathwayId: R-HSA-6809371
NodeType: Pathway | PathwayName: Formation of the nephric duct | PathwayId: R-HSA-9830364
NodeType: Pathway | PathwayName: Formation of the posterior neural plate | PathwayId: R-HSA-9832991
NodeType: Pathway | PathwayName: Formation of the ternary complex, and subsequently, the 43S complex | PathwayId: R-HSA-72695
NodeType: Pathway | PathwayName: Formation of the ureteric bud | PathwayId: R-HSA-9830674
NodeType: Pathway | PathwayName: Formation of tubulin folding intermediates by CCT/TriC | PathwayId: R-HSA-389960
NodeType: Pathway | PathwayName: Formation of xylulose-5-phosphate | PathwayId: R-HSA-5661270
NodeType: Pathway | PathwayName: Formyl peptide receptors bind formyl peptides and many other ligands | PathwayId: R-HSA-444473
NodeType: Pathway | PathwayName: Free fatty acid receptors | PathwayId: R-HSA-444209
NodeType: Pathway | PathwayName: Free fatty acids regulate insulin secretion | PathwayId: R-HSA-400451
NodeType: Pathway | PathwayName: Frs2-mediated activation | PathwayId: R-HSA-170968
NodeType: Pathway | PathwayName: Fructose biosynthesis | PathwayId: R-HSA-5652227
NodeType: Pathway | PathwayName: Fructose catabolism | PathwayId: R-HSA-70350
NodeType: Pathway | PathwayName: Fructose metabolism | PathwayId: R-HSA-5652084
NodeType: Pathway | PathwayName: Fusion and Uncoating of the Influenza Virion | PathwayId: R-HSA-168270
NodeType: Pathway | PathwayName: Fusion of the Influenza Virion to the Host Cell Endosome | PathwayId: R-HSA-168288
NodeType: Pathway | PathwayName: G alpha (12/13) signalling events | PathwayId: R-HSA-416482
NodeType: Pathway | PathwayName: G alpha (i) signalling events | PathwayId: R-HSA-418594
NodeType: Pathway | PathwayName: G alpha (q) signalling events | PathwayId: R-HSA-416476
NodeType: Pathway | PathwayName: G alpha (s) signalling events | PathwayId: R-HSA-418555
NodeType: Pathway | PathwayName: G alpha (z) signalling events | PathwayId: R-HSA-418597
NodeType: Pathway | PathwayName: G beta:gamma signalling through BTK | PathwayId: R-HSA-8964315
NodeType: Pathway | PathwayName: G beta:gamma signalling through CDC42 | PathwayId: R-HSA-8964616
NodeType: Pathway | PathwayName: G beta:gamma signalling through PI3Kgamma | PathwayId: R-HSA-392451
NodeType: Pathway | PathwayName: G beta:gamma signalling through PLC beta | PathwayId: R-HSA-418217
NodeType: Pathway | PathwayName: G protein gated Potassium channels | PathwayId: R-HSA-1296059
NodeType: Pathway | PathwayName: G-protein activation | PathwayId: R-HSA-202040
NodeType: Pathway | PathwayName: G-protein beta:gamma signalling | PathwayId: R-HSA-397795
NodeType: Pathway | PathwayName: G-protein mediated events | PathwayId: R-HSA-112040
NodeType: Pathway | PathwayName: G0 and Early G1 | PathwayId: R-HSA-1538133
NodeType: Pathway | PathwayName: G1 Phase | PathwayId: R-HSA-69236
NodeType: Pathway | PathwayName: G1/S DNA Damage Checkpoints | PathwayId: R-HSA-69615
NodeType: Pathway | PathwayName: G1/S Transition | PathwayId: R-HSA-69206
NodeType: Pathway | PathwayName: G1/S-Specific Transcription | PathwayId: R-HSA-69205
NodeType: Pathway | PathwayName: G2 Phase | PathwayId: R-HSA-68911
NodeType: Pathway | PathwayName: G2/M Checkpoints | PathwayId: R-HSA-69481
NodeType: Pathway | PathwayName: G2/M DNA damage checkpoint | PathwayId: R-HSA-69473
NodeType: Pathway | PathwayName: G2/M DNA replication checkpoint | PathwayId: R-HSA-69478
NodeType: Pathway | PathwayName: G2/M Transition | PathwayId: R-HSA-69275
NodeType: Pathway | PathwayName: GAB1 signalosome | PathwayId: R-HSA-180292
NodeType: Pathway | PathwayName: GABA B receptor activation | PathwayId: R-HSA-977444
NodeType: Pathway | PathwayName: GABA receptor activation | PathwayId: R-HSA-977443
NodeType: Pathway | PathwayName: GABA synthesis | PathwayId: R-HSA-888568
NodeType: Pathway | PathwayName: GABA synthesis, release, reuptake and degradation | PathwayId: R-HSA-888590
NodeType: Pathway | PathwayName: GDP-fucose biosynthesis | PathwayId: R-HSA-6787639
NodeType: Pathway | PathwayName: GLI proteins bind promoters of Hh responsive genes to promote transcription | PathwayId: R-HSA-5635851
NodeType: Pathway | PathwayName: GLI3 is processed to GLI3R by the proteasome | PathwayId: R-HSA-5610785
NodeType: Pathway | PathwayName: GP1b-IX-V activation signalling | PathwayId: R-HSA-430116
NodeType: Pathway | PathwayName: GPCR downstream signalling | PathwayId: R-HSA-388396
NodeType: Pathway | PathwayName: GPCR ligand binding | PathwayId: R-HSA-500792
NodeType: Pathway | PathwayName: GPER1 signaling | PathwayId: R-HSA-9634597
NodeType: Pathway | PathwayName: GPVI-mediated activation cascade | PathwayId: R-HSA-114604
NodeType: Pathway | PathwayName: GRB2 events in EGFR signaling | PathwayId: R-HSA-179812
NodeType: Pathway | PathwayName: GRB2 events in ERBB2 signaling | PathwayId: R-HSA-1963640
NodeType: Pathway | PathwayName: GRB2:SOS provides linkage to MAPK signaling for Integrins | PathwayId: R-HSA-354194
NodeType: Pathway | PathwayName: NADE modulates death signalling | PathwayId: R-HSA-205025
NodeType: Pathway | PathwayName: NADPH regeneration | PathwayId: R-HSA-389542
NodeType: Pathway | PathwayName: NCAM signaling for neurite out-growth | PathwayId: R-HSA-375165
NodeType: Pathway | PathwayName: NCAM1 interactions | PathwayId: R-HSA-419037
NodeType: Pathway | PathwayName: NEIL3-mediated resolution of ICLs | PathwayId: R-HSA-9636003
NodeType: Pathway | PathwayName: NEP/NS2 Interacts with the Cellular Export Machinery | PathwayId: R-HSA-168333
NodeType: Pathway | PathwayName: NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | PathwayId: R-HSA-933543
NodeType: Pathway | PathwayName: NF-kB is activated and signals survival | PathwayId: R-HSA-209560
NodeType: Pathway | PathwayName: NFE2L2 regulates pentose phosphate pathway genes | PathwayId: R-HSA-9818028
NodeType: Pathway | PathwayName: NFE2L2 regulating ER-stress associated genes | PathwayId: R-HSA-9818035
NodeType: Pathway | PathwayName: NFE2L2 regulating MDR associated enzymes | PathwayId: R-HSA-9818032
NodeType: Pathway | PathwayName: NFE2L2 regulating TCA cycle genes | PathwayId: R-HSA-9818025
NodeType: Pathway | PathwayName: NFE2L2 regulating anti-oxidant/detoxification enzymes | PathwayId: R-HSA-9818027
NodeType: Pathway | PathwayName: NFE2L2 regulating inflammation associated genes | PathwayId: R-HSA-9818026
NodeType: Pathway | PathwayName: NFE2L2 regulating tumorigenic genes | PathwayId: R-HSA-9818030
NodeType: Pathway | PathwayName: NFG and proNGF binds to p75NTR | PathwayId: R-HSA-205017
NodeType: Pathway | PathwayName: NGF processing | PathwayId: R-HSA-167060
NodeType: Pathway | PathwayName: NGF-independant TRKA activation | PathwayId: R-HSA-187024
NodeType: Pathway | PathwayName: NGF-stimulated transcription | PathwayId: R-HSA-9031628
NodeType: Pathway | PathwayName: NIK-->noncanonical NF-kB signaling | PathwayId: R-HSA-5676590
NodeType: Pathway | PathwayName: NOD1/2 Signaling Pathway | PathwayId: R-HSA-168638
NodeType: Pathway | PathwayName: NOSIP mediated eNOS trafficking | PathwayId: R-HSA-203754
NodeType: Pathway | PathwayName: NOSTRIN mediated eNOS trafficking | PathwayId: R-HSA-203641
NodeType: Pathway | PathwayName: NOTCH1 Intracellular Domain Regulates Transcription | PathwayId: R-HSA-2122947
NodeType: Pathway | PathwayName: NOTCH2 Activation and Transmission of Signal to the Nucleus | PathwayId: R-HSA-2979096
NodeType: Pathway | PathwayName: NOTCH2 intracellular domain regulates transcription | PathwayId: R-HSA-2197563
NodeType: Pathway | PathwayName: NOTCH3 Activation and Transmission of Signal to the Nucleus | PathwayId: R-HSA-9013507
NodeType: Pathway | PathwayName: NOTCH3 Intracellular Domain Regulates Transcription | PathwayId: R-HSA-9013508
NodeType: Pathway | PathwayName: NOTCH4 Activation and Transmission of Signal to the Nucleus | PathwayId: R-HSA-9013700
NodeType: Pathway | PathwayName: NOTCH4 Intracellular Domain Regulates Transcription | PathwayId: R-HSA-9013695
NodeType: Pathway | PathwayName: NPAS4 regulates expression of target genes | PathwayId: R-HSA-9768919
NodeType: Pathway | PathwayName: NR1D1 (REV-ERBA) represses gene expression | PathwayId: R-HSA-1368071
NodeType: Pathway | PathwayName: NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis | PathwayId: R-HSA-9632974
NodeType: Pathway | PathwayName: NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | PathwayId: R-HSA-9029558
NodeType: Pathway | PathwayName: NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | PathwayId: R-HSA-9031528
NodeType: Pathway | PathwayName: NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | PathwayId: R-HSA-9623433
NodeType: Pathway | PathwayName: NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | PathwayId: R-HSA-9031525
NodeType: Pathway | PathwayName: NR1H2 and NR1H3-mediated signaling | PathwayId: R-HSA-9024446
NodeType: Pathway | PathwayName: NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | PathwayId: R-HSA-9029569
NodeType: Pathway | PathwayName: NRAGE signals death through JNK | PathwayId: R-HSA-193648
NodeType: Pathway | PathwayName: NRIF signals cell death from the nucleus | PathwayId: R-HSA-205043
NodeType: Pathway | PathwayName: NS1 Mediated Effects on Host Pathways | PathwayId: R-HSA-168276
NodeType: Pathway | PathwayName: NTF3 activates NTRK2 (TRKB) signaling | PathwayId: R-HSA-9025046
NodeType: Pathway | PathwayName: NTF3 activates NTRK3 signaling | PathwayId: R-HSA-9034013
NodeType: Pathway | PathwayName: NTF4 activates NTRK2 (TRKB) signaling | PathwayId: R-HSA-9026357
NodeType: Pathway | PathwayName: NTRK2 activates RAC1 | PathwayId: R-HSA-9032759
NodeType: Pathway | PathwayName: NTRK3 as a dependence receptor | PathwayId: R-HSA-9603505
NodeType: Pathway | PathwayName: NVP-TAE684-resistant ALK mutants | PathwayId: R-HSA-9717301
NodeType: Pathway | PathwayName: Na+/Cl- dependent neurotransmitter transporters | PathwayId: R-HSA-442660
NodeType: Pathway | PathwayName: Nectin/Necl  trans heterodimerization | PathwayId: R-HSA-420597
NodeType: Pathway | PathwayName: Neddylation | PathwayId: R-HSA-8951664
NodeType: Pathway | PathwayName: Nef Mediated CD4 Down-regulation | PathwayId: R-HSA-167590
NodeType: Pathway | PathwayName: Nef Mediated CD8 Down-regulation | PathwayId: R-HSA-182218
NodeType: Pathway | PathwayName: Nef and signal transduction | PathwayId: R-HSA-164944
NodeType: Pathway | PathwayName: Nef mediated downregulation of CD28 cell surface expression | PathwayId: R-HSA-164939
NodeType: Pathway | PathwayName: Nef mediated downregulation of MHC class I complex cell surface expression | PathwayId: R-HSA-164940
NodeType: Pathway | PathwayName: Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | PathwayId: R-HSA-164938
NodeType: Pathway | PathwayName: Negative epigenetic regulation of rRNA expression | PathwayId: R-HSA-5250941
NodeType: Pathway | PathwayName: Negative feedback regulation of MAPK pathway | PathwayId: R-HSA-5674499
NodeType: Pathway | PathwayName: Negative regulation of FGFR1 signaling | PathwayId: R-HSA-5654726
NodeType: Pathway | PathwayName: Negative regulation of FGFR2 signaling | PathwayId: R-HSA-5654727
NodeType: Pathway | PathwayName: Negative regulation of FGFR3 signaling | PathwayId: R-HSA-5654732
NodeType: Pathway | PathwayName: Negative regulation of FGFR4 signaling | PathwayId: R-HSA-5654733
NodeType: Pathway | PathwayName: Negative regulation of FLT3 | PathwayId: R-HSA-9706369
NodeType: Pathway | PathwayName: Negative regulation of MAPK pathway | PathwayId: R-HSA-5675221
NodeType: Pathway | PathwayName: Negative regulation of MET activity | PathwayId: R-HSA-6807004
NodeType: Pathway | PathwayName: Negative regulation of NMDA receptor-mediated neuronal transmission | PathwayId: R-HSA-9617324
NodeType: Pathway | PathwayName: Negative regulation of NOTCH4 signaling | PathwayId: R-HSA-9604323
NodeType: Pathway | PathwayName: Negative regulation of TCF-dependent signaling by DVL-interacting proteins | PathwayId: R-HSA-5368598
NodeType: Pathway | PathwayName: Negative regulation of TCF-dependent signaling by WNT ligand antagonists | PathwayId: R-HSA-3772470
NodeType: Pathway | PathwayName: Negative regulation of activity of TFAP2 (AP-2) family transcription factors | PathwayId: R-HSA-8866904
NodeType: Pathway | PathwayName: Negative regulation of the PI3K/AKT network | PathwayId: R-HSA-199418
NodeType: Pathway | PathwayName: Negative regulators of DDX58/IFIH1 signaling | PathwayId: R-HSA-936440
NodeType: Pathway | PathwayName: Nephrin family interactions | PathwayId: R-HSA-373753
NodeType: Pathway | PathwayName: Nephron development | PathwayId: R-HSA-9831926
NodeType: Pathway | PathwayName: Nervous system development | PathwayId: R-HSA-9675108
NodeType: Pathway | PathwayName: Netrin mediated repulsion signals | PathwayId: R-HSA-418886
NodeType: Pathway | PathwayName: Netrin-1 signaling | PathwayId: R-HSA-373752
NodeType: Pathway | PathwayName: Neurexins and neuroligins | PathwayId: R-HSA-6794361
NodeType: Pathway | PathwayName: Neurodegenerative Diseases | PathwayId: R-HSA-8863678
NodeType: Pathway | PathwayName: Neurofascin interactions | PathwayId: R-HSA-447043
NodeType: Pathway | PathwayName: Neuronal System | PathwayId: R-HSA-112316
NodeType: Pathway | PathwayName: Neurophilin interactions with VEGF and VEGFR | PathwayId: R-HSA-194306
NodeType: Pathway | PathwayName: Neurotoxicity of clostridium toxins | PathwayId: R-HSA-168799
NodeType: Pathway | PathwayName: Neurotransmitter clearance | PathwayId: R-HSA-112311
NodeType: Pathway | PathwayName: Neurotransmitter receptors and postsynaptic signal transmission | PathwayId: R-HSA-112314
NodeType: Pathway | PathwayName: Neurotransmitter release cycle | PathwayId: R-HSA-112310
NodeType: Pathway | PathwayName: Neurotransmitter uptake and metabolism In glial cells | PathwayId: R-HSA-112313
NodeType: Pathway | PathwayName: Neutrophil degranulation | PathwayId: R-HSA-6798695
NodeType: Pathway | PathwayName: Nicotinamide salvaging | PathwayId: R-HSA-197264
NodeType: Pathway | PathwayName: Nicotinate metabolism | PathwayId: R-HSA-196807
NodeType: Pathway | PathwayName: Nilotinib-resistant KIT mutants | PathwayId: R-HSA-9669926
NodeType: Pathway | PathwayName: Nitric oxide stimulates guanylate cyclase | PathwayId: R-HSA-392154
NodeType: Pathway | PathwayName: NoRC negatively regulates rRNA expression | PathwayId: R-HSA-427413
NodeType: Pathway | PathwayName: Non-integrin membrane-ECM interactions | PathwayId: R-HSA-3000171
NodeType: Pathway | PathwayName: Noncanonical activation of NOTCH3 | PathwayId: R-HSA-9017802
NodeType: Pathway | PathwayName: Nonhomologous End-Joining (NHEJ) | PathwayId: R-HSA-5693571
NodeType: Pathway | PathwayName: Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | PathwayId: R-HSA-975957
NodeType: Pathway | PathwayName: Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | PathwayId: R-HSA-975956
NodeType: Pathway | PathwayName: Nonsense-Mediated Decay (NMD) | PathwayId: R-HSA-927802
NodeType: Pathway | PathwayName: Norepinephrine Neurotransmitter Release Cycle | PathwayId: R-HSA-181430
NodeType: Pathway | PathwayName: Notch-HLH transcription pathway | PathwayId: R-HSA-350054
NodeType: Pathway | PathwayName: NrCAM interactions | PathwayId: R-HSA-447038
NodeType: Pathway | PathwayName: Nuclear Envelope (NE) Reassembly | PathwayId: R-HSA-2995410
NodeType: Pathway | PathwayName: Nuclear Envelope Breakdown | PathwayId: R-HSA-2980766
NodeType: Pathway | PathwayName: Nuclear Events (kinase and transcription factor activation) | PathwayId: R-HSA-198725
NodeType: Pathway | PathwayName: Nuclear Pore Complex (NPC) Disassembly | PathwayId: R-HSA-3301854
NodeType: Pathway | PathwayName: Nuclear Receptor transcription pathway | PathwayId: R-HSA-383280
NodeType: Pathway | PathwayName: Nuclear events mediated by NFE2L2 | PathwayId: R-HSA-9759194
NodeType: Pathway | PathwayName: Nuclear events stimulated by ALK signaling in cancer | PathwayId: R-HSA-9725371
NodeType: Pathway | PathwayName: Nuclear import of Rev protein | PathwayId: R-HSA-180746
NodeType: Pathway | PathwayName: Nuclear signaling by ERBB4 | PathwayId: R-HSA-1251985
NodeType: Pathway | PathwayName: Nucleosome assembly | PathwayId: R-HSA-774815
NodeType: Pathway | PathwayName: Nucleotide Excision Repair | PathwayId: R-HSA-5696398
NodeType: Pathway | PathwayName: Nucleotide biosynthesis | PathwayId: R-HSA-8956320
NodeType: Pathway | PathwayName: Nucleotide catabolism | PathwayId: R-HSA-8956319
NodeType: Pathway | PathwayName: Nucleotide catabolism defects | PathwayId: R-HSA-9735786
NodeType: Pathway | PathwayName: Nucleotide salvage | PathwayId: R-HSA-8956321
NodeType: Pathway | PathwayName: Nucleotide salvage defects | PathwayId: R-HSA-9734207
NodeType: Pathway | PathwayName: Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | PathwayId: R-HSA-168643
NodeType: Pathway | PathwayName: Nucleotide-like (purinergic) receptors | PathwayId: R-HSA-418038
NodeType: Pathway | PathwayName: O-glycosylation of TSR domain-containing proteins | PathwayId: R-HSA-5173214
NodeType: Pathway | PathwayName: O-linked glycosylation | PathwayId: R-HSA-5173105
NodeType: Pathway | PathwayName: O-linked glycosylation of mucins | PathwayId: R-HSA-913709
NodeType: Pathway | PathwayName: O2/CO2 exchange in erythrocytes | PathwayId: R-HSA-1480926
NodeType: Pathway | PathwayName: OADH complex synthesizes glutaryl-CoA from 2-OA | PathwayId: R-HSA-9858328
NodeType: Pathway | PathwayName: OAS antiviral response | PathwayId: R-HSA-8983711
NodeType: Pathway | PathwayName: OGDH complex synthesizes succinyl-CoA from 2-OG | PathwayId: R-HSA-9853506
NodeType: Pathway | PathwayName: Oleoyl-phe metabolism | PathwayId: R-HSA-9673163
NodeType: Pathway | PathwayName: Olfactory Signaling Pathway | PathwayId: R-HSA-381753
NodeType: Pathway | PathwayName: Oligomerization of connexins into connexons | PathwayId: R-HSA-190704
NodeType: Pathway | PathwayName: Oncogene Induced Senescence | PathwayId: R-HSA-2559585
NodeType: Pathway | PathwayName: Oncogenic MAPK signaling | PathwayId: R-HSA-6802957
NodeType: Pathway | PathwayName: Opioid Signalling | PathwayId: R-HSA-111885
NodeType: Pathway | PathwayName: Opsins | PathwayId: R-HSA-419771
NodeType: Pathway | PathwayName: Orc1 removal from chromatin | PathwayId: R-HSA-68949
NodeType: Pathway | PathwayName: Orexin and neuropeptides FF and QRFP bind to their respective receptors | PathwayId: R-HSA-389397
NodeType: Pathway | PathwayName: Organelle biogenesis and maintenance | PathwayId: R-HSA-1852241
NodeType: Pathway | PathwayName: Organic anion transport | PathwayId: R-HSA-561048
NodeType: Pathway | PathwayName: Organic anion transporters | PathwayId: R-HSA-428643
NodeType: Pathway | PathwayName: Organic cation transport | PathwayId: R-HSA-549127
NodeType: Pathway | PathwayName: Organic cation/anion/zwitterion transport | PathwayId: R-HSA-549132
NodeType: Pathway | PathwayName: Other interleukin signaling | PathwayId: R-HSA-449836
NodeType: Pathway | PathwayName: Other semaphorin interactions | PathwayId: R-HSA-416700
NodeType: Pathway | PathwayName: Ovarian tumor domain proteases | PathwayId: R-HSA-5689896
NodeType: Pathway | PathwayName: Oxidative Stress Induced Senescence | PathwayId: R-HSA-2559580
NodeType: Pathway | PathwayName: Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | PathwayId: R-HSA-1234176
NodeType: Pathway | PathwayName: P2Y receptors | PathwayId: R-HSA-417957
NodeType: Pathway | PathwayName: PAOs oxidise polyamines to amines | PathwayId: R-HSA-141334
NodeType: Pathway | PathwayName: PCNA-Dependent Long Patch Base Excision Repair | PathwayId: R-HSA-5651801
NodeType: Pathway | PathwayName: PCP/CE pathway | PathwayId: R-HSA-4086400
NodeType: Pathway | PathwayName: PD-1 signaling | PathwayId: R-HSA-389948
NodeType: Pathway | PathwayName: PDE3B signalling | PathwayId: R-HSA-165160
NodeType: Pathway | PathwayName: PDGFR mutants bind TKIs | PathwayId: R-HSA-9674428
NodeType: Pathway | PathwayName: PDH complex synthesizes acetyl-CoA from PYR | PathwayId: R-HSA-9861559
NodeType: Pathway | PathwayName: PECAM1 interactions | PathwayId: R-HSA-210990
NodeType: Pathway | PathwayName: PERK regulates gene expression | PathwayId: R-HSA-381042
NodeType: Pathway | PathwayName: PI Metabolism | PathwayId: R-HSA-1483255
NodeType: Pathway | PathwayName: PI and PC transport between ER and Golgi membranes | PathwayId: R-HSA-1483196
NodeType: Pathway | PathwayName: PI-3K cascade:FGFR1 | PathwayId: R-HSA-5654689
NodeType: Pathway | PathwayName: PI-3K cascade:FGFR2 | PathwayId: R-HSA-5654695
NodeType: Pathway | PathwayName: PI-3K cascade:FGFR3 | PathwayId: R-HSA-5654710
NodeType: Pathway | PathwayName: PI-3K cascade:FGFR4 | PathwayId: R-HSA-5654720
NodeType: Pathway | PathwayName: PI3K Cascade | PathwayId: R-HSA-109704
NodeType: Pathway | PathwayName: PI3K events in ERBB2 signaling | PathwayId: R-HSA-1963642
NodeType: Pathway | PathwayName: PI3K events in ERBB4 signaling | PathwayId: R-HSA-1250342
NodeType: Pathway | PathwayName: PI3K/AKT Signaling in Cancer | PathwayId: R-HSA-2219528
NodeType: Pathway | PathwayName: PI3K/AKT activation | PathwayId: R-HSA-198203
NodeType: Pathway | PathwayName: PI5P Regulates TP53 Acetylation | PathwayId: R-HSA-6811555
NodeType: Pathway | PathwayName: PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | PathwayId: R-HSA-6811558
NodeType: Pathway | PathwayName: PINK1-PRKN Mediated Mitophagy | PathwayId: R-HSA-5205685
NodeType: Pathway | PathwayName: PIP3 activates AKT signaling | PathwayId: R-HSA-1257604
NodeType: Pathway | PathwayName: PIPs transport between Golgi and plasma membranes | PathwayId: R-HSA-1660510
NodeType: Pathway | PathwayName: PIPs transport between early and late endosome membranes | PathwayId: R-HSA-1660502
NodeType: Pathway | PathwayName: PIPs transport between early endosome and Golgi membranes | PathwayId: R-HSA-1660537
NodeType: Pathway | PathwayName: PIPs transport between late endosome and Golgi membranes | PathwayId: R-HSA-1660508
NodeType: Pathway | PathwayName: PIPs transport between plasma and early endosome membranes | PathwayId: R-HSA-1660524
NodeType: Pathway | PathwayName: PIWI-interacting RNA (piRNA) biogenesis | PathwayId: R-HSA-5601884
NodeType: Pathway | PathwayName: PKA activation | PathwayId: R-HSA-163615
NodeType: Pathway | PathwayName: PKA activation in glucagon signalling | PathwayId: R-HSA-164378
NodeType: Pathway | PathwayName: PKA-mediated phosphorylation of CREB | PathwayId: R-HSA-111931
NodeType: Pathway | PathwayName: PKA-mediated phosphorylation of key metabolic factors | PathwayId: R-HSA-163358
NodeType: Pathway | PathwayName: PKB-mediated events | PathwayId: R-HSA-109703
NodeType: Pathway | PathwayName: PKMTs methylate histone lysines | PathwayId: R-HSA-3214841
NodeType: Pathway | PathwayName: PKR-mediated signaling | PathwayId: R-HSA-9833482
NodeType: Pathway | PathwayName: PLC beta mediated events | PathwayId: R-HSA-112043
NodeType: Pathway | PathwayName: PLC-gamma1 signalling | PathwayId: R-HSA-167021
NodeType: Pathway | PathwayName: PLCG1 events in ERBB2 signaling | PathwayId: R-HSA-1251932
NodeType: Pathway | PathwayName: POLB-Dependent Long Patch Base Excision Repair | PathwayId: R-HSA-110362
NodeType: Pathway | PathwayName: POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | PathwayId: R-HSA-2892247
NodeType: Pathway | PathwayName: POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | PathwayId: R-HSA-2892245
NodeType: Pathway | PathwayName: PP2A-mediated dephosphorylation of key metabolic factors | PathwayId: R-HSA-163767
NodeType: Pathway | PathwayName: PPARA activates gene expression | PathwayId: R-HSA-1989781
NodeType: Pathway | PathwayName: PRC2 methylates histones and DNA | PathwayId: R-HSA-212300
NodeType: Pathway | PathwayName: PTEN Loss of Function in Cancer | PathwayId: R-HSA-5674404
NodeType: Pathway | PathwayName: PTEN Regulation | PathwayId: R-HSA-6807070
NodeType: Pathway | PathwayName: PTK6 Activates STAT3 | PathwayId: R-HSA-8849474
NodeType: Pathway | PathwayName: PTK6 Down-Regulation | PathwayId: R-HSA-8849472
NodeType: Pathway | PathwayName: PTK6 Expression | PathwayId: R-HSA-8849473
NodeType: Pathway | PathwayName: PTK6 Regulates Cell Cycle | PathwayId: R-HSA-8849470
NodeType: Pathway | PathwayName: PTK6 Regulates Proteins Involved in RNA Processing | PathwayId: R-HSA-8849468
NodeType: Pathway | PathwayName: PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases | PathwayId: R-HSA-8849471
NodeType: Pathway | PathwayName: PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | PathwayId: R-HSA-8849469
NodeType: Pathway | PathwayName: PTK6 promotes HIF1A stabilization | PathwayId: R-HSA-8857538
NodeType: Pathway | PathwayName: Packaging Of Telomere Ends | PathwayId: R-HSA-171306
NodeType: Pathway | PathwayName: Packaging of Eight RNA Segments | PathwayId: R-HSA-168303
NodeType: Pathway | PathwayName: Paracetamol ADME | PathwayId: R-HSA-9753281
NodeType: Pathway | PathwayName: Paradoxical activation of RAF signaling by kinase inactive BRAF | PathwayId: R-HSA-6802955
NodeType: Pathway | PathwayName: Parasite infection | PathwayId: R-HSA-9664407
NodeType: Pathway | PathwayName: Parasitic Infection Pathways | PathwayId: R-HSA-9824443
NodeType: Pathway | PathwayName: Passive transport by Aquaporins | PathwayId: R-HSA-432047
NodeType: Pathway | PathwayName: Pausing and recovery of HIV elongation | PathwayId: R-HSA-167290
NodeType: Pathway | PathwayName: Pausing and recovery of Tat-mediated HIV elongation | PathwayId: R-HSA-167238
NodeType: Pathway | PathwayName: Pentose phosphate pathway | PathwayId: R-HSA-71336
NodeType: Pathway | PathwayName: Pentose phosphate pathway disease | PathwayId: R-HSA-6791465
NodeType: Pathway | PathwayName: Peptide chain elongation | PathwayId: R-HSA-156902
NodeType: Pathway | PathwayName: Peptide hormone biosynthesis | PathwayId: R-HSA-209952
NodeType: Pathway | PathwayName: Peptide hormone metabolism | PathwayId: R-HSA-2980736
NodeType: Pathway | PathwayName: Peptide ligand-binding receptors | PathwayId: R-HSA-375276
NodeType: Pathway | PathwayName: Peroxisomal lipid metabolism | PathwayId: R-HSA-390918
NodeType: Pathway | PathwayName: Peroxisomal protein import | PathwayId: R-HSA-9033241
NodeType: Pathway | PathwayName: Pervasive developmental disorders | PathwayId: R-HSA-9005895
NodeType: Pathway | PathwayName: Pexophagy | PathwayId: R-HSA-9664873
NodeType: Pathway | PathwayName: Phagocyte cell death caused by cytosolic Mtb | PathwayId: R-HSA-9637698
NodeType: Pathway | PathwayName: Phase 0 - rapid depolarisation | PathwayId: R-HSA-5576892
NodeType: Pathway | PathwayName: Phase 1 - inactivation of fast Na+ channels | PathwayId: R-HSA-5576894
NodeType: Pathway | PathwayName: Phase 2 - plateau phase | PathwayId: R-HSA-5576893
NodeType: Pathway | PathwayName: Phase 3 - rapid repolarisation | PathwayId: R-HSA-5576890
NodeType: Pathway | PathwayName: Phase 4 - resting membrane potential | PathwayId: R-HSA-5576886
NodeType: Pathway | PathwayName: Phase I - Functionalization of compounds | PathwayId: R-HSA-211945
NodeType: Pathway | PathwayName: Phase II - Conjugation of compounds | PathwayId: R-HSA-156580
NodeType: Pathway | PathwayName: Phenylalanine and tyrosine metabolism | PathwayId: R-HSA-8963691
NodeType: Pathway | PathwayName: Phenylalanine metabolism | PathwayId: R-HSA-8964208
NodeType: Pathway | PathwayName: Phenylketonuria | PathwayId: R-HSA-2160456
NodeType: Pathway | PathwayName: Phosphate bond hydrolysis by NTPDase proteins | PathwayId: R-HSA-8850843
NodeType: Pathway | PathwayName: Phosphate bond hydrolysis by NUDT proteins | PathwayId: R-HSA-2393930
NodeType: Pathway | PathwayName: Phospholipase C-mediated cascade: FGFR1 | PathwayId: R-HSA-5654219
NodeType: Pathway | PathwayName: Phospholipase C-mediated cascade; FGFR2 | PathwayId: R-HSA-5654221
NodeType: Pathway | PathwayName: Phospholipase C-mediated cascade; FGFR3 | PathwayId: R-HSA-5654227
NodeType: Pathway | PathwayName: Phospholipase C-mediated cascade; FGFR4 | PathwayId: R-HSA-5654228
NodeType: Pathway | PathwayName: Phospholipid metabolism | PathwayId: R-HSA-1483257
NodeType: Pathway | PathwayName: Phosphorylation of CD3 and TCR zeta chains | PathwayId: R-HSA-202427
NodeType: Pathway | PathwayName: Phosphorylation of Emi1 | PathwayId: R-HSA-176417
NodeType: Pathway | PathwayName: Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | PathwayId: R-HSA-69200
NodeType: Pathway | PathwayName: Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 complexes | PathwayId: R-HSA-170145
NodeType: Pathway | PathwayName: Phosphorylation of the APC/C | PathwayId: R-HSA-176412
NodeType: Pathway | PathwayName: Physiological factors | PathwayId: R-HSA-5578768
NodeType: Pathway | PathwayName: Plasma lipoprotein assembly | PathwayId: R-HSA-8963898
NodeType: Pathway | PathwayName: Plasma lipoprotein assembly, remodeling, and clearance | PathwayId: R-HSA-174824
NodeType: Pathway | PathwayName: Plasma lipoprotein clearance | PathwayId: R-HSA-8964043
NodeType: Pathway | PathwayName: Plasma lipoprotein remodeling | PathwayId: R-HSA-8963899
NodeType: Pathway | PathwayName: Plasmalogen biosynthesis | PathwayId: R-HSA-75896
NodeType: Pathway | PathwayName: Platelet Adhesion to exposed collagen | PathwayId: R-HSA-75892
NodeType: Pathway | PathwayName: Platelet Aggregation (Plug Formation) | PathwayId: R-HSA-76009
NodeType: Pathway | PathwayName: Platelet activation, signaling and aggregation | PathwayId: R-HSA-76002
NodeType: Pathway | PathwayName: Platelet calcium homeostasis | PathwayId: R-HSA-418360
NodeType: Pathway | PathwayName: Platelet degranulation | PathwayId: R-HSA-114608
NodeType: Pathway | PathwayName: Platelet homeostasis | PathwayId: R-HSA-418346
NodeType: Pathway | PathwayName: Platelet sensitization by LDL | PathwayId: R-HSA-432142
NodeType: Pathway | PathwayName: Plus-strand DNA synthesis | PathwayId: R-HSA-164525
NodeType: Pathway | PathwayName: Polo-like kinase mediated events | PathwayId: R-HSA-156711
NodeType: Pathway | PathwayName: Polymerase switching | PathwayId: R-HSA-69091
NodeType: Pathway | PathwayName: Polymerase switching on the C-strand of the telomere | PathwayId: R-HSA-174411
NodeType: Pathway | PathwayName: Positive epigenetic regulation of rRNA expression | PathwayId: R-HSA-5250913
NodeType: Pathway | PathwayName: Post NMDA receptor activation events | PathwayId: R-HSA-438064
NodeType: Pathway | PathwayName: Post-chaperonin tubulin folding pathway | PathwayId: R-HSA-389977
NodeType: Pathway | PathwayName: Post-transcriptional silencing by small RNAs | PathwayId: R-HSA-426496
NodeType: Pathway | PathwayName: Post-translational modification: synthesis of GPI-anchored proteins | PathwayId: R-HSA-163125
NodeType: Pathway | PathwayName: Post-translational protein modification | PathwayId: R-HSA-597592
NodeType: Pathway | PathwayName: Post-translational protein phosphorylation | PathwayId: R-HSA-8957275
NodeType: Pathway | PathwayName: Postmitotic nuclear pore complex (NPC) reformation | PathwayId: R-HSA-9615933
NodeType: Pathway | PathwayName: Postsynaptic nicotinic acetylcholine receptors | PathwayId: R-HSA-622327
NodeType: Pathway | PathwayName: Potassium Channels | PathwayId: R-HSA-1296071
NodeType: Pathway | PathwayName: Potassium transport channels | PathwayId: R-HSA-1296067
NodeType: Pathway | PathwayName: Potential therapeutics for SARS | PathwayId: R-HSA-9679191
NodeType: Pathway | PathwayName: Pre-NOTCH Expression and Processing | PathwayId: R-HSA-1912422
NodeType: Pathway | PathwayName: Pre-NOTCH Processing in Golgi | PathwayId: R-HSA-1912420
NodeType: Pathway | PathwayName: Pre-NOTCH Processing in the Endoplasmic Reticulum | PathwayId: R-HSA-1912399
NodeType: Pathway | PathwayName: Pre-NOTCH Transcription and Translation | PathwayId: R-HSA-1912408
NodeType: Pathway | PathwayName: Prednisone ADME | PathwayId: R-HSA-9757110
NodeType: Pathway | PathwayName: Prefoldin mediated transfer of substrate  to CCT/TriC | PathwayId: R-HSA-389957
NodeType: Pathway | PathwayName: Pregnenolone biosynthesis | PathwayId: R-HSA-196108
NodeType: Pathway | PathwayName: Presynaptic depolarization and calcium channel opening | PathwayId: R-HSA-112308
NodeType: Pathway | PathwayName: Presynaptic function of Kainate receptors | PathwayId: R-HSA-500657
NodeType: Pathway | PathwayName: Presynaptic nicotinic acetylcholine receptors | PathwayId: R-HSA-622323
NodeType: Pathway | PathwayName: Presynaptic phase of homologous DNA pairing and strand exchange | PathwayId: R-HSA-5693616
NodeType: Pathway | PathwayName: Prevention of phagosomal-lysosomal fusion | PathwayId: R-HSA-9636383
NodeType: Pathway | PathwayName: Processing and activation of SUMO | PathwayId: R-HSA-3215018
NodeType: Pathway | PathwayName: Processing of Capped Intron-Containing Pre-mRNA | PathwayId: R-HSA-72203
NodeType: Pathway | PathwayName: Processing of Capped Intronless Pre-mRNA | PathwayId: R-HSA-75067
NodeType: Pathway | PathwayName: Processing of DNA double-strand break ends | PathwayId: R-HSA-5693607
NodeType: Pathway | PathwayName: Processing of Intronless Pre-mRNAs | PathwayId: R-HSA-77595
NodeType: Pathway | PathwayName: Processing of SMDT1 | PathwayId: R-HSA-8949664
NodeType: Pathway | PathwayName: Processive synthesis on the C-strand of the telomere | PathwayId: R-HSA-174414
NodeType: Pathway | PathwayName: Processive synthesis on the lagging strand | PathwayId: R-HSA-69183
NodeType: Pathway | PathwayName: Programmed Cell Death | PathwayId: R-HSA-5357801
NodeType: Pathway | PathwayName: Progressive trimming of alpha-1,2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2 | PathwayId: R-HSA-964827
NodeType: Pathway | PathwayName: Prolactin receptor signaling | PathwayId: R-HSA-1170546
NodeType: Pathway | PathwayName: Proline catabolism | PathwayId: R-HSA-70688
NodeType: Pathway | PathwayName: Prolonged ERK activation events | PathwayId: R-HSA-169893
NodeType: Pathway | PathwayName: Propionyl-CoA catabolism | PathwayId: R-HSA-71032
NodeType: Pathway | PathwayName: Prostacyclin signalling through prostacyclin receptor | PathwayId: R-HSA-392851
NodeType: Pathway | PathwayName: Prostanoid ligand receptors | PathwayId: R-HSA-391908
NodeType: Pathway | PathwayName: Protein folding | PathwayId: R-HSA-391251
NodeType: Pathway | PathwayName: Protein hydroxylation | PathwayId: R-HSA-9629569
NodeType: Pathway | PathwayName: Protein lipoylation | PathwayId: R-HSA-9857492
NodeType: Pathway | PathwayName: Protein localization | PathwayId: R-HSA-9609507
NodeType: Pathway | PathwayName: Protein methylation | PathwayId: R-HSA-8876725
NodeType: Pathway | PathwayName: Protein repair | PathwayId: R-HSA-5676934
NodeType: Pathway | PathwayName: Protein ubiquitination | PathwayId: R-HSA-8852135
NodeType: Pathway | PathwayName: Protein-protein interactions at synapses | PathwayId: R-HSA-6794362
NodeType: Pathway | PathwayName: Proton-coupled monocarboxylate transport | PathwayId: R-HSA-433692
NodeType: Pathway | PathwayName: Proton-coupled neutral amino acid transporters | PathwayId: R-HSA-428559
NodeType: Pathway | PathwayName: Proton/oligopeptide cotransporters | PathwayId: R-HSA-427975
NodeType: Pathway | PathwayName: Purine catabolism | PathwayId: R-HSA-74259
NodeType: Pathway | PathwayName: Purine ribonucleoside monophosphate biosynthesis | PathwayId: R-HSA-73817
NodeType: Pathway | PathwayName: Purine salvage | PathwayId: R-HSA-74217
NodeType: Pathway | PathwayName: Purinergic signaling in leishmaniasis infection | PathwayId: R-HSA-9660826
NodeType: Pathway | PathwayName: Pyrimidine biosynthesis | PathwayId: R-HSA-500753
NodeType: Pathway | PathwayName: Pyrimidine catabolism | PathwayId: R-HSA-73621
NodeType: Pathway | PathwayName: Pyrimidine salvage | PathwayId: R-HSA-73614
NodeType: Pathway | PathwayName: Pyrophosphate hydrolysis | PathwayId: R-HSA-71737
NodeType: Pathway | PathwayName: Pyroptosis | PathwayId: R-HSA-5620971
NodeType: Pathway | PathwayName: Pyruvate metabolism | PathwayId: R-HSA-70268
NodeType: Pathway | PathwayName: RA biosynthesis pathway | PathwayId: R-HSA-5365859
NodeType: Pathway | PathwayName: RAB GEFs exchange GTP for GDP on RABs | PathwayId: R-HSA-8876198
NodeType: Pathway | PathwayName: RAB geranylgeranylation | PathwayId: R-HSA-8873719
NodeType: Pathway | PathwayName: RAC1 GTPase cycle | PathwayId: R-HSA-9013149
NodeType: Pathway | PathwayName: RAC2 GTPase cycle | PathwayId: R-HSA-9013404
NodeType: Pathway | PathwayName: RAC3 GTPase cycle | PathwayId: R-HSA-9013423
NodeType: Pathway | PathwayName: RAF activation | PathwayId: R-HSA-5673000
NodeType: Pathway | PathwayName: RAF-independent MAPK1/3 activation | PathwayId: R-HSA-112409
NodeType: Pathway | PathwayName: RAF/MAP kinase cascade | PathwayId: R-HSA-5673001
NodeType: Pathway | PathwayName: RAS GTPase cycle mutants | PathwayId: R-HSA-9649913
NodeType: Pathway | PathwayName: RAS processing | PathwayId: R-HSA-9648002
NodeType: Pathway | PathwayName: RAS signaling downstream of NF1 loss-of-function variants | PathwayId: R-HSA-6802953
NodeType: Pathway | PathwayName: RET signaling | PathwayId: R-HSA-8853659
NodeType: Pathway | PathwayName: RHO GTPase Effectors | PathwayId: R-HSA-195258
NodeType: Pathway | PathwayName: RHO GTPase cycle | PathwayId: R-HSA-9012999
NodeType: Pathway | PathwayName: RHO GTPases Activate Formins | PathwayId: R-HSA-5663220
NodeType: Pathway | PathwayName: RHO GTPases Activate NADPH Oxidases | PathwayId: R-HSA-5668599
NodeType: Pathway | PathwayName: RHO GTPases Activate ROCKs | PathwayId: R-HSA-5627117
NodeType: Pathway | PathwayName: RHO GTPases Activate Rhotekin and Rhophilins | PathwayId: R-HSA-5666185
NodeType: Pathway | PathwayName: RHO GTPases Activate WASPs and WAVEs | PathwayId: R-HSA-5663213
NodeType: Pathway | PathwayName: RHO GTPases activate CIT | PathwayId: R-HSA-5625900
NodeType: Pathway | PathwayName: RHO GTPases activate IQGAPs | PathwayId: R-HSA-5626467
NodeType: Pathway | PathwayName: RHO GTPases activate KTN1 | PathwayId: R-HSA-5625970
NodeType: Pathway | PathwayName: RHO GTPases activate PAKs | PathwayId: R-HSA-5627123
NodeType: Pathway | PathwayName: RHO GTPases activate PKNs | PathwayId: R-HSA-5625740
NodeType: Pathway | PathwayName: RHO GTPases regulate CFTR trafficking | PathwayId: R-HSA-5627083
NodeType: Pathway | PathwayName: RHOA GTPase cycle | PathwayId: R-HSA-8980692
NodeType: Pathway | PathwayName: RHOB GTPase cycle | PathwayId: R-HSA-9013026
NodeType: Pathway | PathwayName: RHOBTB GTPase Cycle | PathwayId: R-HSA-9706574
NodeType: Pathway | PathwayName: RHOBTB1 GTPase cycle | PathwayId: R-HSA-9013422
NodeType: Pathway | PathwayName: RHOBTB2 GTPase cycle | PathwayId: R-HSA-9013418
NodeType: Pathway | PathwayName: RHOBTB3 ATPase cycle | PathwayId: R-HSA-9706019
NodeType: Pathway | PathwayName: RHOC GTPase cycle | PathwayId: R-HSA-9013106
NodeType: Pathway | PathwayName: RHOD GTPase cycle | PathwayId: R-HSA-9013405
NodeType: Pathway | PathwayName: RHOF GTPase cycle | PathwayId: R-HSA-9035034
NodeType: Pathway | PathwayName: RHOG GTPase cycle | PathwayId: R-HSA-9013408
NodeType: Pathway | PathwayName: RHOH GTPase cycle | PathwayId: R-HSA-9013407
NodeType: Pathway | PathwayName: RHOJ GTPase cycle | PathwayId: R-HSA-9013409
NodeType: Pathway | PathwayName: RHOQ GTPase cycle | PathwayId: R-HSA-9013406
NodeType: Pathway | PathwayName: RHOT1 GTPase cycle | PathwayId: R-HSA-9013425
NodeType: Pathway | PathwayName: RHOT2 GTPase cycle | PathwayId: R-HSA-9013419
NodeType: Pathway | PathwayName: RHOU GTPase cycle | PathwayId: R-HSA-9013420
NodeType: Pathway | PathwayName: RHOV GTPase cycle | PathwayId: R-HSA-9013424
NodeType: Pathway | PathwayName: RIP-mediated NFkB activation via ZBP1 | PathwayId: R-HSA-1810476
NodeType: Pathway | PathwayName: RIPK1-mediated regulated necrosis | PathwayId: R-HSA-5213460
NodeType: Pathway | PathwayName: RMTs methylate histone arginines | PathwayId: R-HSA-3214858
NodeType: Pathway | PathwayName: RNA Pol II CTD phosphorylation and interaction with CE | PathwayId: R-HSA-77075
NodeType: Pathway | PathwayName: RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | PathwayId: R-HSA-167160
NodeType: Pathway | PathwayName: RNA Polymerase I Promoter Clearance | PathwayId: R-HSA-73854
NodeType: Pathway | PathwayName: RNA Polymerase I Promoter Escape | PathwayId: R-HSA-73772
NodeType: Pathway | PathwayName: RNA Polymerase I Promoter Opening | PathwayId: R-HSA-73728
NodeType: Pathway | PathwayName: RNA Polymerase I Transcription | PathwayId: R-HSA-73864
NodeType: Pathway | PathwayName: RNA Polymerase I Transcription Initiation | PathwayId: R-HSA-73762
NodeType: Pathway | PathwayName: RNA Polymerase I Transcription Termination | PathwayId: R-HSA-73863
NodeType: Pathway | PathwayName: RNA Polymerase II HIV Promoter Escape | PathwayId: R-HSA-167162
NodeType: Pathway | PathwayName: RNA Polymerase II Pre-transcription Events | PathwayId: R-HSA-674695
NodeType: Pathway | PathwayName: RNA Polymerase II Promoter Escape | PathwayId: R-HSA-73776
NodeType: Pathway | PathwayName: RNA Polymerase II Transcription | PathwayId: R-HSA-73857
NodeType: Pathway | PathwayName: RNA Polymerase II Transcription Elongation | PathwayId: R-HSA-75955
NodeType: Pathway | PathwayName: RNA Polymerase II Transcription Initiation | PathwayId: R-HSA-75953
NodeType: Pathway | PathwayName: RNA Polymerase II Transcription Initiation And Promoter Clearance | PathwayId: R-HSA-76042
NodeType: Pathway | PathwayName: RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | PathwayId: R-HSA-73779
NodeType: Pathway | PathwayName: RNA Polymerase II Transcription Termination | PathwayId: R-HSA-73856
NodeType: Pathway | PathwayName: RNA Polymerase III Abortive And Retractive Initiation | PathwayId: R-HSA-749476
NodeType: Pathway | PathwayName: RNA Polymerase III Chain Elongation | PathwayId: R-HSA-73780
NodeType: Pathway | PathwayName: RNA Polymerase III Transcription | PathwayId: R-HSA-74158
NodeType: Pathway | PathwayName: RNA Polymerase III Transcription Initiation | PathwayId: R-HSA-76046
NodeType: Pathway | PathwayName: RNA Polymerase III Transcription Initiation From Type 1 Promoter | PathwayId: R-HSA-76061
NodeType: Pathway | PathwayName: RNA Polymerase III Transcription Initiation From Type 2 Promoter | PathwayId: R-HSA-76066
NodeType: Pathway | PathwayName: RNA Polymerase III Transcription Initiation From Type 3 Promoter | PathwayId: R-HSA-76071
NodeType: Pathway | PathwayName: RNA Polymerase III Transcription Termination | PathwayId: R-HSA-73980
NodeType: Pathway | PathwayName: RNA polymerase II transcribes snRNA genes | PathwayId: R-HSA-6807505
NodeType: Pathway | PathwayName: RND1 GTPase cycle | PathwayId: R-HSA-9696273
NodeType: Pathway | PathwayName: RND2 GTPase cycle | PathwayId: R-HSA-9696270
NodeType: Pathway | PathwayName: RND3 GTPase cycle | PathwayId: R-HSA-9696264
NodeType: Pathway | PathwayName: ROBO receptors bind AKAP5 | PathwayId: R-HSA-9010642
NodeType: Pathway | PathwayName: RORA activates gene expression | PathwayId: R-HSA-1368082
NodeType: Pathway | PathwayName: ROS and RNS production in phagocytes | PathwayId: R-HSA-1222556
NodeType: Pathway | PathwayName: RPIA deficiency: failed conversion of R5P to RU5P | PathwayId: R-HSA-5659996
NodeType: Pathway | PathwayName: RPIA deficiency: failed conversion of RU5P to R5P | PathwayId: R-HSA-6791461
NodeType: Pathway | PathwayName: RSK activation | PathwayId: R-HSA-444257
NodeType: Pathway | PathwayName: RSV-host interactions | PathwayId: R-HSA-9833110
NodeType: Pathway | PathwayName: RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | PathwayId: R-HSA-8877330
NodeType: Pathway | PathwayName: RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | PathwayId: R-HSA-8939243
NodeType: Pathway | PathwayName: RUNX1 regulates estrogen receptor mediated transcription | PathwayId: R-HSA-8931987
NodeType: Pathway | PathwayName: RUNX1 regulates expression of components of tight junctions | PathwayId: R-HSA-8935964
NodeType: Pathway | PathwayName: RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | PathwayId: R-HSA-8936459
NodeType: Pathway | PathwayName: RUNX1 regulates transcription of genes involved in BCR signaling | PathwayId: R-HSA-8939245
NodeType: Pathway | PathwayName: RUNX1 regulates transcription of genes involved in WNT signaling | PathwayId: R-HSA-8939256
NodeType: Pathway | PathwayName: RUNX1 regulates transcription of genes involved in differentiation of HSCs | PathwayId: R-HSA-8939236
NodeType: Pathway | PathwayName: RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | PathwayId: R-HSA-8939242
NodeType: Pathway | PathwayName: RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | PathwayId: R-HSA-8939246
NodeType: Pathway | PathwayName: RUNX1 regulates transcription of genes involved in interleukin signaling | PathwayId: R-HSA-8939247
NodeType: Pathway | PathwayName: RUNX2 regulates bone development | PathwayId: R-HSA-8941326
NodeType: Pathway | PathwayName: RUNX2 regulates chondrocyte maturation | PathwayId: R-HSA-8941284
NodeType: Pathway | PathwayName: RUNX2 regulates genes involved in cell migration | PathwayId: R-HSA-8941332
NodeType: Pathway | PathwayName: RUNX2 regulates genes involved in differentiation of myeloid cells | PathwayId: R-HSA-8941333
NodeType: Pathway | PathwayName: RUNX2 regulates osteoblast differentiation | PathwayId: R-HSA-8940973
NodeType: Pathway | PathwayName: RUNX3 Regulates Immune Response and Cell Migration | PathwayId: R-HSA-8949275
NodeType: Pathway | PathwayName: RUNX3 regulates BCL2L11 (BIM) transcription | PathwayId: R-HSA-8952158
NodeType: Pathway | PathwayName: RUNX3 regulates CDKN1A transcription | PathwayId: R-HSA-8941855
NodeType: Pathway | PathwayName: RUNX3 regulates NOTCH signaling | PathwayId: R-HSA-8941856
NodeType: Pathway | PathwayName: RUNX3 regulates RUNX1-mediated transcription | PathwayId: R-HSA-8951911
NodeType: Pathway | PathwayName: RUNX3 regulates WNT signaling | PathwayId: R-HSA-8951430
NodeType: Pathway | PathwayName: RUNX3 regulates YAP1-mediated transcription | PathwayId: R-HSA-8951671
NodeType: Pathway | PathwayName: RUNX3 regulates p14-ARF | PathwayId: R-HSA-8951936
NodeType: Pathway | PathwayName: Rab regulation of trafficking | PathwayId: R-HSA-9007101
NodeType: Pathway | PathwayName: Rap1 signalling | PathwayId: R-HSA-392517
NodeType: Pathway | PathwayName: Ras activation upon Ca2+ influx through NMDA receptor | PathwayId: R-HSA-442982
NodeType: Pathway | PathwayName: Reactions specific to the complex N-glycan synthesis pathway | PathwayId: R-HSA-975578
NodeType: Pathway | PathwayName: Reactions specific to the hybrid N-glycan synthesis pathway | PathwayId: R-HSA-975574
NodeType: Pathway | PathwayName: Receptor Mediated Mitophagy | PathwayId: R-HSA-8934903
NodeType: Pathway | PathwayName: Receptor-type tyrosine-protein phosphatases | PathwayId: R-HSA-388844
NodeType: Pathway | PathwayName: Recognition and association of DNA glycosylase with site containing an affected purine | PathwayId: R-HSA-110330
NodeType: Pathway | PathwayName: Recognition and association of DNA glycosylase with site containing an affected pyrimidine | PathwayId: R-HSA-110328
NodeType: Pathway | PathwayName: Recognition of DNA damage by PCNA-containing replication complex | PathwayId: R-HSA-110314
NodeType: Pathway | PathwayName: Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | PathwayId: R-HSA-5693565
NodeType: Pathway | PathwayName: Recruitment of NuMA to mitotic centrosomes | PathwayId: R-HSA-380320
NodeType: Pathway | PathwayName: Recruitment of mitotic centrosome proteins and complexes | PathwayId: R-HSA-380270
NodeType: Pathway | PathwayName: Recycling of bile acids and salts | PathwayId: R-HSA-159418
NodeType: Pathway | PathwayName: Recycling of eIF2:GDP | PathwayId: R-HSA-72731
NodeType: Pathway | PathwayName: Recycling pathway of L1 | PathwayId: R-HSA-437239
NodeType: Pathway | PathwayName: Reduction of cytosolic Ca++ levels | PathwayId: R-HSA-418359
NodeType: Pathway | PathwayName: Reelin signalling pathway | PathwayId: R-HSA-8866376
NodeType: Pathway | PathwayName: Regorafenib-resistant KIT mutants | PathwayId: R-HSA-9669929
NodeType: Pathway | PathwayName: Regorafenib-resistant PDGFR mutants | PathwayId: R-HSA-9674403
NodeType: Pathway | PathwayName: Regulated Necrosis | PathwayId: R-HSA-5218859
NodeType: Pathway | PathwayName: Regulated proteolysis of p75NTR | PathwayId: R-HSA-193692
NodeType: Pathway | PathwayName: Regulation by TREX1 | PathwayId: R-HSA-3248023
NodeType: Pathway | PathwayName: Regulation by c-FLIP | PathwayId: R-HSA-3371378
NodeType: Pathway | PathwayName: Regulation of APC/C activators between G1/S and early anaphase | PathwayId: R-HSA-176408
NodeType: Pathway | PathwayName: Regulation of Apoptosis | PathwayId: R-HSA-169911
NodeType: Pathway | PathwayName: Regulation of BACH1 activity | PathwayId: R-HSA-9708530
NodeType: Pathway | PathwayName: Regulation of CDH11 Expression and Function | PathwayId: R-HSA-9759475
NodeType: Pathway | PathwayName: Regulation of CDH11 function | PathwayId: R-HSA-9762292
NodeType: Pathway | PathwayName: Regulation of CDH11 gene transcription | PathwayId: R-HSA-9762293
NodeType: Pathway | PathwayName: Regulation of CDH11 mRNA translation by microRNAs | PathwayId: R-HSA-9759811
NodeType: Pathway | PathwayName: Regulation of CDH19 Expression and Function | PathwayId: R-HSA-9764302
NodeType: Pathway | PathwayName: Regulation of Complement cascade | PathwayId: R-HSA-977606
NodeType: Pathway | PathwayName: Regulation of Expression and Function of Type II Classical Cadherins | PathwayId: R-HSA-9764260
NodeType: Pathway | PathwayName: Regulation of FOXO transcriptional activity by acetylation | PathwayId: R-HSA-9617629
NodeType: Pathway | PathwayName: Regulation of FZD by ubiquitination | PathwayId: R-HSA-4641263
NodeType: Pathway | PathwayName: Regulation of Glucokinase by Glucokinase Regulatory Protein | PathwayId: R-HSA-170822
NodeType: Pathway | PathwayName: Regulation of HMOX1 expression and activity | PathwayId: R-HSA-9707587
NodeType: Pathway | PathwayName: Regulation of HSF1-mediated heat shock response | PathwayId: R-HSA-3371453
NodeType: Pathway | PathwayName: Regulation of Homotypic Cell-Cell Adhesion | PathwayId: R-HSA-9759476
NodeType: Pathway | PathwayName: Regulation of IFNA/IFNB signaling | PathwayId: R-HSA-912694
NodeType: Pathway | PathwayName: Regulation of IFNG signaling | PathwayId: R-HSA-877312
NodeType: Pathway | PathwayName: Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | PathwayId: R-HSA-381426
NodeType: Pathway | PathwayName: Regulation of KIT signaling | PathwayId: R-HSA-1433559
NodeType: Pathway | PathwayName: Regulation of MECP2 expression and activity | PathwayId: R-HSA-9022692
NodeType: Pathway | PathwayName: Regulation of MITF-M dependent genes involved in invasion | PathwayId: R-HSA-9854909
NodeType: Pathway | PathwayName: Regulation of MITF-M dependent genes involved in metabolism | PathwayId: R-HSA-9854907
NodeType: Pathway | PathwayName: Regulation of MITF-M-dependent genes involved in DNA damage repair and senescence | PathwayId: R-HSA-9825895
NodeType: Pathway | PathwayName: Regulation of MITF-M-dependent genes involved in apoptosis | PathwayId: R-HSA-9824594
NodeType: Pathway | PathwayName: Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | PathwayId: R-HSA-9825892
NodeType: Pathway | PathwayName: Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy | PathwayId: R-HSA-9857377
NodeType: Pathway | PathwayName: Regulation of MITF-M-dependent genes involved in pigmentation | PathwayId: R-HSA-9824585
NodeType: Pathway | PathwayName: Regulation of NF-kappa B signaling | PathwayId: R-HSA-9758274
NodeType: Pathway | PathwayName: Regulation of NFE2L2 gene expression | PathwayId: R-HSA-9818749
NodeType: Pathway | PathwayName: Regulation of NPAS4 gene expression | PathwayId: R-HSA-9768759
NodeType: Pathway | PathwayName: Regulation of NPAS4 gene transcription | PathwayId: R-HSA-9768777
NodeType: Pathway | PathwayName: Regulation of NPAS4 mRNA translation | PathwayId: R-HSA-9768778
NodeType: Pathway | PathwayName: Regulation of PAK-2p34 activity by PS-GAP/RHG10 | PathwayId: R-HSA-211728
NodeType: Pathway | PathwayName: Regulation of PLK1 Activity at G2/M Transition | PathwayId: R-HSA-2565942
NodeType: Pathway | PathwayName: Regulation of PTEN gene transcription | PathwayId: R-HSA-8943724
NodeType: Pathway | PathwayName: Regulation of PTEN localization | PathwayId: R-HSA-8948747
NodeType: Pathway | PathwayName: Regulation of PTEN mRNA translation | PathwayId: R-HSA-8943723
NodeType: Pathway | PathwayName: Regulation of PTEN stability and activity | PathwayId: R-HSA-8948751
NodeType: Pathway | PathwayName: Regulation of RAS by GAPs | PathwayId: R-HSA-5658442
NodeType: Pathway | PathwayName: Regulation of RUNX1 Expression and Activity | PathwayId: R-HSA-8934593
NodeType: Pathway | PathwayName: Regulation of RUNX2 expression and activity | PathwayId: R-HSA-8939902
NodeType: Pathway | PathwayName: Regulation of RUNX3 expression and activity | PathwayId: R-HSA-8941858
NodeType: Pathway | PathwayName: Regulation of TBK1, IKK (IKBKE)-mediated activation of IRF3, IRF7  | PathwayId: R-HSA-9824878
NodeType: Pathway | PathwayName: Regulation of TBK1, IKK-mediated activation of IRF3, IRF7 upon TLR3 ligation | PathwayId: R-HSA-9828211
NodeType: Pathway | PathwayName: Regulation of TLR by endogenous ligand | PathwayId: R-HSA-5686938
NodeType: Pathway | PathwayName: Regulation of TNFR1 signaling | PathwayId: R-HSA-5357905
NodeType: Pathway | PathwayName: Regulation of TP53 Activity | PathwayId: R-HSA-5633007
NodeType: Pathway | PathwayName: Regulation of TP53 Activity through Acetylation | PathwayId: R-HSA-6804758
NodeType: Pathway | PathwayName: Regulation of TP53 Activity through Association with Co-factors | PathwayId: R-HSA-6804759
NodeType: Pathway | PathwayName: Regulation of TP53 Activity through Methylation | PathwayId: R-HSA-6804760
NodeType: Pathway | PathwayName: Regulation of TP53 Activity through Phosphorylation | PathwayId: R-HSA-6804756
NodeType: Pathway | PathwayName: Regulation of TP53 Degradation | PathwayId: R-HSA-6804757
NodeType: Pathway | PathwayName: Regulation of TP53 Expression | PathwayId: R-HSA-6804754
NodeType: Pathway | PathwayName: Regulation of TP53 Expression and Degradation | PathwayId: R-HSA-6806003
NodeType: Pathway | PathwayName: Regulation of actin dynamics for phagocytic cup formation | PathwayId: R-HSA-2029482
NodeType: Pathway | PathwayName: Regulation of activated PAK-2p34 by proteasome mediated degradation | PathwayId: R-HSA-211733
NodeType: Pathway | PathwayName: Regulation of beta-cell development | PathwayId: R-HSA-186712
NodeType: Pathway | PathwayName: Regulation of cholesterol biosynthesis by SREBP (SREBF) | PathwayId: R-HSA-1655829
NodeType: Pathway | PathwayName: Regulation of commissural axon pathfinding by SLIT and ROBO | PathwayId: R-HSA-428542
NodeType: Pathway | PathwayName: Regulation of cortical dendrite branching | PathwayId: R-HSA-8985801
NodeType: Pathway | PathwayName: Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | PathwayId: R-HSA-446388
NodeType: Pathway | PathwayName: Regulation of endogenous retroelements | PathwayId: R-HSA-9842860
NodeType: Pathway | PathwayName: Regulation of endogenous retroelements by KRAB-ZFP proteins | PathwayId: R-HSA-9843940
NodeType: Pathway | PathwayName: Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | PathwayId: R-HSA-9845323
NodeType: Pathway | PathwayName: Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | PathwayId: R-HSA-9843970
NodeType: Pathway | PathwayName: Regulation of expression of SLITs and ROBOs | PathwayId: R-HSA-9010553
NodeType: Pathway | PathwayName: Regulation of gap junction activity | PathwayId: R-HSA-191650
NodeType: Pathway | PathwayName: Regulation of gene expression by Hypoxia-inducible Factor | PathwayId: R-HSA-1234158
NodeType: Pathway | PathwayName: Regulation of gene expression in beta cells | PathwayId: R-HSA-210745
NodeType: Pathway | PathwayName: Regulation of gene expression in early pancreatic precursor cells | PathwayId: R-HSA-210747
NodeType: Pathway | PathwayName: Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells | PathwayId: R-HSA-210746
NodeType: Pathway | PathwayName: Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | PathwayId: R-HSA-210744
NodeType: Pathway | PathwayName: Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | PathwayId: R-HSA-9634600
NodeType: Pathway | PathwayName: Tolerance of reactive oxygen produced by macrophages | PathwayId: R-HSA-1222387
NodeType: Pathway | PathwayName: Toll Like Receptor 10 (TLR10) Cascade | PathwayId: R-HSA-168142
NodeType: Pathway | PathwayName: Toll Like Receptor 2 (TLR2) Cascade | PathwayId: R-HSA-181438
NodeType: Pathway | PathwayName: Toll Like Receptor 3 (TLR3) Cascade | PathwayId: R-HSA-168164
NodeType: Pathway | PathwayName: Toll Like Receptor 4 (TLR4) Cascade | PathwayId: R-HSA-166016
NodeType: Pathway | PathwayName: Toll Like Receptor 5 (TLR5) Cascade | PathwayId: R-HSA-168176
NodeType: Pathway | PathwayName: Toll Like Receptor 7/8 (TLR7/8) Cascade | PathwayId: R-HSA-168181
NodeType: Pathway | PathwayName: Toll Like Receptor 9 (TLR9) Cascade | PathwayId: R-HSA-168138
NodeType: Pathway | PathwayName: Toll Like Receptor TLR1:TLR2 Cascade | PathwayId: R-HSA-168179
NodeType: Pathway | PathwayName: Toll Like Receptor TLR6:TLR2 Cascade | PathwayId: R-HSA-168188
NodeType: Pathway | PathwayName: Toll-like Receptor Cascades | PathwayId: R-HSA-168898
NodeType: Pathway | PathwayName: Toxicity of botulinum toxin type A (botA) | PathwayId: R-HSA-5250968
NodeType: Pathway | PathwayName: Toxicity of botulinum toxin type B (botB) | PathwayId: R-HSA-5250958
NodeType: Pathway | PathwayName: Toxicity of botulinum toxin type C (botC) | PathwayId: R-HSA-5250971
NodeType: Pathway | PathwayName: Toxicity of botulinum toxin type D (botD) | PathwayId: R-HSA-5250955
NodeType: Pathway | PathwayName: Toxicity of botulinum toxin type E (botE) | PathwayId: R-HSA-5250992
NodeType: Pathway | PathwayName: Toxicity of botulinum toxin type F (botF) | PathwayId: R-HSA-5250981
NodeType: Pathway | PathwayName: Toxicity of botulinum toxin type G (botG) | PathwayId: R-HSA-5250989
NodeType: Pathway | PathwayName: Toxicity of tetanus toxin (tetX) | PathwayId: R-HSA-5250982
NodeType: Pathway | PathwayName: Trafficking and processing of endosomal TLR | PathwayId: R-HSA-1679131
NodeType: Pathway | PathwayName: Trafficking of AMPA receptors | PathwayId: R-HSA-399719
NodeType: Pathway | PathwayName: Trafficking of GluR2-containing AMPA receptors | PathwayId: R-HSA-416993
NodeType: Pathway | PathwayName: Trafficking of myristoylated proteins to the cilium | PathwayId: R-HSA-5624138
NodeType: Pathway | PathwayName: Transcription from mitochondrial promoters | PathwayId: R-HSA-75944
NodeType: Pathway | PathwayName: Transcription of E2F targets under negative control by DREAM complex | PathwayId: R-HSA-1362277
NodeType: Pathway | PathwayName: Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | PathwayId: R-HSA-1362300
NodeType: Pathway | PathwayName: Transcription of SARS-CoV-1 sgRNAs | PathwayId: R-HSA-9682708
NodeType: Pathway | PathwayName: Transcription of SARS-CoV-2 sgRNAs | PathwayId: R-HSA-9694786
NodeType: Pathway | PathwayName: Transcription of the HIV genome | PathwayId: R-HSA-167172
NodeType: Pathway | PathwayName: Transcription-Coupled Nucleotide Excision Repair (TC-NER) | PathwayId: R-HSA-6781827
NodeType: Pathway | PathwayName: Transcriptional  activation of  cell cycle inhibitor p21 | PathwayId: R-HSA-69895
NodeType: Pathway | PathwayName: Transcriptional Regulation by E2F6 | PathwayId: R-HSA-8953750
NodeType: Pathway | PathwayName: Transcriptional Regulation by MECP2 | PathwayId: R-HSA-8986944
NodeType: Pathway | PathwayName: Transcriptional Regulation by NPAS4 | PathwayId: R-HSA-9634815
NodeType: Pathway | PathwayName: Transcriptional Regulation by TP53 | PathwayId: R-HSA-3700989
NodeType: Pathway | PathwayName: Transcriptional Regulation by VENTX | PathwayId: R-HSA-8853884
NodeType: Pathway | PathwayName: Transcriptional activation of mitochondrial biogenesis | PathwayId: R-HSA-2151201
NodeType: Pathway | PathwayName: Transcriptional activation of p53 responsive genes | PathwayId: R-HSA-69560
NodeType: Pathway | PathwayName: Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | PathwayId: R-HSA-2173793
NodeType: Pathway | PathwayName: Transcriptional and post-translational regulation of MITF-M expression and activity | PathwayId: R-HSA-9856649
NodeType: Pathway | PathwayName: Transcriptional regulation by RUNX1 | PathwayId: R-HSA-8878171
NodeType: Pathway | PathwayName: Transcriptional regulation by RUNX2 | PathwayId: R-HSA-8878166
NodeType: Pathway | PathwayName: Transcriptional regulation by RUNX3 | PathwayId: R-HSA-8878159
NodeType: Pathway | PathwayName: Transcriptional regulation by small RNAs | PathwayId: R-HSA-5578749
NodeType: Pathway | PathwayName: Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | PathwayId: R-HSA-8864260
NodeType: Pathway | PathwayName: Transcriptional regulation of brown and beige adipocyte differentiation | PathwayId: R-HSA-9843743
NodeType: Pathway | PathwayName: Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | PathwayId: R-HSA-9844594
NodeType: Pathway | PathwayName: Transcriptional regulation of granulopoiesis | PathwayId: R-HSA-9616222
NodeType: Pathway | PathwayName: Transcriptional regulation of pluripotent stem cells | PathwayId: R-HSA-452723
NodeType: Pathway | PathwayName: Transcriptional regulation of testis differentiation | PathwayId: R-HSA-9690406
NodeType: Pathway | PathwayName: Transcriptional regulation of white adipocyte differentiation | PathwayId: R-HSA-381340
NodeType: Pathway | PathwayName: Transfer of LPS from LBP carrier to CD14 | PathwayId: R-HSA-166020
NodeType: Pathway | PathwayName: Transferrin endocytosis and recycling | PathwayId: R-HSA-917977
NodeType: Pathway | PathwayName: Translation | PathwayId: R-HSA-72766
NodeType: Pathway | PathwayName: Translation initiation complex formation | PathwayId: R-HSA-72649
NodeType: Pathway | PathwayName: Translation of Accessory Proteins | PathwayId: R-HSA-9727281
NodeType: Pathway | PathwayName: Translation of Replicase and Assembly of the Replication Transcription Complex | PathwayId: R-HSA-9679504
NodeType: Pathway | PathwayName: Translation of Replicase and Assembly of the Replication Transcription Complex | PathwayId: R-HSA-9694676
NodeType: Pathway | PathwayName: Translation of Structural Proteins | PathwayId: R-HSA-9683701
NodeType: Pathway | PathwayName: Translation of Structural Proteins | PathwayId: R-HSA-9694635
NodeType: Pathway | PathwayName: Translation of respiratory syncytial virus mRNAs | PathwayId: R-HSA-9828721
NodeType: Pathway | PathwayName: Translesion Synthesis by POLH | PathwayId: R-HSA-110320
NodeType: Pathway | PathwayName: Translesion synthesis by POLI | PathwayId: R-HSA-5656121
NodeType: Pathway | PathwayName: Translesion synthesis by POLK | PathwayId: R-HSA-5655862
NodeType: Pathway | PathwayName: Translesion synthesis by REV1 | PathwayId: R-HSA-110312
NodeType: Pathway | PathwayName: Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | PathwayId: R-HSA-110313
NodeType: Pathway | PathwayName: Translocation of SLC2A4 (GLUT4) to the plasma membrane | PathwayId: R-HSA-1445148
NodeType: Pathway | PathwayName: Translocation of ZAP-70 to Immunological synapse | PathwayId: R-HSA-202430
NodeType: Pathway | PathwayName: Transmission across Chemical Synapses | PathwayId: R-HSA-112315
NodeType: Pathway | PathwayName: Transmission across Electrical Synapses | PathwayId: R-HSA-112307
NodeType: Pathway | PathwayName: Transport and synthesis of PAPS | PathwayId: R-HSA-174362
NodeType: Pathway | PathwayName: Transport of HA trimer, NA tetramer and M2 tetramer from the endoplasmic reticulum to the Golgi Apparatus | PathwayId: R-HSA-168874
NodeType: Pathway | PathwayName: Transport of Mature Transcript to Cytoplasm | PathwayId: R-HSA-72202
NodeType: Pathway | PathwayName: Transport of Mature mRNA Derived from an Intronless Transcript | PathwayId: R-HSA-159231
NodeType: Pathway | PathwayName: Transport of Mature mRNA derived from an Intron-Containing Transcript | PathwayId: R-HSA-159236
NodeType: Pathway | PathwayName: Transport of Mature mRNAs Derived from Intronless Transcripts | PathwayId: R-HSA-159234
NodeType: Pathway | PathwayName: Transport of RCbl within the body | PathwayId: R-HSA-9758890
NodeType: Pathway | PathwayName: Transport of Ribonucleoproteins into the Host Nucleus | PathwayId: R-HSA-168271
NodeType: Pathway | PathwayName: Transport of bile salts and organic acids, metal ions and amine compounds | PathwayId: R-HSA-425366
NodeType: Pathway | PathwayName: Transport of connexins along the secretory pathway | PathwayId: R-HSA-190827
NodeType: Pathway | PathwayName: Transport of connexons to the plasma membrane | PathwayId: R-HSA-190872
NodeType: Pathway | PathwayName: Transport of fatty acids | PathwayId: R-HSA-804914
NodeType: Pathway | PathwayName: Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus | PathwayId: R-HSA-159763
NodeType: Pathway | PathwayName: Transport of glycerol from adipocytes to the liver by Aquaporins | PathwayId: R-HSA-432030
NodeType: Pathway | PathwayName: Transport of inorganic cations/anions and amino acids/oligopeptides | PathwayId: R-HSA-425393
NodeType: Pathway | PathwayName: Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane | PathwayId: R-HSA-83936
NodeType: Pathway | PathwayName: Transport of nucleotide sugars | PathwayId: R-HSA-727802
NodeType: Pathway | PathwayName: Transport of organic anions | PathwayId: R-HSA-879518
NodeType: Pathway | PathwayName: Transport of small molecules | PathwayId: R-HSA-382551
NodeType: Pathway | PathwayName: Transport of the SLBP Dependant Mature mRNA | PathwayId: R-HSA-159230
NodeType: Pathway | PathwayName: Transport of the SLBP independent Mature mRNA | PathwayId: R-HSA-159227
NodeType: Pathway | PathwayName: Transport of vitamins, nucleosides, and related molecules | PathwayId: R-HSA-425397
NodeType: Pathway | PathwayName: Transport to the Golgi and subsequent modification | PathwayId: R-HSA-948021
NodeType: Pathway | PathwayName: Triglyceride biosynthesis | PathwayId: R-HSA-75109
NodeType: Pathway | PathwayName: Triglyceride catabolism | PathwayId: R-HSA-163560
NodeType: Pathway | PathwayName: Triglyceride metabolism | PathwayId: R-HSA-8979227
NodeType: Pathway | PathwayName: Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | PathwayId: R-HSA-450513
NodeType: Pathway | PathwayName: Truncations of AMER1 destabilize the destruction complex | PathwayId: R-HSA-5467348
NodeType: Pathway | PathwayName: Tryptophan catabolism | PathwayId: R-HSA-71240
NodeType: Pathway | PathwayName: Type I hemidesmosome assembly | PathwayId: R-HSA-446107
NodeType: Pathway | PathwayName: Type II Na+/Pi cotransporters | PathwayId: R-HSA-427589
NodeType: Pathway | PathwayName: Tyrosine catabolism | PathwayId: R-HSA-8963684
NodeType: Pathway | PathwayName: UCH proteinases | PathwayId: R-HSA-5689603
NodeType: Pathway | PathwayName: UNC93B1 deficiency - HSE | PathwayId: R-HSA-5602415
NodeType: Pathway | PathwayName: Ub-specific processing proteases | PathwayId: R-HSA-5689880
NodeType: Pathway | PathwayName: Ubiquinol biosynthesis | PathwayId: R-HSA-2142789
NodeType: Pathway | PathwayName: Ubiquitin Mediated Degradation of Phosphorylated Cdc25A | PathwayId: R-HSA-69601
NodeType: Pathway | PathwayName: Ubiquitin-dependent degradation of Cyclin D | PathwayId: R-HSA-75815
NodeType: Pathway | PathwayName: Unblocking of NMDA receptors, glutamate binding and activation | PathwayId: R-HSA-438066
NodeType: Pathway | PathwayName: Uncoating of the HIV Virion | PathwayId: R-HSA-162585
NodeType: Pathway | PathwayName: Uncoating of the Influenza Virion | PathwayId: R-HSA-168336
NodeType: Pathway | PathwayName: Unfolded Protein Response (UPR) | PathwayId: R-HSA-381119
NodeType: Pathway | PathwayName: Unwinding of DNA | PathwayId: R-HSA-176974
NodeType: Pathway | PathwayName: Uptake and actions of bacterial toxins | PathwayId: R-HSA-5339562
NodeType: Pathway | PathwayName: Uptake and function of anthrax toxins | PathwayId: R-HSA-5210891
NodeType: Pathway | PathwayName: Uptake and function of diphtheria toxin | PathwayId: R-HSA-5336415
NodeType: Pathway | PathwayName: Uptake of dietary cobalamins into enterocytes | PathwayId: R-HSA-9758881
NodeType: Pathway | PathwayName: Urea cycle | PathwayId: R-HSA-70635
NodeType: Pathway | PathwayName: Utilization of Ketone Bodies | PathwayId: R-HSA-77108
NodeType: Pathway | PathwayName: VEGF binds to VEGFR leading to receptor dimerization | PathwayId: R-HSA-195399
NodeType: Pathway | PathwayName: VEGF ligand-receptor interactions | PathwayId: R-HSA-194313
NodeType: Pathway | PathwayName: VEGFA-VEGFR2 Pathway | PathwayId: R-HSA-4420097
NodeType: Pathway | PathwayName: VEGFR2 mediated cell proliferation | PathwayId: R-HSA-5218921
NodeType: Pathway | PathwayName: VEGFR2 mediated vascular permeability | PathwayId: R-HSA-5218920
NodeType: Pathway | PathwayName: VLDL assembly | PathwayId: R-HSA-8866423
NodeType: Pathway | PathwayName: VLDL clearance | PathwayId: R-HSA-8964046
NodeType: Pathway | PathwayName: VLDLR internalisation and degradation | PathwayId: R-HSA-8866427
NodeType: Pathway | PathwayName: Variant SLC6A14 may confer susceptibility towards obesity | PathwayId: R-HSA-5619094
NodeType: Pathway | PathwayName: Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) | PathwayId: R-HSA-5619101
NodeType: Pathway | PathwayName: Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) | PathwayId: R-HSA-5660686
NodeType: Pathway | PathwayName: Vasopressin regulates renal water homeostasis via Aquaporins | PathwayId: R-HSA-432040
NodeType: Pathway | PathwayName: Vasopressin-like receptors | PathwayId: R-HSA-388479
NodeType: Pathway | PathwayName: Vesicle-mediated transport | PathwayId: R-HSA-5653656
NodeType: Pathway | PathwayName: Vif-mediated degradation of APOBEC3G | PathwayId: R-HSA-180585
NodeType: Pathway | PathwayName: Viral Infection Pathways | PathwayId: R-HSA-9824446
NodeType: Pathway | PathwayName: Viral Messenger RNA Synthesis | PathwayId: R-HSA-168325
NodeType: Pathway | PathwayName: Viral RNP Complexes in the Host Cell Nucleus | PathwayId: R-HSA-168330
NodeType: Pathway | PathwayName: Viral mRNA Translation | PathwayId: R-HSA-192823
NodeType: Pathway | PathwayName: Virion Assembly and Release | PathwayId: R-HSA-9694322
NodeType: Pathway | PathwayName: Virion Assembly and Release | PathwayId: R-HSA-9679509
NodeType: Pathway | PathwayName: Virus Assembly and Release | PathwayId: R-HSA-168268
NodeType: Pathway | PathwayName: Visual phototransduction | PathwayId: R-HSA-2187338
NodeType: Pathway | PathwayName: Vitamin B1 (thiamin) metabolism | PathwayId: R-HSA-196819
NodeType: Pathway | PathwayName: Vitamin B2 (riboflavin) metabolism | PathwayId: R-HSA-196843
NodeType: Pathway | PathwayName: Vitamin B5 (pantothenate) metabolism | PathwayId: R-HSA-199220
NodeType: Pathway | PathwayName: Vitamin B6 activation to pyridoxal phosphate | PathwayId: R-HSA-964975
NodeType: Pathway | PathwayName: Vitamin C (ascorbate) metabolism | PathwayId: R-HSA-196836
NodeType: Pathway | PathwayName: Vitamin D (calciferol) metabolism | PathwayId: R-HSA-196791
NodeType: Pathway | PathwayName: Vitamin E | PathwayId: R-HSA-8877627
NodeType: Pathway | PathwayName: Vitamins | PathwayId: R-HSA-211916
NodeType: Pathway | PathwayName: Voltage gated Potassium channels | PathwayId: R-HSA-1296072
NodeType: Pathway | PathwayName: Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization | PathwayId: R-HSA-180897
NodeType: Pathway | PathwayName: Vpr-mediated nuclear import of PICs | PathwayId: R-HSA-180910
NodeType: Pathway | PathwayName: Vpu mediated degradation of CD4 | PathwayId: R-HSA-180534
NodeType: Pathway | PathwayName: VxPx cargo-targeting to cilium | PathwayId: R-HSA-5620916
NodeType: Pathway | PathwayName: WNT ligand biogenesis and trafficking | PathwayId: R-HSA-3238698
NodeType: Pathway | PathwayName: WNT mediated activation of DVL | PathwayId: R-HSA-201688
NodeType: Pathway | PathwayName: WNT5:FZD7-mediated leishmania damping | PathwayId: R-HSA-9673324
NodeType: Pathway | PathwayName: WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | PathwayId: R-HSA-5140745
NodeType: Pathway | PathwayName: WNT5A-dependent internalization of FZD4 | PathwayId: R-HSA-5099900
NodeType: Pathway | PathwayName: Wax and plasmalogen biosynthesis | PathwayId: R-HSA-8848584
NodeType: Pathway | PathwayName: Wax biosynthesis | PathwayId: R-HSA-9640463
NodeType: Pathway | PathwayName: XAV939 stabilizes AXIN | PathwayId: R-HSA-5545619
NodeType: Pathway | PathwayName: XBP1(S) activates chaperone genes | PathwayId: R-HSA-381038
NodeType: Pathway | PathwayName: Xenobiotics | PathwayId: R-HSA-211981
NodeType: Pathway | PathwayName: YAP1- and WWTR1 (TAZ)-stimulated gene expression | PathwayId: R-HSA-2032785
NodeType: Pathway | PathwayName: Z-decay: degradation of maternal mRNAs by zygotically expressed factors | PathwayId: R-HSA-9820865
NodeType: Pathway | PathwayName: ZBP1(DAI) mediated induction of type I IFNs | PathwayId: R-HSA-1606322
NodeType: Pathway | PathwayName: Zinc efflux and compartmentalization by the SLC30 family | PathwayId: R-HSA-435368
NodeType: Pathway | PathwayName: Zinc influx into cells by the SLC39 gene family | PathwayId: R-HSA-442380
NodeType: Pathway | PathwayName: Zinc transporters | PathwayId: R-HSA-435354
NodeType: Pathway | PathwayName: Zygotic genome activation (ZGA) | PathwayId: R-HSA-9819196
NodeType: Pathway | PathwayName: activated TAK1 mediates p38 MAPK activation | PathwayId: R-HSA-450302
NodeType: Pathway | PathwayName: alectinib-resistant ALK mutants | PathwayId: R-HSA-9717316
NodeType: Pathway | PathwayName: alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | PathwayId: R-HSA-2046104
NodeType: Pathway | PathwayName: alpha-linolenic acid (ALA) metabolism | PathwayId: R-HSA-2046106
NodeType: Pathway | PathwayName: betaKlotho-mediated ligand binding | PathwayId: R-HSA-1307965
NodeType: Pathway | PathwayName: brigatinib-resistant ALK mutants | PathwayId: R-HSA-9717319
NodeType: Pathway | PathwayName: cGMP effects | PathwayId: R-HSA-418457
NodeType: Pathway | PathwayName: cRNA Synthesis | PathwayId: R-HSA-192869
NodeType: Pathway | PathwayName: ceritinib-resistant ALK mutants | PathwayId: R-HSA-9717323
NodeType: Pathway | PathwayName: crenolanib-resistant FLT3 mutants | PathwayId: R-HSA-9702581
NodeType: Pathway | PathwayName: crizotinib-resistant ALK mutants | PathwayId: R-HSA-9717326
NodeType: Pathway | PathwayName: eNOS activation | PathwayId: R-HSA-203615
NodeType: Pathway | PathwayName: gilteritinib-resistant FLT3 mutants | PathwayId: R-HSA-9702590
NodeType: Pathway | PathwayName: lestaurtinib-resistant FLT3 mutants | PathwayId: R-HSA-9702596
NodeType: Pathway | PathwayName: linifanib-resistant FLT3 mutants | PathwayId: R-HSA-9702998
NodeType: Pathway | PathwayName: lorlatinib-resistant ALK mutants | PathwayId: R-HSA-9717329
NodeType: Pathway | PathwayName: mRNA 3'-end processing | PathwayId: R-HSA-72187
NodeType: Pathway | PathwayName: mRNA Capping | PathwayId: R-HSA-72086
NodeType: Pathway | PathwayName: mRNA Editing | PathwayId: R-HSA-75072
NodeType: Pathway | PathwayName: mRNA Editing: A to I Conversion | PathwayId: R-HSA-75064
NodeType: Pathway | PathwayName: mRNA Editing: C to U Conversion | PathwayId: R-HSA-72200
NodeType: Pathway | PathwayName: mRNA Splicing | PathwayId: R-HSA-72172
NodeType: Pathway | PathwayName: mRNA Splicing - Major Pathway | PathwayId: R-HSA-72163
NodeType: Pathway | PathwayName: mRNA Splicing - Minor Pathway | PathwayId: R-HSA-72165
NodeType: Pathway | PathwayName: mRNA decay by 3' to 5' exoribonuclease | PathwayId: R-HSA-429958
NodeType: Pathway | PathwayName: mRNA decay by 5' to 3' exoribonuclease | PathwayId: R-HSA-430039
NodeType: Pathway | PathwayName: mTORC1-mediated signalling | PathwayId: R-HSA-166208
NodeType: Pathway | PathwayName: midostaurin-resistant FLT3 mutants | PathwayId: R-HSA-9702600
NodeType: Pathway | PathwayName: mitochondrial fatty acid beta-oxidation of saturated fatty acids | PathwayId: R-HSA-77286
NodeType: Pathway | PathwayName: mitochondrial fatty acid beta-oxidation of unsaturated fatty acids | PathwayId: R-HSA-77288
NodeType: Pathway | PathwayName: p130Cas linkage to MAPK signaling for integrins | PathwayId: R-HSA-372708
NodeType: Pathway | PathwayName: p38MAPK events | PathwayId: R-HSA-171007
NodeType: Pathway | PathwayName: p53-Dependent G1 DNA Damage Response | PathwayId: R-HSA-69563
NodeType: Pathway | PathwayName: p53-Dependent G1/S DNA damage checkpoint | PathwayId: R-HSA-69580
NodeType: Pathway | PathwayName: p53-Independent DNA Damage Response | PathwayId: R-HSA-69610
NodeType: Pathway | PathwayName: p53-Independent G1/S DNA damage checkpoint | PathwayId: R-HSA-69613
NodeType: Pathway | PathwayName: p75 NTR receptor-mediated signalling | PathwayId: R-HSA-193704
NodeType: Pathway | PathwayName: p75NTR negatively regulates cell cycle via SC1 | PathwayId: R-HSA-193670
NodeType: Pathway | PathwayName: p75NTR recruits signalling complexes | PathwayId: R-HSA-209543
NodeType: Pathway | PathwayName: p75NTR regulates axonogenesis | PathwayId: R-HSA-193697
NodeType: Pathway | PathwayName: p75NTR signals via NF-kB | PathwayId: R-HSA-193639
NodeType: Pathway | PathwayName: pexidartinib-resistant FLT3 mutants | PathwayId: R-HSA-9702605
NodeType: Pathway | PathwayName: phospho-PLA2 pathway | PathwayId: R-HSA-111995
NodeType: Pathway | PathwayName: ponatinib-resistant FLT3 mutants | PathwayId: R-HSA-9702614
NodeType: Pathway | PathwayName: quizartinib-resistant FLT3 mutants | PathwayId: R-HSA-9702620
NodeType: Pathway | PathwayName: rRNA modification in the mitochondrion | PathwayId: R-HSA-6793080
NodeType: Pathway | PathwayName: rRNA modification in the nucleus and cytosol | PathwayId: R-HSA-6790901
NodeType: Pathway | PathwayName: rRNA processing | PathwayId: R-HSA-72312
NodeType: Pathway | PathwayName: rRNA processing in the mitochondrion | PathwayId: R-HSA-8868766
NodeType: Pathway | PathwayName: rRNA processing in the nucleus and cytosol | PathwayId: R-HSA-8868773
NodeType: Pathway | PathwayName: semaxanib-resistant FLT3 mutants | PathwayId: R-HSA-9702577
NodeType: Pathway | PathwayName: snRNP Assembly | PathwayId: R-HSA-191859
NodeType: Pathway | PathwayName: sorafenib-resistant FLT3 mutants | PathwayId: R-HSA-9702624
NodeType: Pathway | PathwayName: sunitinib-resistant FLT3 mutants | PathwayId: R-HSA-9702632
NodeType: Pathway | PathwayName: t(4;14) translocations of FGFR3 | PathwayId: R-HSA-2033515
NodeType: Pathway | PathwayName: tRNA Aminoacylation | PathwayId: R-HSA-379724
NodeType: Pathway | PathwayName: tRNA modification in the mitochondrion | PathwayId: R-HSA-6787450
NodeType: Pathway | PathwayName: tRNA modification in the nucleus and cytosol | PathwayId: R-HSA-6782315
NodeType: Pathway | PathwayName: tRNA processing | PathwayId: R-HSA-72306
NodeType: Pathway | PathwayName: tRNA processing in the mitochondrion | PathwayId: R-HSA-6785470
NodeType: Pathway | PathwayName: tRNA processing in the nucleus | PathwayId: R-HSA-6784531
NodeType: Pathway | PathwayName: tRNA-derived small RNA (tsRNA or tRNA-related fragment, tRF) biogenesis | PathwayId: R-HSA-9708296
NodeType: Pathway | PathwayName: tamatinib-resistant FLT3 mutants | PathwayId: R-HSA-9703009
NodeType: Pathway | PathwayName: tandutinib-resistant FLT3 mutants | PathwayId: R-HSA-9702636
NodeType: Pathway | PathwayName: trans-Golgi Network Vesicle Budding | PathwayId: R-HSA-199992
NodeType: Pathway | PathwayName: vRNA Synthesis | PathwayId: R-HSA-192814
NodeType: Pathway | PathwayName: vRNP Assembly | PathwayId: R-HSA-192905
